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Abstract 
This thesis focuses on the synthesis of a variety of heterocycles and carbocycles such as 
pyrrolidines, dihydrofurans, dihydropyrroles, cyclopentenes, and 2,5-dihydrooxepines. 
Traditional synthetic methods are discussed first, followed by the manipulation of donor-
acceptor cyclopropanes towards the above-mentioned compounds. This leads to a discussion 
about an important pyrrolidine-containing natural product known as kainic acid. Kainic acid 
has been studied in the neuroscience field for its biological properties which have led to a 
better understanding of common human neurological disorders like epilepsy, Huntington’s 
disease and the after-effects of strokes.  
Chapter two focuses on a common rearrangement of donor-acceptor cyclopropanes known as 
the Cloke-Wilson reaction. Without isolating the desired cyclopropane, two modes of 
reactivity were observed which depended solely on the choice of starting reagent. The first 
was the traditional Cloke-Wilson rearrangement generating dihydrofurans and the second 
was a vinylogous variant forming 2,5-dihydrooxepines. It was discovered that with careful 
choice of Lewis acid or transition metal catalysts, each of the obtained compounds can be 
manipulated to other dihydrofuran derivatives or dihydropyrrole heterocycles. One of the 
dihydropyrrole compounds obtained was deemed as a viable synthetic precursor towards 
kainic acid. 
Chapter three describes the synthetic efforts towards kainic acid utilizing the methodology 
from chapter two. The difficulties towards this natural molecule will be presented with the 
major issue resulting from stereochemical constraints. This resulted in the successful 
synthesis of β-allokainic acid which is one of the less active isomers of naturally occurring 
kainic acid.  
Chapter four discloses a single-step manipulation of the dihydrofurans synthesized via 
Cloke-Wilson rearrangement to their corresponding cyclopentenes. Extensive screening of 
Lewis acids and solvents provided insights into the possible mechanism of this reaction. 
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Lay Audience Abstract 
This thesis describes the synthesis of molecules known as carbocycles and heterocycles. 
These types of compounds are abundant in products obtained from natural sources and are 
highly sought in the pharmaceutical industry. Finding new ways of synthesizing carbocycles 
and heterocycles is always in high demand. Common synthetic procedures are discussed, 
followed by how cyclopropanes can be utilized towards the mentioned compounds. This 
leads to a discussion about a heterocycle-containing natural product known as kainic acid. 
The biological properties of this compound were studied which lead to a better understanding 
of common human neurological disorders such as epilepsy, Huntington’s disease and the 
after-effects of strokes. 
Chapter two focuses on a common reaction involving cyclopropanes and their rearrangement 
to heterocycles of value. The reaction proceeds by a famous transformation known as the 
Cloke-Wilson rearrangement. It was discovered that with a careful choice of catalyst, each of 
the compounds can be manipulated to other heterocycles that are seen in desired 
pharmaceuticals and natural products. We determined one of the compounds to be a useful 
starting reagent towards the synthesis of kainic acid. 
Chapter three describes the synthetic efforts towards kainic acid. Initial synthetic problems 
are discussed with the most significant issue arising once the relative three-dimensional 
arrangement of atoms on a specific intermediate was determined, also known as 
stereochemistry. Attempts at obtaining the correct stereochemistry failed which resulted in 
the synthesis of one of the isomers of kainic acid known as β-allokainic acid.  
Chapter four discloses the rearrangement of products obtained in chapter two to their 
corresponding cyclopentene derivatives. An extensive testing of catalysts and solvents were 
preformed which helped obtain the cyclopentenes in high yields and provided insights into 
the possible mechanism of the rearrangement.     
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Chapter 1  
1 The Importance of Heterocycles and Carbocycles in 
Life and Synthesis 
Structures that are studied for their important biological properties, whether isolated from 
natural sources or synthesized in the lab, typically have one or more cyclic motifs either 
fused together or connected by a small linker chain1–3. Due to the rigidity of cyclic 
structures, better interactions with the binding sites are typically obtained since the active 
conformation is locked in place. Acyclic systems however, contain multiple rotating 
bonds resulting in many different conformations, only one of which results in the desired 
binding interaction3. Therefore, ideal pharmaceutical candidates contain heterocyclic or 
carbocyclic structures. 
Cyclic compounds are extremely important for normal life functions1,2,4. DNA, which 
contains the genetic information of all life forms on our planet, is made of heterocyclic 
compounds, nucleic acids and carbohydrates (Figure 1-1a). Amino acids, which are the 
building blocks of proteins also contain several cyclic motifs (Figure 1-1b). Important 
porphyrins, which are heterocyclic macrocycles, such as chlorophyll-a and heme are vital 
compounds for photosynthesis and the transfer of oxygen to body tissues respectively 
(Figure 1-1c). Drugs that many people take on a regular basis to maintain a healthy 
lifestyle like vitamins are all composed of heterocyclic systems (Figure 1-1d). 
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Figure 1-1. Important biological compounds. [a] Nucleic acids and carbohydrate segment of DNA. 
[b] Amino acids. [c] Heterocyclic macrocycles responsible for photosynthesis and transfer of oxygen 
to blood. [d] Vitamins 
Since cyclic structures are so important in life and highly desirable in the pharmaceutical 
industry, ways of synthesizing hetero- and carbocycles is one of the most explored fields 
of organic chemistry. New methodologies are published on a regular basis that can 
provide easy access to complex cyclic motifs towards natural product synthesis or for 
pharmaceutical studies. From the vast array of hetero- and carbocycles, only a select few 
are discussed in this dissertation. This includes five-membered carbo- and heterocyclic 
rings and seven-membered oxacycles (Figure 1-2). Examples of such structures in natural 
products and pharmaceuticals will be presented. 
 
Figure 1-2. The hetero- and carbocycles of interest 
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1.1 Synthesis of Five-Membered Carbocycles and 
Heterocycles 
1.1.1 Synthesis of Pyrrolidines 
Pyrrolidines are among the most important heterocyclic compounds that are featured in a 
wide array of naturally occurring and synthesized compounds that contain many 
biological properties.5–7 (Figure 1-3a). Paraherquamide A8 (1-10) is a potent anthelmintic 
agent with activity against drug resistant intestinal parasites. γ-Carboxyglutamic 
derivatives9 (1-11) have been shown to be useful towards the synthesis of neuroprotective 
agents. Kainic acid10 (1-12) possesses important neuroexcitatory properties that will be 
discussed in greater detail in the upcoming sections. Enantiomerically pure pyrrolidines 
(1-13 to 1-15) also have a dominant role as organocatalysts11,12 (Figure 1-3b).  
 
Figure 1-3. [a] Select examples of naturally occurring and synthetically made compounds with 
biological properties. [b] Examples of organocatalysts. 
Thus, discovering ways of synthesizing pyrrolidines can have a great impact in synthetic 
and pharmaceutical communities. The most common synthetic strategy of forming the 
pyrrolidine core is by [3+2]-cycloaddition and annulation chemistry.11–19 
Recently, Singh and co-workers showed a synthesis of pyrrolidines rings (1-18) by a 
[3+2]-cycloaddition between α,β-unsaturated pyrazolamide (1-16) and azomethine ylides 
(1-17) using a Ag(I) catalyst and chiral ligand (1-19) (Scheme 1-1).20   
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Scheme 1-1. Diastereo- and enantioselective synthesis of highly substituted pyrrolidines using a chiral 
Ag(I) catalyst 
The pyrrolidines synthesized contained four contiguous stereogenic centers and were 
produced in excellent diastereoselectivity, high yields, and enantioselectivities. The group 
also showcased transformations of the pyrrolidine products to various synthetically useful 
advanced intermediates.  
Since the first introduction of Pd-trimethylenemethane (Pd-TMM) complexes by Trost 
and Chan21, their utility as three-carbon synthons for [3+2]-cycloaddition chemistry has 
grown significantly with the formation of a variety of carbo- and heterocycles of various 
ring sizes.16,17,22,23 Trost et al. recently published an enantioselective synthesis of 
pyrrolidines (1-22) containing a quaternary center with the first use of disubstituted 
donors (1-20) in a Pd-TMM cycloaddition with imines (1-21).24 The reaction was made 
possible with the use of diamidophosphite ligands (1-23 and 1-24) (Scheme 1-2).   
 
Scheme 1-2. Pd-TMM cycloaddition with disubstituted TMM-donors and imines forming 
enantioselective pyrrolidines containing quaternary centers 
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Continuing with the synthesis of pyrrolidines containing quaternary centers, Chandra Pan 
and co-workers utilized an organocatalyzed double Michael addition/annulation 
chemistry towards highly enantioselective pyrrolidines.25 Using a cinchonidine derived 
bifunctional amino-squaramide catalyst (1-28), both N-tosyl amino-methyl enones (1-25) 
and trans-α-cyano-α,β-unsaturated ketones (1-26) were activated simultaneously towards 
a double Michael addition reaction to form pyrrolidines (1-27) (Scheme 1-3).  
 
Scheme 1-3. Organocatalyzed enantioselective double Michael addition towards highly substituted 
pyrrolidines 
Although not enantioselective, Kang and co-workers were able to show the conversion of 
2,3-dihydroisoxazoles (1-29) to fully substituted pyrrolidines (1-31) through an iridium-
complex catalyzed N-O bond cleavage/rearrangement/cyclization of (1-29) with various 
alkenes (1-30)26 (Scheme 1-4).  
 
Scheme 1-4. Single step transformation of 1,3-dihydroisoxazoles to pyrrolidines 
The reaction was found to work with a variety of substrates bearing aromatic 
substituents; however, any alkyl substituents except for (R3) resulted in no observed 
product. The iridium catalyst used could be recycled up to seven times with only a slight 
drop in yield which can be advantageous in industrial-scale reactions. 
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1.1.2 Synthesis of Dihydropyrroles 
Similar to pyrrolidines, except with an extra unit of unsaturation, dihydropyrroles are 
another class of five-membered heterocycles that have a prominent role in natural 
products and pharmaceuticals (Figure 1-4). Anthramycin (1-32) has been shown to 
interact in the minor groove of DNA to form covalent bonds with guanine bases. This 
interrupts biological processes that involve transcription factors and RNA polymerase 
which can aid in the treatment of various cancers.27 Dihydropyrrole (1-33) has been 
proven to inhibit protein geranylgeranyltransferase type I which is an enzyme that is 
important for the regulation of many protein functions.28,29 Dihydropyrrole (1-34) is an 
example of nonpeptide peptidomimetics which are an important class of compounds that 
mimic natural peptide strands and overcome the limitations of these peptides in 
therapeutic interventions.30  
 
Figure 1-4. Natural and synthetic dihydropyrroles with important biological properties 
Dihydropyrroles are commonly synthesized through cycloaddition and annulation 
chemistry. However, cycloisomerization reactions are also prevalent. Wender et al. were 
able to showcase the formation of dihydropyrroles (1-37) by treating aziridines (1-35) 
with silver or Bronsted acid catalysts. This resulted in the formation of 1,3-dipoles which 
reacted with a variety of alkynes (1-36) in a formal [3+2]-cycloaddition.31 The reaction 
was shown to be highly regioselective (Scheme 1-5).   
 
Scheme 1-5. Highly regioselective formation of dihydropyrroles through a formal [3+2]-cycloaddition 
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Asymmetric formal cycloadditions towards dihydropyrrole derivatives are also possible. 
Recently, Guo and co-workers performed a Ph3P catalyzed [3+2]-cycloaddition with 
sulfamate derived cyclic imines (1-38) and allenoates (1-39) forming sulfamate fused 
dihydropyrroles (1-40) in high yields.32 Using a phosphine chiral catalyst (1-41), an 
asymmetric version was developed forming the desired products in high enantiomeric 
purity (1-42) (Scheme 1-6). Sulfamate fused dihydropyrroles are interesting heterocycles 
that could potentially be used in the pharmaceutical industry.33 
 
Scheme 1-6. Phosphine catalyzed [3+2]-cycloaddition of sulfamate derived cyclic imines with 
allenoates 
As mentioned above, cycloisomerizations are another common technique used towards 
dihydropyrrole synthesis. Ye and co-workers performed a gold catalyzed 
cycloisomerization of chiral homopropargyl sulfonamides (1-43) forming enantiopure 
dihydropyrroles (1-44)34 (Scheme 1-7). The reaction proceeded through an anti-
Markovnikov addition. With careful examination of reaction conditions, the authors 
determined that adding a catalytic amount of base suppressed an undesirable dimerization 
reaction.35 
 
Scheme 1-7. Cycloisomerization reaction producing enantiopure dihydropyrroles 
Multicomponent reactions (MCRs) are useful techniques that involve the reaction of 
three or more reactants in a single reaction vessel to produce a single product containing 
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majority of the reactants.36 MCRs are a great way to form a variety of complex 
heterocycles and carbocycles since the reaction is highly chemo- and regioselective, atom 
economical, and step efficient.36 Miranda et al. were able to show a four component Ugi 
reaction forming a propargyl-Ugi product (1-49). This was then treated with a strong base 
forming a Ugi-allenamide intermediate (1-50) that underwent a cycloisomerization to 
form dihydropyrrole derivatives (1-51)37 (Scheme 1-8).  
 
Scheme 1-8. Four component Ugi reaction followed by base mediated cycloisomerization towards 
dihydropyrrole derivatives 
The utility of this transformation has been expanded by synthesizing advanced 
intermediates in a single step (Scheme 1-9). Using dihydropyrrole (1-52), the group was 
able to form a bicyclic structure (1-53) by performing a Heck cross-coupling reaction. 2-
arylpyrrolidine (1-54) was formed through a reduction using triethylsilane hydride which 
are pharmacologically important compounds.38 
 
Scheme 1-9. Subsequent transformations of dihydropyrroles 
Another interesting MCR was developed by Gong et al. resulting in the first catalytic 
asymmetric formal [3+2] cycloaddition of electron deficient alkynes and azomethine 
ylides under chiral phosphoric acid conditions.39 The use of various aldehydes (1-56) and 
α-amino esters (1-57) generated the desired azomethine ylide in-situ which reacted with 
various alkynes (1-55) forming dihydropyrrole (1-58) derivatives in high yields and high 
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enantioselectivities (Scheme 1-10). Compound (1-59) showed to have potential 
bioactivities in vitro against mammary carcinoma cell line, MCF7.   
 
Scheme 1-10. First catalytic asymmetric formal [3+2]-cycloaddition using electron deficient alkynes 
and azomethine ylides to form dihydropyrroles 
DFT studies showed that the chiral phosphoric acid has a duel role in the reaction: it 
behaves as a Bronsted acid and Lewis base (Scheme 1-11). The alkyne becomes more 
electron deficient once the carbonyl oxygen interacted with the OH group on the 
phosphorus through H-bonding. Simultaneously, the anion of the azomethine ylide 
became more reactive through H-bonding between the N-H of the ylide and the Lewis 
basic phosphoryl oxygen (1-60). This resulted in a conjugate addition of the azomethine 
ylide to the alkyne followed by a Mannich-type cyclization (1-61) forming 
dihydropyrrole (1-62).  
 
Scheme 1-11. Proposed mechanism towards dihydropyrrole formation showcasing the dual role of 
the chiral phosphoric acid 
1.1.3 Synthesis of Dihydrofurans 
Dihydrofurans are found in numerous natural products and pharmaceuticals but also 
serve as precursors in an array of organic transformations.40,41 Radical-induced 
cyclizations between 1,3-dicarbonyl species or similar variants and alkenes is a common 
way of synthesizing dihydrofurans. Nishino and co-workers reported an oxidative radical 
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cyclization of a variety of 1,3-dicarbonyl compounds (1-63) and 1,1-diarylethene (1-64) 
promoted by Mn(OAc)3 in an AcOH-HCO2H media forming dihydrofurans containing a 
quaternary center (1-65) (Scheme 1-12).42 
 
Scheme 1-12. Oxidative radical cyclization forming dihydrofuran derivatives 
The addition of formic acid results in increased reaction rates and yields. The explanation 
of the rate enhancement with the addition of a secondary strong acid was explained by 
Kochi (Scheme 1-13).43 Under typical reaction conditions involving acetic acid (AcOH), 
complex A is thought to undergo ligand exchange with the 1,3-dicarbonyl species 
generating Mn(III)-enolate complex, which was found to be the rate-limiting step. 
However, with the introduction of formic acid, ligand exchange between complex A 
occurs forming complex C. Due to the production of both ion-pair and cationic Mn(III) 
species, the reactivity of the intermediate is increased resulting in a rate-enhancement for 
the 1,3-dicarbonyl ligand exchange forming complex D. This is followed by two SET 
additions that resulted in carbocation G which underwent cyclization forming the final 
product H.     
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Scheme 1-13. Rate-enhancement of the oxidative radical cyclization with the introduction of formic 
acid 
In a similar reaction, Yilmaz and co-workers performed an oxidative radical cyclization 
between 3-oxopropanenitriles (1-66) and various alkenes (1-67) induced by Mn(OAc)3 
which furnished a variety of 3-cyanodihydrofuran derivatives (1-68) (Scheme 1-14).44  
 
Scheme 1-14. Formation of 3-cyanodihydrofuran derivatives via oxidative radical cyclization 
Biological studies were conducted with the compounds synthesized against a variety of 
Gram-positive and Gram-negative bacteria. The results obtained showed that all 3-
cyanodihydrofuran derivatives had stronger antimicrobial activity against the bacteria 
studied when comparing to more traditional antibiotics such as the β-lactams or 
tetracyclines. 
The main limitation of performing these and similar reactions is the need to use large 
excess of transition metal oxidants, which upon scale-up can be costly. With recent 
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reports of iodine serving as an alternative catalyst to transition metals in many 
reactions45, the group of Lei wanted to see if they could substitute the typical transition 
metals used in oxidative radical cyclizations between 1,3-dicarbonyls (1-69) and alkenes 
(1-70) with iodine to form various dihydrofuran compounds (1-71).46 After screening 
many conditions, it was found that I2 and tert-butyl peroxybenzoate (TBPB), with 
NaOAc as an additive, furnished dihydrofurans in good yields (Scheme 1-15). 
 
Scheme 1-15. The use of iodine towards an oxidative radical cyclization 
1.1.4 Synthesis of Cyclopentenes 
Although heterocyclic compounds have a greater presence in the pharmaceutical 
industries than their carbocyclic counterparts, cyclopentane and cyclopentene motifs have 
been utilized as the main scaffold in several medicinally active compounds.47–49 The five 
membered carbocycle is also present in many naturally occurring compounds each with 
their own unique biological properties.47,49–51 Many of these compounds contain highly 
substituted cyclo-pentane or -pentene cores, thus synthetic efforts for synthesizing 
complex five membered carbocycles gained considerable interest in the chemical 
community. There are a number of different ways that five-membered carbocycles can be 
synthesized: cycloaddition reactions, electrocyclizations, transition metal mediated 
cyclizations, rearrangements, and Aldol-type reactions.51 
The presence of functionalized cyclopentenes in natural products or pharmaceuticals is 
limited compared to its saturated counterpart; however, the ability to synthesize 
cyclopentene cores can serve as key intermediates towards cyclopentane motifs. An 
important example is the synthesis of vicinal 2-arylated cyclopentenylamines.48 The work 
by Zhang et al. showcased the formation of such cyclopentenes (1-74) by performing a 
Rh(III) catalyzed directing group (DG) assisted C-H functionalization of arenes (1-73) 
and desymmetrization of diazabicycles (1-72) (Scheme 1-16).48 The products were 
obtained under mild conditions and high yields. 
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Scheme 1-16. Rh(III)-catalyzed C-H activation/desymmetrization of diazabicycles with arenes 
towards the synthesis of functionalized cyclopentenes 
Recently, the Lopez group reported the synthesis of functionalized cyclopentenes (1-77) 
by reacting vinylazides (1-76) with alkenyldiazo compounds (1-75) in the presence of a 
copper catalyst in a formal [3+2]-cycloaddition/allylic azide rearrangement (Scheme 1-
17)52. 
 
Scheme 1-17. [3+2]-cycloaddition/allylic azide rearrangement towards cyclopentenes 
The first step in the proposed mechanism involves generation of a copper carbene 
complex (1-79) (Scheme 1-18). The vinylazide (1-80) reacted with the carbene complex 
as an enamine-type nucleophile forming intermediate (1-81) followed by cyclization 
generating cycloadduct (1-82). This cycloadduct underwent a [3+3]-sigmatropic 
isomerization forming the final product (1-83). 
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Scheme 1-18. Proposed mechanism towards cyclopentene formation 
Due to the retention of the azide functionality, further chemical manipulations were 
studied. Under Staudinger conditions, the azide (1-84) was reduced to the amino 
derivative (1-85). An azide-click reaction was also performed forming triazole derivative 
(1-86) and this reaction was efficiently executed in a one-pot fashion (Scheme 1-19).   
 
Scheme 1-19. Manipulations of the azide functionality to amino and triazole derivatives 
Cycloadditions involving metal-free conditions can provide easy access to complex 
products in a cost-effective process. Recently, Li and co-workers were able to show the 
synthesis of highly substituted cyclopentenes (1-87) or indenes (1-88) via a metal-free 
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oxidative decarbonylative [3+2]-annulation of terminal alkynes (1-89) with tertiary alkyl 
aldehydes (1-90a,b) (Scheme 1-20)53. 
 
Scheme 1-20. Metal free oxidative decarbonylation, [3+2]-annulation between tertiary aldehydes and 
terminal alkynes towards functionalized cyclopentenes and indenes 
The reactions worked well with a variety of (hetero)aryl and alkyl alkynes, as well as 
with a variety of alkyl aldehydes. Secondary alkyl aldehydes failed to provide any desired 
products and the reaction temperature seemed to play an important role as small 
deviations from 100 °C resulted in irreproducible results.  
1.2 Synthesis of Seven-Membered Oxacycles 
Compounds containing a seven membered oxacycle are found in numerous natural 
products that were found to possess antiviral (1-91)54, inhibition of histamine release 
from mast cells (1-92)55, and anti-inflammatory properties (1-93)56 (Figure 1-5). 
 
Figure 1-5. Bioactive natural products containing a seven-membered oxacycle 
The structural complexity and biological properties of these seven-membered oxacycles 
resulted in considerable synthetic efforts.54,57,58 Nicolaou et al. showed a mild three step 
sequence towards the synthesis of a variety of 4,5-dihydrooxepines59. Beginning with an 
array of cyclohexenones (1-94), a regioselective Baeyer-Villiger oxidation was achieved 
forming enol lactone (1-96) in good yields. The enol lactone was then converted to an 
enol phosphate (1-97) that was either reduced under palladium catalysis and a suitable 
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reducing agent or various C-C bond forming reactions were done furnishing the desired 
dihydrooxepines (1-98a,b) (Scheme 1-21).  
 
Scheme 1-21. Three step sequence towards dihydrooxepines 
The complex structure of epidithiodiketopiperazines (ETP) such as (1-92) (Figure 1-5) 
has attracted many research groups towards its total synthesis. Liang and co-workers 
recently reported the synthesis of dihydrooxepines (1-101) through a radical [2+2+3]-
annulation of 1,6-enynes (1-99) with α-bromo-1,3-dicarbonyl compounds (1-100) 
(Scheme 1-22).60 The products were formed in good yields and were identified as 
important scaffolds for the ETP class of natural products. 
 
Scheme 1-22. Radical annulation towards dihydrooxepines 
Benzooxepines such as (1-93) (Figure 1-5) are another common structural scaffold found 
in numerous natural products and pharmaceuticals. Recently, Kotha et al. devised a 
simple synthetic method towards benzooxepines.61 Under basic conditions, a variety of 
cyclic 1,3-diones (1-102) were reacted with 1,2,4,5-tetrakis(bromomethylbenzene) (1-
103) providing benzooxepines (1-104) in moderate yields (Scheme 1-23). With the 
functional handles presented, subsequent steps were performed in high yields providing 
an array of polycyclic benzooxepines (105a,b,c). 
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Scheme 1-23. Synthesis of benzooxepines and subsequent steps towards polycyclic benzooxepines 
The work by Du and co-workers showed the synthesis of spirocyclic benzooxepines (1-
108) bearing oxindole scaffolds in good to excellent yields and good 
diastereoselectivities.62 This was accomplished by a Lewis base catalyzed [4+3]-
annulation of o-Quinone methides (o-QMs) (1-106) and Morita-Baylis-Hillman (MBH) 
carbonates (1-107) (Scheme 1-24). The reaction worked regardless of variation in the 
substitution pattern. Only a slight decrease in yields were seen when larger ester groups 
were present in (1-107). 
 
Scheme 1-24. [4+3]-annulation between o-QMs and MBH carbonates under Lewis basic conditions 
towards spirocyclic benzooxepines 
The Lecourt group showcased the synthesis of highly functionalized benzooxepines (1-
111) containing a quaternary center through a ring expansion of chromene derivatives (1-
109) with donor-acceptor diazo compounds (1-110)63 (Scheme 1-25a). 
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Scheme 1-25. [a] Synthesis of benzooxepines through the ring expansion of chromene derivatives. [b] 
Proposed mechanism of the reaction. 
Treating chromene derivatives (1-109) under a Lewis acid formed benzopyrylium (1-112) 
followed by addition of the diazo species (1-110) forming (1-113). A 1,2-migration of the 
endocyclic C-C bond resulted in the oxocarbenium ion (1-114) with the extrusion of 
nitrogen gas. Trapping (1-114) with the initially generated TMSOMe formed (1-115) and 
in the same pot, treating (1-115) with TiCl4 reformed the oxocarbenium ion (1-114) 
which was trapped with various nucleophiles forming (1-111) (Scheme 1-25b). 
Structures containing pyrrolidines, dihydropyrroles, dihydrofurans, cyclopentenes, and 
dihydrooxepines in their scaffolds have numerous biological applications and are found 
in many natural products. Thus, the discovery of new synthetic methodologies towards 
these highly desirable structural motifs is a major focus in the synthetic community and 
pharmaceutical research. An area of research providing several advancements in 
methodologies towards the abovementioned structures is the use of donor-acceptor (DA) 
cyclopropanes.  
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1.3 Reactivity of Donor-Acceptor Cyclopropanes and Their 
Uses in the Formation of Hetero- and Carbo-cycles 
Cyclopropanes have emerged to be useful synthetic building blocks in organic chemistry 
because of its highly strained three-membered ring.64–73 Cyclopropanes that contain 
donor (D) and acceptor (A) groups located vicinally to one another are termed DA 
cyclopropanes (1-116).74 The presence of the DA groups amplifies the reactivity of the 
cyclopropane ring due to a synergistic electron “push-pull” effect which greatly weakens 
the vicinal C-C bond (Scheme 1-26a). Typically, moieties with electron-rich aryl groups, 
heteroatoms, alkyl or alkenyl serve as the donor group and electron withdrawing moieties 
such as carbonyl, sulfonyl, and nitro serve as the acceptor group.72 Upon treatment with a 
Lewis acid, the DA cyclopropane is proposed to undergo ring opening forming a 1,3-
dipole (1-117) and depending on the reaction conditions, many different products can be 
obtained (Scheme 1-26b).66,71,72 A high regioselectivity is observed within these reactions 
due to the added stability of the positive and negative charges imparted by the D and A 
groups. 
 
Scheme 1-26. [a] DA cyclopropane showing the weakened vicinal C-C bond due to the push-pull 
effect. [b] Reactivity of DA cyclopropanes.  
Of interest, are annulation and rearrangement reactions involving DA cyclopropanes as 
this readily allows the formation of a variety of carbo- and heterocycles of various ring 
sizes. 
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1.3.1 Annulation reactions involving DA-Cyclopropanes 
Annulation reactions of DA-cyclopropanes with dipolarophiles, 1,3-dipoles, and dienes 
have been reported to highlight the formation of carbo- and heterocycles in 
pharmaceuticals or target oriented synthesis. The utilization of these transformations will 
be featured towards the formation of cyclopentenes, pyrrolidines and dihydropyrroles.  
1.3.1.1 Synthesis of Cyclopentenes 
Unlike the formation of heterocycles, the formation of carbocycles is much less prevalent 
since the cyclopropane ring-opening event is less favorable with carbon nucleophiles.71 
Nevertheless, DA cyclopropanes have been shown to react with a variety of carbon-based 
dipolarophiles in [3+2]-annulation chemistry to make cyclopentene rings.67,75 Yadav was 
able to take advantage of this reactivity by using aryl acetylene nucleophiles (1-123) and 
a stoichiometric amount of Lewis acid generating substituted cyclopentenes (1-124) in 
moderate to good yields and cis selectivity up to 95:5 (Scheme 1-27a).76 Intramolecular 
variants were also subjected to the reaction conditions which formed polycyclic (1-126) 
and spirocyclic motifs (1-129), the latter of which are found in many natural compounds 
(Scheme 1-27b).77 
 
Scheme 1-27. [a] Synthesis of cyclopentenes through a [3+2]-annulation of DA cyclopropanes and 
acetylenes. [b] Intramolecular variants. 
21 
 
Budynina expanded these examples with doubly-substituted alkynes (1-131) and DA 
cyclopropanes (1-130) in a [3+2]-annulation initiated using a Lewis acid or Bronsted acid 
towards the formation of indenes (1-132).  These classes of compounds are important for 
their bioactivities and fluorescent properties (Scheme 1-28).  
 
Scheme 1-28. [3+2] annulation between DA cyclopropane and alkynes forming indenes 
The proposed mechanism involved formation of the 1,3-dipole equivalent (1-134) upon 
treating the cyclopropane (1-133) with a Lewis acid or Bronsted acid. Nucleophilic attack 
by the alkyne formed vinyl cation intermediate (1-135) which underwent an 
intramolecular Friedel-Crafts reaction onto the vinyl cation affording the final indene 
product (1-136) (Scheme 1-29).78  
 
Scheme 1-29. Proposed mechanism for indene formation 
Recently, Wang et al. was able to showcase the formation of highly functionalized 
cyclopenta[b]furans (1-139) through a DBU promoted cascade annulation of 
nitroarylcyclopropane-1,1-dicarbonitriles (1-137) and 3-aryl-2-cyanoacrylates (1-138)79 
(Scheme 1-30). For cyclopropane derivatives (1-137), only o- or p-nitro groups were 
tolerated since the negative charge from deprotonation of the α-proton was stabilized by 
the strong inductive and conjugative effects of the nitro group which was not seen for m-
nitro positions.  
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Scheme 1-30. Highly stereoselective formation of cyclopenta[b]furan rings from DA cyclopropanes 
Johnson et al. were able to react a variety of DA cyclopropanes (1-140) and ynamides (1-
141) in a [3+2]-annulation in the presence of a Lewis acid forming highly substituted 
cyclopentene sulfonamides (1-142) (Scheme 1-31a).80 With the use of enantiopure 
cyclopropanes, complete inversion of stereochemistry was observed at the donor site of 
the cyclopropane. These cyclopentene sulfonamides were efficiently converted to their 
cyclopentanone counterparts (1-144) as a single diastereomer via two-step sequence of 
tosyl removal followed by enamine hydrolysis with concurrent decarboxylations (Scheme 
1-31b). 
 
Scheme 1-31. [a] [3+2]-annulation between DA cyclopropanes and ynamides. [b] conversion of 
cyclopentene sulfonamides to cyclopentanones. 
The work by Yoshikai and co-workers showed the first reported example of an 
intermolecular coupling between cyclopropanols (1-145) and unfunctionalized alkynes 
(1-131) producing cyclopentenols (1-146) (Scheme 1-32).81 
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Scheme 1-32. Reaction between cyclopropanols and unfunctionalized alkynes to furnish 
cyclopentenols 
The proposed catalytic cycle began with the generation of the active Co(I) species (1-
147) from the Co(II) pre-catalyst and Zn. Deprotonation with DABCO formed a cobalt 
cyclopropoxide species (1-148) that underwent ring-opening which resulted in a cobalt 
homoenolate complex (1-149). Insertion of the alkyne gave an alkenylcobalt species (1-
150) which underwent an intramolecular carbonyl addition (1-151) followed by 
protodemetallation affording the final product (1-146) (Scheme 1-33).  
 
Scheme 1-33. Proposed catalytic cycle for the formation of cyclopentenols 
1.3.1.2 Formation of Five-Membered Heterocycles 
The ability to find new ways of forming heterocycles constitutes one of the largest areas 
of research in organic chemistry. The unique reactivity of DA cyclopropane derivatives 
has been exploited throughout the years towards the synthesis of compounds that may be 
of interest from structural or biological standpoints.  
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As mentioned earlier, pyrrolidines are an important class of heterocycles due to their 
presence in natural products and pharmaceuticals. It is not surprising that the reactivity of 
DA cyclopropanes has been exploited towards pyrrolidine synthesis. The Werz group 
showed the synthesis of pyrrolidines (1-155) by reacting DA cyclopropanes (1-152) with 
a formaldimine surrogate (1-154), 1,3,5-triazinanes (1-153), under Lewis acid catalysis 
(Scheme 1-34a).82 A variety of alkyl and (hetero)aryl cyclopropanes were tolerated and 
various 1,3,5-triazinanes worked as well. When using enantiopure cyclopropane under 
these reaction conditions, complete retention of stereochemistry was observed indicating 
a double SN2-type mechanism (Scheme 1-34b).  
 
Scheme 1-34. [a] Synthesis of pyrrolidines via the reaction of DA cyclopropanes and 1,3,5-
triazinanes. [b] Proposed double SN2-type mechanism.  
In a similar reaction involving aldimines as the dipolarophile in a [3+2]-annulation, the 
Kerr group showcased a highly diastereoselective synthesis of 2,5-cis-pyrrolidines (1-
164) through the ring-opening of DA cyclopropanes (1-163). This was accomplished with 
in-situ generated aldimines (1-162) under Lewis acid catalysis (Scheme 1-35).83 Aryl or 
heteroaryl aldehydes (1-160) provided the best results whereas both primary alkylamines 
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and anilines (1-161) were also well tolerated. This research was showcased in the total 
synthesis of FR901483.84 
 
Scheme 1-35. Formation of cis-2,5-pyrrolidine rings through ring-opening of DA cyclopropanes with 
aldimines 
The Kerr group expanded the synthesis of pyrrolidines with the use of DA cyclopropanes 
tethered to alkoxyamines (1-165) (Scheme 1-36).85 This intramolecular reaction resulted 
in the diastereoselective formation of substituted pyrrolo-isoxazolidines with high 
enantiopurity (1-166a,b). Reversing the addition order of catalyst and substrate resulted 
in the formation of two discrete diastereomers which were subjected to N-O bond 
cleavage providing highly substituted 2,5-trans- (1-167a) or 2,5-cis-pyrrolidines (1-167b) 
in a predictable manner. In order to avoid epimerization during the N-O bond cleavage, 
methanolic HCl was used which likely suppressed the retro-Mannich isomerization 
pathway. 
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Scheme 1-36. Highly diastereo- and enantioselective formation of pyrrolidines with the use of 
tethered DA cyclopropanes-alkoxyamines 
Liu et al. recently showed a formal [3+2]-cycloaddition of vinylcyclopropanes (1-170) 
and aldimines (1-168) or isatin-derived ketimines (1-169) under palladium catalysis and 
chiral phosphoramidite ligands (1-173, 1-174) towards the formation of highly 
functionalized and optically enriched pyrrolidines (1-171) or spiro-[pyrrolidin-3,2’-
oxindole] derivatives (1-172) (Scheme 1-37).86 This was the first enantioselective 
example involving ketimines as the dipolarophile in a formal [3+2]-cycloaddition 
involving DA cyclopropanes. 
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Scheme 1-37. Formal [3+2]-cycloaddition between DA cyclopropanes and aldimines or ketimines 
The reactivity of DA cyclopropanes can also be utilized in annulation reactions towards 
dihydropyrroles. The Pagenkopf group utilized glycal-derived DA cyclopropanes (1-175) 
and were the first to perform formal [3+2]-cycloadditions with a variety of nitriles 
providing complex dihydropyrroles (1-176) in high yields (Scheme 1-38).87 
 
Scheme 1-38. Formal [3+2]-cycloadditions with glycal derived DA cyclopropanes and nitriles towards 
dihydropyrroles 
More recently, France and co-workers showed a nucleophilic ring-opening of DA 
cyclopropanes (1-177) with primary amines (1-178) followed by cyclization forming 
dihydropyrroles (1-179) in good to excellent yields (Scheme 1-39).88 However, it can be 
argued that imine formation occurs prior to cyclization which would be followed by a 
Cloke-Wilson type rearrangement through a zwitterionic intermediate. This process will 
be discussed in greater detail in the following section.  
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Scheme 1-39. Ring-opening/cyclization of DA cyclopropanes with primary amines 
Annulation reactions involving DA cyclopropanes towards the synthesis of various 
carbocycles and heterocycles is a vast area of ongoing research with unique scaffolds 
being synthesized regularly.  
1.3.2   Rearrangements of DA Cyclopropanes 
Rearrangements of DA cyclopropanes is another large area of research in organic 
chemistry since it allows the formation of various cyclic structures in a quick and atom 
economical manner. One of the most famous examples of cyclopropane rearrangements 
is the vinylcyclopropane-cyclopentene rearrangement64,65,89–93 (Scheme 1-40).  
 
Scheme 1-40. Vinylcyclopropane-cyclopentene rearrangement 
Since the discovery of this reaction, numerous reviews were published which debated its 
exact mechanism. Today, the majority of the evidence suggests a diradical mechanism or 
through zwitterionic intermediates (Scheme 1-41); however, a concerted [1,3] process is 
still argued.94–96  
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Scheme 1-41. Vinylcyclopropane-cyclopentene rearrangement. [a] diradical mechanism. [b] 
zwitterionic intermediate mechanism. 
A much less known variant of this reaction is the heteroatom version known as the 
Cloke-Wilson reaction. Cloke discovered the formation of 2-phenylpyrroline 
hydrochloride (1-190) when he attempted to distill phenyl cyclopropyl ketimine 
hydrochloride (1-189) under vacuum. Wilson separately reported the formation of 
dihydrofurans (1-192) from the thermal rearrangement of cyclopropylcarboxaldehyde (1-
191) (Scheme 1-42).92  
 
Scheme 1-42. Cloke-Wilson rearrangements towards the formation of dihydropyrroles and 
dihydrofurans 
The vinylcyclopropane-cyclopentene and Cloke-Wilson rearrangements were not widely 
applicable due to the extremely high temperatures required to induce the rearrangement.92 
However, with the introduction of DA cyclopropanes, these types of rearrangements 
could be carried out under much milder conditions. Davies et al. showed a highly 
stereoselective formation of cyclopentenes (1-194) using vinyl DA cyclopropane (1-193) 
under mild conditions in the presence of an aluminum catalyst (Scheme 1-43).95 
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Scheme 1-43. Stereoselective vinylcyclopropane-cyclopentene rearrangement under mild conditions 
To explain the high stereoselectivity of the rearrangement, Davies proposed that the 
rearrangement underwent a formal [1,3]-sigmatropic rearrangement proceeding 
suprafacially with retention of configuration. However, it was also proposed that the DA 
cyclopropane underwent ring-opening to the zwitterionic intermediate and re-closed to 
the cyclopentene before any bond rotation occurred. This may be possible due to the 
extremely low temperature the reaction was performed in.  
Recently, Robiette et al. developed a highly diastereo- and enantioselective one-pot 
protocol that gave cyclopentenes (1-200) via the vinylcyclopropane-cyclopentene 
rearrangement. Chiral sulfur ylides (1-196) underwent a formal [4+1]-annulation with 
1,1-bis-activated 1,3-dienes (1-195) to yield in situ vinylcyclopropane (1-197). The 
cyclopropane was then treated with MgI2 which resulted in a vinylcyclopropane-
cyclopentene rearrangement with complete retention of stereochemistry (Scheme 1-44).97 
Computational studies were conducted to gain insight into the mechanism and results 
suggested that the reaction underwent two SN2 reactions which accounted for the 
stereochemistry. Upon coordination of MgI2 onto the EWG of the cyclopropane (1-198), 
the displaced iodide opened the cyclopropane in an SN2 fashion (1-199) followed by ring 
closure with expulsion of the iodide in a second SN2 reaction to form the cyclopentene 
ring (1-200).   
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Scheme 1-44. Diastereo- and enantioselective vinylcyclopropane-cyclopentene rearrangement 
undergoing a double SN2 displacement 
Wenkert was able to utilize the reactivity of DA cyclopropanes and perform the Cloke-
Wilson rearrangement under mild conditions forming various dihydrofurans.98 
Ethylformyldiazoacetate (1-201) was reacted with n-butylvinyl ethers (1-202) under 
metal carbenoid chemistry forming cyclopropane intermediate (1-203) that underwent the 
Cloke-Wilson rearrangement which furnished dihydrofuran (1-204) in good yields 
(Scheme 1-45). 
 
Scheme 1-45. Cloke-Wilson rearrangement of DA cyclopropane to dihydrofuran 
Recently, the group of Xu showcased a high yielding organocatalytic Cloke-Wilson 
rearrangement of cyclopropyl ketones (1-205) to dihydrofurans (1-208) with the use of 
DABCO (1-206) (Scheme 1-46).99 The products were obtained in high yields and 
mechanistic studies supported a SN1 type (zwitterionic) (1-207) mechanism.  
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Scheme 1-46. Proposed mechanism for the organocatalyzed Cloke-Wilson rearrangement 
Formation of dihydropyrroles via the Cloke-Wilson rearrangement was employed under 
mild conditions upon introduction of DA cyclopropanes. Spirocyclic DA cyclopropanes 
(1-209) were reacted with a variety of primary amines (1-210) at room temperature 
without any catalyst forming bicyclic dihydropyrroles (1-211) in excellent yields 
(Scheme 1-47).100 To show the utility of these transformations, the group transformed a 
select example to its corresponding indole derivative (1-212). 
 
Scheme 1-47. Cloke-Wilson rearrangement of DA cyclopropanes to dihydropyrroles 
DFT studies were conducted for the Cloke-Wilson rearrangement involving up to 72 DA 
cyclopropanes.71,101 It was found that in the absence of a catalyst, the rearrangement 
occurred through a concerted process.101,102 The corresponding zwitterionic or biradical 
intermediates were shown to have higher activation barriers in all cases.101 An example of 
this is shown by Werz and co-workers where they synthesized [n,5]-spiroketals (1-217, 1-
218) (n = 5 or 6) through the Cloke-Wilson rearrangement of DA cyclopropanes (1-
214)103 (Scheme 1-48). 
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Scheme 1-48. Rearrangement of DA cyclopropanes to spiroketals 
When no Lewis acid was used, high diastereoselectivity was observed supporting a 
concerted mechanism (1-215). In the presence of a Lewis acid, the yields increased and a 
mixture of diastereomers (1-217, 1-218) was observed, supporting a zwitterionic 
intermediate (1-216).  
Larger ring systems can be formed with the use of divinylcyclopropanes (1-219) which 
undergo a Cope rearrangement to furnish cycloheptadiene compounds (1-220)104 
(Scheme 1-49). 
 
Scheme 1-49. Divinylcyclopropane-cycloheptadiene rearrangement 
The heteroatom version of the divinylcyclopropane-cycloheptadiene rearrangement is 
also known and useful for making 7-membered heterocycles. This work was pioneered 
by Reissig and Boeckman in the mid 1990s. Boeckman synthesized vinylcyclopropane 
(1-221) and after oxidation with DMP he formed the required (hetero)-
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divinylcyclopropane (1-222) which instantly underwent a retro-Claisen rearrangement 
furnishing 2,5-dihydrooxepines (1-223) in good to excellent yields (Scheme 1-50).105 
 
Scheme 1-50. Boeckman's (hetero)-divinylcyclopropane rearrangement to 2,5-dihydrooxepines 
Similarly, Reissig synthesized vinylcyclopropane (1-224) and after further chemical 
transformations he formed the required (hetero)-divinylcyclopropane (1-225). This 
intermediate instantly underwent a retro-Claisen rearrangement furnishing 2,5-
dihydrooxepines (1-226) in moderate to good yields (Scheme 1-51).106 
 
Scheme 1-51. Reissig’s (hetero)-divinylcyclopropane rearrangement to 2,5-dihydrooxepines 
An enantioselective version of this transformation was recently reported by the Ryu 
group. The required enantiopure DA cyclopropane (1-229) was formed via a Michael 
addition initiated cyclopropanation between substituted acroleins (1-227) and 
vinyldiazoesters (1-228) under chiral oxazaborolidinium ion (COBI) (1-231) catalyst 
(Scheme 1-52).107 The cyclopropane instantly underwent a retro-Claisen rearrangement 
generating 2,5-dihydrooxepines (1-230) in high yields and enantioselectivities. This was 
the first reported example of a catalytic asymmetric formation of 2,5-dihydrooxepines 
through tandem cyclopropanation/retro-Claisen rearrangement.  
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Scheme 1-52. First enantioselective formation of dihydrooxepines through a tandem 
cyclopropanation/retro-Claisen rearrangement 
DA cyclopropanes are synthons whose innate dipole moments are appropriate to produce 
carbocyclic and heterocyclic compounds. Rearrangement reactions are important since 
they allow the formation of said compounds in an atom economical process. Many of 
these examples require only mild conditions without the need of any catalysts. These 
types of rearrangements will be the main focus of the upcoming chapters, which 
ultimately leads into the work towards pyrrolidine-containing product kainic acid. 
1.4 Kainic Acid 
1.4.1 Isolation and biological activity 
The kainoid amino acids are densely functionalized pyrrolidine motifs that are 
structurally related to glutamic acid (1-232h), which is an excitatory neurotransmitter 
(Figure 1-6).108–111 The parent of the kainoids, α-kainic acid (1-232a), was first isolated 
by Takemoto in 1953 from the Japanese marine algae Digenea simplex along with its C-4 
epimer α-allokainic acid (1-232b).108–111 A few years after its isolation, Morimoto was 
the first to deduce the relative stereochemistry of the pyrrolidine ring through X-ray 
analysis and it was not until the first total synthesis by Oppolzer and Thirring in 1982 
where the absolute stereochemistry was confirmed.108–112   
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Figure 1-6. Kainoid amino acid family and their resemblance to glutamic acid 
Since the initial isolation of kainic acid, the compound received attention from chemists 
and biologist due to its neuroexcitatory properties. L-glutamic acid (1-232h), which is the 
most abundant excitatory neurotransmitter, interacts with two classes of receptors. The 
first are called ionotropic glutamate receptors (iGluRs), which are coupled to ion 
channels that control the flux of ions to nerve cells and are capable of millisecond or 
faster response times. The second are metabotropic glutamate receptors (mGluRs) which 
have slower response times compared to the first, but produce long lasting changes to 
nerve cells.109 When L-glutamic acid (1-232h) was administered subcutaneously to 
animals, it destroyed neurons of the inner retina which suggested that excessive 
activation of iGluRs can cause a cascade of events that leads to cell death.109 When kainic 
acid (1-232a) was administered, it was discovered that it behaved as an agonist for the 
iGluRs, mediating the effects caused by glutamic acid which helped to elucidate the 
neurophysiological role of glutamic acid.109,113 It was later understood that when in direct 
contact with neurons, kainic acid induced motor hyperactivity and seizures, as well as 
destroyed neurons in specific regions of the brain that contained high concentrations of 
the molecule.108,109 It was then realized that these symptoms resembled several human 
pathological conditions which resulted in creating model conditions for the better 
understanding of epilepsy, stroke and Huntington’s chorea.109,111 
With its interesting biological properties, kainic acid became high in demand in the 
neuroscience field; however, limited supply from natural sources resulted in a shortage 
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and high price (50mg from sigma-aldrich costs $1260.00). Due to this demand, kainic 
acid sparked interest in organic chemists, resulting in over 70 published synthetic 
routes.114 
1.4.2 Total syntheses of Kainic acid 
Oppolzer and Thirring’s kainic acid synthesis was instrumental for the determination of 
its absolute stereochemistry (Scheme 1-53).112 
 
Scheme 1-53. First total synthesis of kainic acid 
Starting from a derivative of L-glutamic acid (1-233), Boc protection of the primary 
amine resulted in carboxylic acid (1-234). Reduction of the carboxylic acid with borane 
followed by protection of the resulting primary alcohol with TBSCl furnished (1-235) in 
52% overall yield. N-alkylation was then performed with (1-236) to provide tertiary 
amine (1-237) in good yield. The α,β-unsaturated ester (1-238) was formed by treating 
(1-237) under strong basic conditions with an organoselenium reagent, followed by 
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Grieco elimination. A key stereocontrolled intramolecular ene reaction was performed by 
heating (1-238) in toluene which furnished the desired pyrrolidine core (1-239) with the 
correct stereochemistry. Deprotection of the silyl group followed by oxidation to the acid 
formed (1-240) in 60% overall yield. Finally, saponification of the ester followed by 
cleavage of the Boc group and purification using ion-exchange resin gave the final 
product (1-232a) in an overall yield of 5%.    
Since the pioneering work by Oppolzer and Thirring112, several highly efficient total 
syntheses of kainic acid have been reported. In 2002, Clayden reported an 
enantioselective synthesis of kainic acid which featured an asymmetric dearomatizing 
cyclization forming isoindolinones as the key substrate115 (Scheme 1-54). Beginning with 
a N-benzyl benzamide derivative (1-241), the asymmetric dearomatizing cyclization was 
made possible with chiral lithium amide (1-242) generating lithium enolate (1-244). This 
intermediate was then protonated (1-245) and hydrolyzed forming isoindolinone (1-246). 
 
Scheme 1-54. Asymmetric dearomatizing cyclization towards enantioenriched isoindolinone 
Following the groups previously reported racemic kainic acid synthesis116 (Scheme 1-55), 
the enantioenriched isoindolinone (1-246) was treated with an organocuprate in the 
presence of TMSCl which formed an enol ether derivative that was hydrolyzed with 
subsequent deprotection forming lactam (1-247). After recrystallization of this 
intermediate, the product lactam was obtained in a 48% yield with 98% ee. Lactam (1-
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247) was then Boc protected forming (1-248) followed by an oxidative removal of the 
aromatic ring generating a carboxylic acid derivative which was esterified with 
diazomethane forming methyl ester (1-249). Baeyer-Villiger oxidation formed lactone (1-
250) regioselectively which was hydrolyzed and esterified forming dimethyl ester (1-
251). Grieco dehydration of (1-251) to give isopropenyl (1-252) was achieved in one step 
by treating the primary alcohol with an organoselenium reagent which was oxidized to a 
selenoxide followed by its elimination. Selective reduction of the lactam with sodium 
trimethoxyborohydride formed Boc-protected pyrrolidine (1-253) which was deprotected 
with subsequent hydrolysis of the methyl esters using a trifluoroacetic acid/water mixture 
forming kainic acid (1-232a) in 11 steps with an overall yield of 4%.         
 
Scheme 1-55. Synthesis of kainic acid utilizing the asymmetric dearomatizing cyclization 
methodology 
 In 2011, Fukuyama reported a multigram total synthesis of kainic acid which featured a 
stereoselective alkylation and hydrolysis of a nitrile derivative accompanied by 
epimerization117 (Scheme 1-56).  
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Scheme 1-56. Fukuyama's multigram synthesis of kainic acid 
The synthesis involved epoxidation of (+)-carvone (1-254) to epoxide (1-255) in high 
yield. The epoxide was then hydrolyzed under acidic conditions producing a 
diastereomeric mixture of diols, which was subjected to oxidative cleavage forming a 
1,2-diketone intermediate (1-256). The diketone intermediate was further oxidized to acid 
(1-257) followed by cyclization involving iodine and base to produce iodolactone (1-
258). Treatment of (1-258) under standard Pinnick conditions followed by Curtius 
rearrangement formed carbamate (1-259). The stereoselective alkylation was then 
performed under basic conditions with tert-butylbromoacetate forming ester (1-260). 
Reductive ring-opening of (1-260) with Zn produced a carboxylic acid intermediate that 
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underwent cyclization with DEPC to form lactam (1-261). Selectively reducing the 
lactam and treating the resulting hemiaminal with methanol and acid formed (1-262) as a 
single diastereomer. Treatment of (1-262) with TMSCN and Lewis acid gave, via an 
acyliminium ion, aminonitrile (1-263) as a 3:1 mixture of diastereomers. This was not an 
issue since epimerization of the unwanted diastereomer occurred during the final 
hydrolysis step producing kainic acid (1-232a) in 13 steps with an overall yield of 10%, 
providing up to 14.6g of product when beginning with 100g of (+)-carvone.   
Lin and co-workers reported the highest overall yield of kainic acid in just seven steps 
with the instrumental step being an asymmetric alkenylation of cyclic α,β-unsaturated 
carbonyl compounds (Scheme 1-57).118 Beginning with lactam (1-264), the asymmetric 
alkenylation was performed forming lactam (1-266) in 82% yield and 99% ee. Next, 
alkylation of (1-266) with tert-butylbromoacetate gave trans-3,4-substituted ester (1-
267). To acquire the syn relationship between C3 and C4 (1-268), a dynamic protonation 
process was executed by deprotonating (1-267) at -78 °C followed by protonation with (-
)-CSA. The next final steps followed a similar procedure to that reported by Fukuyama 
providing kainic acid (1-232a) in seven steps with a 40% overall yield.  
 
Scheme 1-57. Lin et al. synthesis of kainic acid with high overall yield 
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In 2014, Ohshima et al. reported the shortest synthesis of kainic acid to date with a high 
overall yield and the ability to perform the reactions on gram scale without affecting yield 
or enantioselectivity119 (Scheme 1-58). The key steps featured sequential platinum 
catalyzed direct allylic aminations and a thermal ene cyclization. 
 
Scheme 1-58. Oshima's total synthesis of kainic acid 
The synthesis began with the direct amination of allylic alcohol (1-271) and 2,4-
dimethoxybenzylamine (DMB) (1-272) under platinum catalysis forming allylamine (1-
273). The enantiopure epoxide (1-276) required for the second platinum allylation was 
formed in one-pot beginning with oxidizing epoxide (1-274) with TEMPO followed by a 
Wittig olefination with (1-275) to form (1-276) in high yields. With the enantiopure 
epoxide in hand, the second platinum catalyzed allylation was accomplished forming 
diallylamine (1-277). The ene-cyclization was then performed which constructed the 
desired pyrrolidine ring (1-278) with three continuous stereocenters. Upon scale-up, a 
catalytic amount of base was added to avoid partial decomposition of the substrate. 
Oxidizing the primary alcohol to the carboxylic acid (1-279) under Jones conditions 
followed by treatment of the crude material with triethylsilane and TFA resulted in the 
deprotection of the DMB and tert-butyl groups forming the final product (1-232a) in six 
steps with an overall yield of 34-37%.  
Each of the synthetic routes to kainic acid presented have had a great impact in the 
synthetic community. With the goal to synthesize the compound in a quick and efficient 
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manner, new synthetic methodologies were discovered which can potentially be useful 
for other synthetic targets. The ability to provide this compound in multigram scale and 
high overall yields can allow for further biological studies to be conducted.  
1.5 References 
(1)  Quin, L. D.; Tyrell, J. A. Fundamentals of Heterocyclic Chemistry: Importance in 
Nature and in the Synthesis of Pharmaceuticals; John Wiley & Sons, Inc.: 
Hoboken, New Jersey, 2010. 
(2)  Pozharskii, A. F.; Soldatenkov, A. T.; Katritzky, A. R. Heterocycles in Life and 
Society. An Introduction to Heterocyclic Chemistry, Biochemistry and 
Applications, Second.; John Wiley & Sons Ltd: Chichester, West Sussex, 2011. 
(3)  Patrick, G. L. An Introduction to Drug Synthesis; Oxford University Press: New 
York, New York, 2014. 
(4)  Dua, R.; Shrivastava, S.; Sonwane, S. K.; Srivastava, S. K. Advan. Biol. Res. 2011, 
5 (3), 120–144. 
(5)  Marson, C. M. Saturated Heterocycles with Applications in Medicinal Chemistry; 
Elsevier Ltd, 2017; Vol. 121.  
(6)  Zhang, T. Y. The Evolving Landscape of Heterocycles in Drugs and Drug 
Candidates; Elsevier Ltd, 2017; Vol. 121.  
(7)  Chen, W.; Zhan, P.; De Clercq, E.; Liu, X. Curr. Pharm. Des. 2012, 18 (1), 100–
112.  
(8)  Williams, R. M.; Cao, J.; Tsujishima, H. J. Am. Chem. Soc. 2003, 125, 12172–
12178.  
(9)  Alvarez-Ibarra, C.; Csàkÿ, A. G.; De Silanes, I. L.; Quiroga, M. L. J. Org. Chem. 
1997, 62 (3), 479–484.  
(10)  Nicolle, S. M.; Lewis, W.; Hayes, C. J.; Moody, C. J. Angew. Chem. Int. Ed. 2016, 
44 
 
55 (11), 3749–3753.  
(11)  Kumar, I. RSC Adv. 2014, 4 (32), 16397–16408.  
(12)  Bhat, C.; Tilve, S. G. RSC Adv. 2014, 4 (11), 5405–5452.  
(13)  Padwa, A.; Bur, S. Recent Advances of 1,3-Dipolar Cycloaddition Chemistry for 
Alkaloid Synthesis; Elsevier Ltd, 2016; Vol. 119.  
(14)  Bdiri, B.; Zhao, B. J.; Zhou, Z. M. Tetrahedron Asymmetry 2017, 28 (7), 876–899.  
(15)  Narayan, R.; Potowski, M.; Jia, Z. J.; Antonchick, A. P.; Waldmann, H. Acc. 
Chem. Res. 2014, 47 (4), 1296–1310.  
(16)  Kobayashi, S.; Jorgensen, K. A. Cycloaddition Reaction in Organic Synthesis; 
Wiley, 2001. 
(17)  Lautens, M.; Klute, W.; Tam, W. Chem. Rev. 1996, 96 (1), 49–92.  
(18)  Dennis, N. Organic Reaction Mechanims 2015: An Annual Survey Covering the 
Literature Dated January to December 2015; C., K. A., Ed.; John Wiley & Sons 
Ltd, 2019. 
(19)  Hashimoto, T.; Maruoka, K. Chem. Rev. 2015, 115 (11), 5366–5412.  
(20)  Ray, S. K.; Biswas, R. G.; Suneja, A.; Sadhu, M. M.; Singh, V. K. J. Org. Chem. 
2018, 83 (4), 2293–2308.  
(21)  Trost, B. M.; Chan, D. M. T. J. Am. Chem. Soc. 1979, 101 (21), 6429–6432.  
(22)  Trost, B. M.; King, S. A.; Schmidt, T. J. Am. Chem. Soc. 1989, 111, 5902–5915.  
(23)  Trost, B. M.; Marrs, C. M. J. Am. Chem. Soc. 1993, 115, 6636–6645.  
(24)  Trost, B. M.; Lam, T. M.; Herbage, M. A. J. Am. Chem. Soc. 2013, 135 (7), 2459–
2461.  
45 
 
(25)  Mukhopadhyay, S.; Pan, S. C. Org. Biomol. Chem. 2018, 16 (48), 9349–9353.  
(26)  Xiao, Z. F.; Ding, T. H.; Mao, S. W.; Shah, Z.; Ning, X. S.; Kang, Y. B. Org. Lett. 
2016, 18 (21), 5672–5675.  
(27)  Antonow, D.; Thurston, D. E. Chem. Rev. 2011, 111 (4), 2815–2864.  
(28)  Castellano, S.; Fiji, H. D. G.; Kinderman, S. S.; Watanabe, M.; De Leon, P.; 
Tamanoi, F.; Kwon, O. J. Am. Chem. Soc. 2007, 129 (18), 5843–5845.  
(29)  Magedov, I. V.; Luchetti, G.; Evdokimov, N. M.; Manpadi, M.; Steelant, W. F. A.; 
Van slambrouck, S.; Tongwa, P.; Antipin, M. Y.; Kornienko, A. Bioorganic Med. 
Chem. Lett. 2008, 18 (4), 1392–1396.  
(30)  Smith, A. B.; Charnley, A. K.; Hirschmann, R. Acc. Chem. Res. 2011, 44 (3), 180–
193.  
(31)  Wender, P. A.; Strand, D. J. Am. Chem. Soc. 2009, 131 (22), 7528–7529.  
(32)  Yu, H.; Zhang, L.; Yang, Z.; Li, Z.; Zhao, Y.; Xiao, Y.; Guo, H. J. Org. Chem. 
2013, 78 (17), 8427–8436.  
(33)  Winum, J. Y.; Scozzafava, A.; Montero, J. L.; Supuran, C. T. Med. Res. Rev. 2005, 
25 (2), 186–228.  
(34)  Yu, Y. F.; Shu, C.; Zhou, B.; Li, J. Q.; Zhou, J. M.; Ye, L. W. Chem. Commun. 
2015, 51 (11), 2126–2129.  
(35)  Yu, Y. F.; Shu, C.; Shen, C. H.; Li, T. Y.; Ye, L. W. Chem. - An Asian J. 2013, 8 
(12), 2920–2924.  
(36)  Masson, G.; Neuville, L.; Bughin, C.; Fayol, A.; Zhu, J. Multicomponent 
Synthesis of Macrocycles. In Synthesis of Heterocycles via Multicomponent 
Reactions II; Maes, B. U. W., Ruijter, E., Orru, R. V. A., Enders, D., Ley, S. V., 
Mehta, G., Nicolaou, K. C., Noyori, R., Overman, L. E., Padwa, A., et al., Eds.; 
Springer, 2010; pp 1–5. 
46 
 
(37)  Polindara-García, L. A.; Miranda, L. D. Org. Lett. 2012, 14 (21), 5408–5411.  
(38)  Elliot, R. L.; Kopecka, H.; Lin, N.-H.; He, Y.; Garvey, D. S. Synthesis 1995, No. 
7, 772–774. 
(39)  Shi, F.; Luo, S. W.; Tao, Z. L.; He, L.; Yu, J.; Tu, S. J.; Gong, L. Z. Org. Lett. 
2011, 13 (17), 4680–4683.  
(40)  Faul, M. M.; Huff, B. E. Chem. Rev. 2000, 100 (6), 2407–2473. 
(41)  Kilroy, T. G.; O’Sullivan, T. P.; Guiry, P. J. Eur. J. Org. Chem. 2005, No. 23, 
4929–4949.  
(42)  Matsumoto, R.; Nishino, H. Synth. Commun. 2015, 45 (15), 1807–1816.  
(43)  Anderson, J. M.; Kochi, J. K. J. Am. Chem. Soc. 2005, 92 (8), 2450–2460.  
(44)  Loǧoǧlu, E.; Yilmaz, M.; Katircioǧlu, H.; Yakut, M.; Mercan, S. Med. Chem. Res. 
2010, 19 (5), 490–497.  
(45)  Liu, D.; Lei, A. Chem. Asian J. 2015, 10 (4), 806–823.  
(46)  Tang, S.; Liu, K.; Long, Y.; Gao, X.; Gao, M.; Lei, A. Org. Lett. 2015, 17 (10), 
2404–2407.  
(47)  Heasley, B. Curr. Org. Chem. 2014, 18 (6), 641–686.  
(48)  Cui, S.; Zhang, Y.; Wu, Q. Chem. Sci. 2014, 5, 297–302. 
(49)  Barrero, A.; Quilez del Moral, J.; Herrador, M.; Rodriguez, H.; Perez Morales, M. 
Curr. Org. Chem. 2009, 13 (12), 1164–1181.  
(50)  Heasley, B. Eur. J. Org. Chem. 2009, No. 10, 1477–1489.  
(51)  Ferreira, A. J.; Beaudry, C. M. Tetrahedron 2017, 73 (8), 965–1084.  
(52)  López, E.; López, L. A. Angew. Chem. Int. Ed. 2017, 56 (18), 5121–5124.  
47 
 
(53)  Zou, H. X.; Li, Y.; Yang, X. H.; Xiang, J.; Li, J. H. J. Org. Chem. 2018, 83 (15), 
8581–8588.  
(54)  Snyder, N. L.; Haines, H. M.; Peczuh, M. W. Tetrahedron 2006, 62 (40), 9301–
9320.  
(55)  Kawahara, N.; Nakajima, S.; Yamazaki, M.; Kawai, K. Chem. Pharm. Bull. 1989, 
37 (10), 2592–2595. 
(56)  Herrmann, J. M.; Untergehrer, M.; Jürgenliemk, G.; Heilmann, J.; König, B. Eur. 
J. Org. Chem. 2014, 2014 (15), 3170–3181.  
(57)  Elliott, M., C. J. Chem. Soc., Perkin Trans. 1, 2002, 2301–2323.  
(58)  Olivera, R.; Sanmartin, R.; Churruca, F.; Domínguez, E. Org. Prep. Proced. Int. 
2004, 36 (4), 297–330.  
(59)  Nicolaou, K. C.; Yu, R.; Shi, L.; Cai, Q.; Lu, M.; Heretsch, P. Org. Lett. 2013, 15 
(8), 1994–1997.  
(60)  Zheng, L.; Liang, Y. M. J. Org. Chem. 2017, 82 (13), 7000–7007.  
(61)  Kotha, S.; Khedkar, P.; Dommaraju, Y. Tetrahedron Lett. 2019, 60 (9), 631–648.  
(62)  Du, J. Y.; Ma, Y. H.; Meng, F. X.; Zhang, R. R.; Wang, R. N.; Shi, H. L.; Wang, 
Q.; Fan, Y. X.; Huang, H. L.; Cui, J. C.; et al. Org. Lett. 2019, 21 (2), 465–468. 
(63)  Courant, T.; Pasco, M.; Lecourt, T. Org. Lett. 2018, 20 (9), 2757–2761.  
(64)  Wong, H. N. C.; Hon, M.; Tse, C.; Yip, Y.; Tank, J.; Hudlicky, T. Chem. Rev. 
1989, 89, 165–198. 
(65)  Reissig, H.; Zimmer, R. Chem. Rev. 2003, 103, 1151–1196. 
(66)  Yu, M.; Pagenkopf, B. L. Tetrahedron 2005, 61 (2), 321–347.  
(67)  Grover, H. K.; Emmett, M. R.; Kerr, M. A. Org. Biomol. Chem. 2015, 13 (3), 655–
48 
 
671.  
(68)  Carson, C. A.; Kerr, M. A. Chem. Soc. Rev. 2009, 38, 3051–3060.  
(69)  O’Connor, N. R.; Wood, J. L.; Stoltz, B. M. Isr. J. Chem. 2016, 56 (6–7), 431–
444.  
(70)  Pagenkopf, B. L.; Vemula, N. Eur. J. Org. Chem. 2017, 2017 (18), 2561–2567.  
(71)  Schneider, T. F.; Kaschel, J.; Werz, D. B. Angew. Chem. Int. Ed. 2014, 53 (22), 
5504–5523.  
(72)  Cavitt, M. A.; Phun, L. H.; France, S. Chem. Soc. Rev. 2014, 43 (3), 804–818.  
(73)  Gharpure, S. J.; Nanda, L. N. Tetrahedron Lett. 2017, 58 (8), 711–720.  
(74)  Reissig, H.; Hirsch, E. Angew. Chem. Int. Ed. 1980, 19 (10), 814–816. 
(75)  Ivanova, O. A.; Trushkov, I. V. Chem. Rec. 2019, 19, 1–21.  
(76)  Yadav, V. K.; Sriramurthy, V. Angew. Chem. Int. Ed. 2004, 43 (20), 2669–2671.  
(77)  Sannigrahi, M. Tetrahedron 1999, 55, 9007–9071. 
(78)  Rakhmankulov, E. R.; Ivanov, K. L.; Budynina, E. M.; Ivanova, O. A.; 
Chagarovskiy, A. O.; Skvortsov, D. A.; Latyshev, G. V.; Trushkov, I. V.; 
Melnikov, M. Y. Org. Lett. 2015, 17 (4), 770–773.  
(79)  Qian, S.; Xie, Z.; Liu, J.; Li, M.; Wang, S.; Luo, N.; Wang, C. J. Org. Chem. 2018, 
83 (23), 14768–14776.  
(80)  Mackay, W. D.; Fistikci, M.; Carris, R. M.; Johnson, J. S. Org. Lett. 2014, 16 (6), 
1626–1629.  
(81)  Yang, J.; Shen, Y.; Lim, Y. J.; Yoshikai, N. Chem. Sci. 2018, 9 (34), 6928–6934.  
(82)  Garve, L. K. B.; Kreft, A.; Jones, P. G.; Werz, D. B. J. Org. Chem. 2017, 82 (17), 
49 
 
9235–9242. 
(83)  Carson, C. A.; Kerr, M. A. J. Org. Chem. 2005, 70 (20), 8242–8244.  
(84)  Carson, C. A.; Kerr, M. A. Org. Lett. 2009, 11, 777–779.  
(85)  Jackson, S. K.; Karadeolian, A.; Driega, A. B.; Kerr, M. A. J. Am. Chem. Soc. 
2008, 130 (12), 4196–4201.  
(86)  Huang, X. B.; Li, X. J.; Li, T. T.; Chen, B.; Chu, W. D.; He, L.; Liu, Q. Z. Org. 
Lett. 2019, 21 (6), 1713–1716.  
(87)  Yu, M.; Pagenkopf, B. L. J. Am. Chem. Soc. 2003, 125 (27), 8122–8123.  
(88)  Martin, M. C.; Patil, D. V.; France, S. J. Org. Chem. 2014, 79 (7), 3030–3039.  
(89)  Hudlicky, T.; Kutchan, T. M.; Naqvi, S. M. The Vinylcyclopropane-Cyclopentene 
Rearrangement. In Organic Reactions; Kende, A. S., Ed.; John Wiley & Sons Ltd, 
1985; pp 248–331. 
(90)  Baldwin, J. E. Chem. Rev. 2003, 103 (4), 1197–1212.  
(91)  Baldwin, J. E.; Leber, P. A. Org. Biomol. Chem. 2008, 6 (1), 36–47.  
(92)  Hudlicky, T.; Reed, J. W. Angew. Chem. Int. Ed. 2010, 49 (29), 4864–4876.  
(93)  Hudlicky, T. ACS Omega 2018, 3 (12), 17326–17340.  
(94)  Andrews, G. D.; Baldwin, J. E. J. Am. Chem. Soc. 1976, 98 (21), 6705–6706.  
(95)  Davies, H. M. L.; Baihua, H. J. Org. Chem. 1992, 57 (11), 3186–3190.  
(96)  Bulo, R. E.; Ehlers, A. W.; Grimme, S.; Lammertsma, K. J. Am. Chem. Soc. 2002, 
124 (46), 13903–13910.  
(97)  Clergue, S.; Rousseau, O.; Delaunay, T.; Dequirez, G.; Tran, T. Van; Aakchioui, 
S. El; Barozzino-Consiglio, G.; Robiette, R. Chem. Eur. J. 2018, 24 (44), 11417–
50 
 
11425.  
(98)  Wenkert, E.; Ananthanarayan, T. P.; Ferreira, V. F.; Hoffmann, M. G.; Kim, H. J. 
Org. Chem. 1990, 55, 4975–4976. 
(99)  Zhang, J.; Tang, Y.; Wei, W.; Wu, Y.; Li, Y.; Zhang, J.; Zheng, Y.; Xu, S. Org. 
Lett. 2017, 19 (12), 3043–3046.  
(100)  Nambu, H.; Fukumoto, M.; Hirota, W.; Yakura, T. Org. Lett. 2014, 16 (15), 4012–
4015.  
(101)  Schneider, T. F.; Werz, D. B. Org. Lett. 2011, 13, 1848–1851. 
(102)  Sperling, D.; Reißig, H.-U.; Fabian, J. Eur. J. Org. Chem. 1999, 1999, 1107–1114. 
(103)  Brand, C.; Rauch, G.; Zanoni, M.; Dittrich, B.; Werz, D. B. J. Org. Chem. 2009, 
74 (22), 8779–8786.  
(104)  Hudlicky, T.; Fan, R.; Reed, J. W.; Gadamasetti, K. G. Divinylcyclopropane-
CycloheptadieneRearrangement. Organic Reactions. 2004, pp 1–133.  
(105)  Boeckman, R. K.; Shair, M. D.; Vargas, J. R.; Stolz, L. A. J. Org. Chem. 1993, 58 
(6), 1295–1297.  
(106)  Hofmann, B.; Reissig, H.-U. Synlett 1993, 27–29. 
(107)  Shim, S. Y.; Cho, S. M.; Venkateswarlu, A.; Ryu, D. H. Angew. Chem. Int. Ed. 
2017, 56 (30), 8663–8666.  
(108)  Parsons, A. F. Tetrahedron 1996, 52 (12), 4149–4174. 
(109)  Stathakis, C. I.; Yioti, E. G.; Gallos, J. K. Eur. J. Org. Chem. 2012, No. 25, 4661–
4673.  
(110)  Bhat, C.; Kumar, A. Asian J. Org. Chem. 2015, 4 (2), 102–115.  
(111)  Majik, M. S.; Mandrekar, V. K. Curr. Org. Chem. 2016, 20, 939–951. 
51 
 
(112)  Oppolzer, W.; Thirring, K. J. Am. Chem. Soc. 1982, 104 (18), 4978–4979.  
(113)  Hashimoto, K.; Konno, K.; Shirahama, H. J. Org. Chem. 1996, 61 (14), 4685–
4692.  
(114)  Chekan, J. R.; McKinnie, S. M. K.; Moore, M. L.; Poplawski, S. G.; Michael, T. 
P.; Moore, B. S. Angew. Chem. Int. Ed. 2019, 58 (25), 8454–8457.  
(115)  Clayden, J.; Menet, C. J.; Mansfield, D. J. Chem. Commun. 2002, 38–39. 
(116)  Clayden, J.; Tchabanenko, K. Chem. Commun. 2000, 317–318. 
(117)  Takita, S.; Yokoshima, S.; Fukuyama, T. Org. Lett. 2011, 13 (8), 2068–2070.  
(118)  Yu, H. J.; Shao, C.; Cui, Z.; Feng, C. G.; Lin, G. Q. Chem. Eur. J. 2012, 18 (42), 
13274–13278.  
(119)  Zhang, M.; Watanabe, K.; Tsukamoto, M.; Shibuya, R.; Morimoto, H.; Ohshima, 
T. Chem. Eur. J. 2014, 21 (10), 3937–3941.     
52 
 
Chapter 2  
2 The Tandem Cyclopropanation/Vinylogous Cloke-
Wilson Rearrangement for the Synthesis of 
Heterocyclic Scaffolds 
This chapter was adapted from the following manuscript:  
Piotrowski, M. L.; Kerr, M. A. Org. Lett. 2018, 20, 7624-7627 
2.1 Introduction 
The ring strain inherent in DA cyclopropanes and the weakened vicinal C-C bond due to 
the synergistic electron push-pull relationship between the D and A groups has been 
exploited for decades.  Simple nucleophilic ring-opening of a DA cyclopropane (a homo-
Michael addition) or electrophilic ring-opening (homo-enolate addition) results in linear 
compounds, while reaction with dipolar species can result in hetero- or carbocyclic 
products. Rearrangement reactions of DA cyclopropanes represents another class of 
reactivity for an expedient method to access complex chemical structures in an atom 
economical manner.64–73 Perhaps one of the most well-established processes is the 
vinylcyclopropane-cyclopentene rearrangement which results in five membered ring 
products.92 A much less studied variant of this reaction is the Cloke-Wilson 
rearrangement (Scheme 1-42).  In 1929, Cloke reported that treatment of cyclopropyl 
phenyl ketone with ammonium chloride resulted in the formation of a dihydropyrrole.120  
In 1947 Wilson was able to induce rearrangement of cyclopropane carboxyaldehyde to 
dihydrofuran.121  Since these initial discoveries, there have been notable advancements 
including organocatalysis (Scheme 1-46)99, DYKAT (Scheme 2-1a)122, silicon promotion 
(Scheme 2-1b)123, and transition metal catalysis (Scheme 2-1c).124  
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Scheme 2-1. Recent advances in the Cloke-Wilson rearrangement to dihydrofurans 
Herein we report a tandem cyclopropanation/Cloke-Wilson rearrangement as well as a 
rarer but not unprecedented105,106,125–128 vinylogous variant (a retro-Claisen 
rearrangement) to form seven-membered oxacycles. 
2.2 Results and Discussion 
The discovery of the title reactions came about while exploring a route to kainic acid. The 
original plan was to cyclopropanate cyclopentadiene (2-7) with (2-8) to produce (2-9). 
The aldehyde would then be converted to aldimine (2-10) and subjected to a Cloke-
Wilson rearrangement to produce (2-11) which we deemed a possible synthetic precursor 
to kainic acid (2-12) (Scheme 2-2). When subjecting the reactants under metal-carbenoid 
cyclopropanation conditions, the desired cyclopropane was not isolable but formed a new 
product in situ which we first assigned to a Cloke-Wilson product such as (2-14a).  
Extensive NMR analysis, however showed that the product was in fact a 2,5-
dihydrooxepine (2-13a), the product of a vinylogous Cloke-Wilson reaction. With this 
interesting lead result in hand, we sought to explore the reaction for substrate scope and 
mechanistic understanding.  
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Scheme 2-2. Vinylogous Cloke-Wilson rearrangement to 2,5-dihydrooxepines 
Our study commenced with the treatment of 1,3-cyclohexadiene (2-7b) with 2-formyl 
ethyl diazoacetate (2-8) (Table 1). Zero-addition of all reagents in DCM at 40 °C 
provided dihydrooxepine (2-13b) in low yield along with an unknown by-product (entry 
1). It was later realized that the unknown by-product is the dimerization of (2-8) forming 
(2-15) which is a common occurrence in metal carbenoid chemistry (Figure 2-1).129,130  
 
Figure 2-1. Dimerization product of 2-formyl ethyl diazoacetate 
With this information in mind, it was decided to add (2-8) over an extended period of 
time to minimize this side reaction. Addition of the diazo species over a period of 30 
minutes did not show an improved yield (entry 2). Extending the addition time to one 
hour (entry 3) and two hours (entry 4) improved the yield slightly; however, the 
dimerization was still an issue. A switch in equivalence between cyclopentadiene and 
diazo showed an improvement in yield (entry 5). Lowering the reaction temperature to 25 
°C with a two-hour addition time drastically improved the yield (entry 6) while extending 
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the addition time to ten hours did not improve the results (entry 7). Cooling the reaction 
to 0 °C in order to minimize the dimerization even further proved to be effective; 
however, the yield did not improve due to a great deal of decomposition (entry 9). 
Lowering the amount of catalyst to 1 mol % with an addition time of two hours at 25 °C 
proved to be the most effective (entry 8). Other catalysts such as Rh2(OAc)4 provided the 
product in lower yields (entry 10) or were ineffective (entry 12-14).  
Table 1. Tandem cyclopropanation/vinylogous Cloke-Wilson rearrangement with formyldiazoacetate 
and 1,3-cyclohexadiene 
 
Entry Solvent Temp 
(°C) 
Addition time of 
diazo (hours) 
Catalyst (mol %) Diene:diazo Isolated 
yield (%) 
1 DCM 40 0 Rh2(esp)2 (2) 2:1 22 
2 DCM 40 0.5 Rh2(esp)2 (2) 2:1 28 
3 DCM 40 1 Rh2(esp)2 (2) 2:1 30 
4 DCM 40 2 Rh2(esp)2 (2) 2:1 34 
5 DCM 40 2 Rh2(esp)2 (2) 1:2 40 
6 DCM 25 2 Rh2(esp)2 (2) 1:2 64 
7 DCM 25 10 Rh2(esp)2 (2) 1:2 60 
8 DCM 25 2 Rh2(esp)2 (1) 1:2 62 
9 DCM 0 2 Rh2(esp)2 (1) 1:2 50 
56 
 
10 DCM 25 2 Rh2(OAc)4 (1) 1:2 20 
11 DCM 25 2 Rh2(esp)2 (1) 4:1 50 
12 DCM 25 2 Cu(OTf)2 (5) 1:2 No rxn 
13 DCE 85 2 Cu(OTf)2 (5) 1:2 Decomp. 
14 DCE 85 2 Cu(OTf)2 (5) 4:1 Decomp. 
15 DCM 25 2 Rh2(esp)2 (1) 1:3 62 
Treating a variety of readily available butadienes (2-7) with 2-formyl ethyl diazoacetate 
(2-8) under the conditions shown in entry 8 (Table 1), provided the corresponding 2,5-
dihydrooxepines in modest but acceptable yields given the rapid formation of molecular 
complexity (Figure 2-2).  
 
Figure 2-2. Tandem cyclopropanation/vinylogous Cloke-Wilson rearrangement towards 2,5-dihydrooxepines 
The modest yields can be explained by the formation of diastereomers during the 
cyclopropanation stage (Scheme 2-3). For the rearrangement to occur, an endo 
relationship between the aldehyde and the vinyl group is necessary.104,105,131 While one 
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diastereomer (2-16b) would be well positioned to undergo the rearrangement, the other 
(2-16a) would not. At this stage, this is merely a hypothesis as we have never been able 
to isolate products derived from (2-16a).  
 
Scheme 2-3. Mechanistic hypothesis 
We were surprised to see a different reactivity pattern when aryl substituted butadienes 
(2-17) were employed. Rather than the vinylogous reaction pathway, a tandem 
cyclopropanation/Cloke-Wilson process occurred (Figure 2-3). The most electron rich 
butadienes (yielding 2-18b,c) underwent spontaneous rearrangement to the 
dihydrofurans, while the others required treatment with a Lewis acid such as Sc(OTf)3 to 
promote the cyclization.  
 
Figure 2-3. Tandem cyclopropanation/Cloke-Wilson rearrangement towards dihydrofurans. [a] 
Product obtained as a mixture with cyclopropane; required treatment with 5 mol% Sc(OTf)3 in 
DCM at 40 °C to complete cyclization. 
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Interestingly, the dihydrooxepines from (Figure 2-1) underwent rearrangement to their 
dihydrofuran counterparts (2-14) upon treatment with a Lewis acid (Figure 2-4), likely 
via a 1,3-oxygen migration involving an allyl cation (Scheme 2-4). Several things are 
worthy of note. The bicyclic dihydrooxepines underwent this process in exceedingly high 
yields, likely due the favorable strain relief in going from a seven-membered ring to a 
five-membered ring. When the regioisomeric mixture of (2-13d) and (2-13e) was 
subjected to the reaction conditions, only (2-13d) underwent rearrangement.  This result 
is likely due the fact that (2-13d) may form a 3o carbocation while (2-13e) would require 
a higher energy 2o cation. 
 
Figure 2-4. Rearrangement of dihydrooxepines to dihydrofurans 
 
Scheme 2-4. Proposed mechanism for the rearrangement of dihydrooxepines to dihydrofurans 
Inspired by a report by the Ma group132, we sought to perform an oxygen to nitrogen 
transposition to access aza-heterocycles (2-21). The Ma communication reported only a 
single example as a mechanistic study and so this is (to the best of our knowledge) an 
unexplored reaction.  Using slightly modified conditions, we subjected the dihydrofurans 
from (Figures 2-3 and 2-4) and were delighted with the results (Figure 2-5). We limited 
this study to the use of benzylamine except for a single case where p-anisidine was 
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employed successfully. Ma’s paper provides a reasonable mechanism which involves a π-
allyl intermediate. 
 
Figure 2-5. Conversion of dihydrofurans to dihydropyrroles 
To improve the efficiency of the rearrangements described above, we sought ways to 
shorten the number of steps involved (Figure 2-6). When testing a one-pot protocol for 
the tandem cyclopropanation/vinylogous Cloke-Wilson rearrangement followed by the 
1,3-allylic migration, formation of (2-14a) was achieved, however the overall yield was 
inferior. Also, when the oxygen to nitrogen transposition was attempted on 
dihydrooxepine (2-13a), rearrangement was concurrent with nitrogen insertion.  The 
yield for the one-step process was similar to that of the sequential reactions. 
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Figure 2-6. [a] One-pot cyclopropanation/vinylogous Cloke-Wilson rearrangement/1,3-allylic 
migration. [b] Direct conversion of dihydrooxepine to dihydropyrrole. 
2.3 Conclusion 
In summary, we have described a tandem cyclopropanation/Cloke-Wilson rearrangement 
as well as the associated vinylogous Cloke-Wilson rearrangement to provide access to 
2,5-dihydrooxepine and dihydrofuran scaffolds.  Moreover, the dihydrofurans were 
converted to dihydropyrroles via a relatively unknown palladium-catalyzed oxygen to 
nitrogen transposition. 
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2.5 Experimental 
2.5.1 General Considerations 
All reactions were conducted under an atmosphere of argon unless otherwise indicated. 
DCM, toluene, DMF, and THF were dried and deoxygenated by passing the nitrogen 
purged solvents through activated alumina columns. All other solvents and reagents were 
used as purchased from Sigma Aldrich, Alfa Aesar, Caledon, VWR or Oakwood 
Chemicals and used as received. Reaction progress was followed by thin layer 
chromatography (TLC) (Merck, TLC silica gel 60 F254) visualized with UV light, and 
the plates developed with p-anisaldehyde, vanillin, basic potassium permanganate or 
DMP stains. Column chromatography was performed using silica gel (230-400 mesh, 
Silicycle Chemical Division Inc). 
NMR experiments were performed on Varian Mercury 400, Bruker AvIII 400, Inova 400 
and Inova 600 MHz instruments with 13C operating frequencies of 100, 100, 100, and 150 
MHz respectively. Chemical shifts are reported in ppm relative to the residual solvent 
signal; CDCl3, referenced to residual CHCl3 at δ = 7.26 for 
1H and δ = 77.1 for 13C. 
Coupling constants (J) are reported in Hz, and multiplicities of the signals are described 
62 
 
using the following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, quin = 
quintet, m = multiplet, br = broad. High resolution mass spectra (HRMS) were obtained 
on a Thermo Scientific DFS mass spectrometer using electron impact ionization. Melting 
points were determined using a Digimelt MPA160 melting point apparatus from Stanford 
Research Systems (SRS). Infrared spectra were obtained using a Bruker Alpha II 
Platinum ATR spectrometer or as thin films on NaCl plates using a Bruker Vector 33 FT-
IR instrument and are reported in frequency of absorption (cm-1). 
2.5.2 Experimental procedures and characterization data 
General procedure for the synthesis of formyldiazoacetate 2-8 
 
Thionyl chloride (1 equiv, 90 mmol) was added dropwise to anhydrous DMF (1 equiv, 90 
mmol) at room temperature. Once added, the reaction mixture was heated to 40˚ C for 
three hours. The reaction mixture was placed directly under high vacuum until a 
colourless precipitate was formed. The precipitate was dissolved in chloroform (40ml) 
and cooled to -20˚ C using an ice/acetone bath. To the cooled solution, ethyl diazoacetate 
(2 equiv, 180 mmol) was added dropwise over a period of 30 minutes and the reaction 
mixture was stirred at room temperature for an hour. Solvent was removed and the 
orange precipitate was washed with cold ether (50ml) followed by vacuum filtration. The 
precipitate was washed with 100ml cold ether, collected and dissolved in 10% aqueous 
acetic acid (40ml) and stirred overnight at room temperature. The aqueous solution was 
extracted with ether and the combined organic layers were washed with aqueous 
saturated sodium hydrogen carbonate (40ml), 10% aqueous sulfuric acid solution (40ml), 
brine, and dried using MgSO4. The resulting yellow oil was used without further 
purification (36%, 4.5940g). Full characterization can be found in the published articlesa-
c. Note: if all the α-chloroethyl acetate by product hasn’t been removed during the 
vacuum filtration washes with ether, the product obtained after the completed workup can 
be passed through a silica plug eluting with ethyl acetate. 
63 
 
Synthesis of 1,3-dienes 
Procedure for the formation of allyltrimethylphosphonium bromide 
 
Trimethylphosphine (1M in THF) (30ml, 30mmol) in dry DCM (30ml) under Argon gas 
was cooled to 0 ˚C. Allyl bromide (2.6ml, 30mmol) was added dropwise and the reaction 
was stirred at room temperature for 2.5 hours. The solvent was removed under reduced 
pressure to yield the desired compound (quant. 5.9g)d, e.  
General procedure for the synthesis of 1,3-dienes 
 
Allyltrimethylphosphonium bromide (0.25g, 1.25mmol) under argon gas in 6.25ml THF 
was cooled to 0 ˚C. Butyl lithium (2.5M in hexanes) (0.5ml, 1.25mmol) added dropwise 
and stirred for 15mins. Aldehyde (0.11g, 1.0mmol) in 1.25ml THF was added dropwise 
and stirred for one hour at 0 ˚C followed by stirring at room temperature until reaction 
completion monitored by TLC analysis. The reaction mixture was quenched with 
saturated NH4Cl and extracted with ether. The combined organic layers were washed 
with brine, dried with MgSO4, filtered and the solvent was removed under reduced 
pressure. The crude material was filtered through a silica plug eluting with 10% 
Et2O/pentane providing the final diene (0.1555g, 0.97mmol)
f. 
Full characterization of these starting materials can be found in the following references: 
a) F. M. Stojanovic, Z. Arnold, Collect. Czechoslov. Chem. Commun. 1967, 32, 
2155-2160. 
b) L. Jiang, A. Davison, G. Tennant, R. Ramage, Tetrahedron 1998, 54, 14233-
14254. 
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c) J. Linder, T. P. Garner, H. E. L. Williams, M. S. Searle, C. J. Moody, J. Am. 
Chem. Soc. 2011, 133, 1044-1051. 
d) R. Tamura, K. Saegusa, M. Kakihana, D. Oda, J. Org. Chem. 1988, 53, 2723-
2728. 
e) J. McNulty, P. Das, Tetrahedron Lett. 2009, 50, 5737-5740. 
f) A. Lishchynskyi, K. Muniz, Chem. Eur. J. 2012, 18, 2212-2216. 
General procedure for the formation of dihydrooxepine and dihydrofuran compounds (2-
13 and 2-18) 
To a round bottom flask containing a stir bar, Rh2(esp)2 catalyst (1 mol %) was added and 
purged with argon gas. DCM (0.35M) was added followed by the addition of the 1,3-
diene (1 equiv). Formyldiazoacetate 2-8 (2 equiv) in DCM (0.35M) was added at room 
temperature via syringe pump over a period of 2 hours. The reaction mixture was stirred 
at room temperature until completion monitored by TLC analysis. Solvent was removed 
under reduced pressure and the residue was purified by flash chromatography 
(EtOAc/Hexanes; unless otherwise indicated) to yield the desired compounds. For 
dihydrofurans (2-18a, d-f), additional treatment with Sc(OTf)3 in DCM at 40 °C for one 
hour was required to complete the cyclization. The mixture was then filtered through a 
silica plug eluting with EtOAc/Hexanes. 
Ethyl 2-oxabicyclo[3.2.1]octa-3,6-diene-4-carboxylate 2-13a 
 
Reagents employed: formyldiazoacetate 2-8 (0.2g, 1.4 mmol), cyclopentadiene (0.06ml, 
0.7 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (5mg, 0.007 
mmol), DCM (6ml): yield 60% (0.075g, 0.42 mmol) as a yellow oil; Rf = 0.59, 30% 
EtOAc/hexanes; 1H NMR (600 MHz, CDCl3) δ  7.11 (d, J = 1.5 Hz, 1H), 6.51 (dd, J = 
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5.3, 2.4 Hz, 1H), 5.55 (dd, J = 5.3, 2.4 Hz, 1H), 5.05 (m, 1H), 4.17 (q, J = 7.0 Hz, 2H), 
3.35 (br s, 1H), 2.05 (ddd, J = 11.2, 4.1, 2.9 Hz, 1H), 1.85 (d, J = 11.2 Hz, 1H) 1.27 (t, J = 
7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ  166.3, 152.6, 143.4, 121.8, 111.8, 81.6, 
59.9, 35.8, 34.8, 14.5; IR (thin film, cm-1) 2981, 1703, 1605, 1249, 1078; HRMS (EI) 
calc’d for C10H12O3 180.0786, found 180.0781. 
Ethyl 2-oxabicyclo[3.2.2]nona-3,6-diene-4-carboxylate 2-13b 
 
Reagents employed: formyldiazoacetate 2-8 (0.2g, 1.4mmol), 1,3-cyclohexadiene 
(0.07ml, 0.7mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] 
(5mg, 0.007mmol), DCM (6ml): yield 62% (0.084g, 0.43 mmol) as a yellow oil; Rf = 
0.62, 30% EtOAc/hexanes; 1H NMR (400 MHz, CDCl3) δ  7.23 (d, J = 1.3 Hz, 1 H) 6.70 
(ddd, J = 8.8, 6.4, 1.1 Hz, 1 H) 5.97 (ddd, J = 8.8, 6.4, 1.1 Hz, 1 H) 4.62 (ddt, J = 6.5, 5.2, 
1.4 Hz, 1 H) 4.14 (q, J = 7.2 Hz, 2 H) 3.23-3.19 (m, 1 H) 2.51 (dddd, J = 15.4, 9.3, 6.2, 
1.4 Hz, 1 H) 2.24-2.17 (m, 1 H) 1.95-1.87 (m, 1 H) 1.77 (dddd, J = 12.9, 11.3, 6.2, 4.0 
Hz, 1 H) 1.25 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 168.0, 156.3, 141.7, 
123.2, 111.5, 72.5, 60.2, 29.3, 28.6, 27.8, 14.5; IR (thin film, cm-1) 2979, 1697, 1615, 
1196, 1063, 891; HRMS (EI) calc’d for C11H14O3 194.0943, found 194.0944. 
Ethyl 5,6-dimethyl-4,7-dihydrooxepine-3-carboxylate 2-13c 
 
Reagents employed: formyldiazoacetate 2-8 (0.2g, 1.4 mmol), 2,3-dimethyl-1,3-
butadiene (0.08ml, 0.7 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic 
acid)] (5mg, 0.007 mmol), DCM (6ml): purified with column chromatography using 5% 
Et2O/pentane; yield 60% (0.083g, 0.42 mmol) as a yellow oil; Rf = 0.64, 30% 
EtOAc/hexanes; 1H NMR (400 MHz, CDCl3) δ = 7.47 (s, 1H), 4.60 (s, 2H), 4.15 (q, J = 
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7.1 Hz, 2H), 3.19 (s, 2H), 1.80 (br s, 6H), 1.26 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ = 168.9, 158.0, 139.0, 126.4, 106.4, 71.9, 60.2, 30.0, 20.8, 18.4, 14.4; IR (thin 
film, cm-1) 2981, 1698, 1626, 1251, 1210, 1071; HRMS (EI) calc’d for C11H16O3 
196.1099, found 196.1100. 
Ethyl 6-methyl-4,7-dihydrooxepine-3-carboxylate 2-13d and 2-13e 
 
Reagents employed: formyldiazoacetate 2-8 (0.43g, 3.0 mmol), isoprene (0.15ml, 1.5 
mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (0.011g, 0.015 
mmol), DCM (13ml): purified with column chromatography using 5% Et2O/pentane; 
yield 46% (0.12g, 0.69 mmol) as an inseparable mixture of isomers (3:1) as a yellow oil; 
Rf = 0.68, 30% EtOAc/hexanes; 1H NMR (400 MHz, CDCl3, 2-13d) δ = 7.52 (t, J = 1.0 
Hz, 1H), 5.74 (t, J = 7.1 Hz, 1H), 4.57 (d, J = 7.1 Hz, 2H), 4.15 (q, J = 7.1 Hz, 2H), 3.22 
(s, 2H), 1.86 (s, 3H), 1.26 (t, J = 7.1 Hz, 3H); 1H NMR (400 MHz, CDCl3, 2-13e) δ = 
7.50 (t, J = 1.0 Hz, 1H), 5.93 (tq, J = 6.3, 1.7 Hz, 1H), 4.60 (s, 2H), 4.15 (q, J = 7.1 Hz, 
2H), 3.15-3.12 (m, 2H), 1.82 (q, J = 1.5 Hz, 3H); 13C NMR (100 MHz, CDCl3, 2-13d) δ 
= 168.8, 158.4, 148.4, 120.0, 105.3, 65.8, 60.3, 29.1, 25.0, 14.5; 13C NMR (100MHz, 
CDCl3, 2-13e) δ = 168.8, 158.2, 134.9, 130.0, 107.3, 70.4, 62.4, 41.0, 23.3, 22.4, 14.2; IR 
(thin film, cm-1) 2978, 1698, 1625, 1223, 1095, 1065; HRMS (EI) calc’d for C10H14O3 
182.0943, found 182.0942. 
(E)-ethyl 5-styryl-4,5-dihydrofuran-3-carboxylate 2-18a 
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Reagents employed: formyldiazoacetate 2-8 (0.22g, 1.54 mmol), (E)-buta-1,3-dien-1-
ylbenzene (0.1g, 0.77 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic 
acid)] (6mg, 0.0077mmol), DCM (7ml); yield 50% (0.095g, 0.39 mmol) as a mixture of 
cyclopropane and dihydrofuran; Rf = 0.61, 30% EtOAc/hexanes; Reagents employed: 
Cyclopropane/dihydrofuran mixture (0.095g, 0.39 mmol), Sc(OTf)3 (0.01g, 0.019 mmol), 
DCM (3ml): yield 100% (0.095g, 0.39 mmol) as a yellow oil; Rf = 0.61, 30% 
EtOAc/hexanes; 1H NMR (400 MHz, CDCl3) δ  7.41-7.38 (m, 2H), 7.35-7.31 (m, 2H), 
7.30-7.27 (m, 2H), 6.64 (d, J = 15.9 Hz, 1H), 6.28 (dd, J = 15.8, 7.3 Hz, 1H), 5.39 (dt, J = 
9.5, 7.6 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.11 (ddd, J = 14.7, 10.6, 1.9 Hz, 1H), 2.74 
(ddd, J = 14.7, 8.0, 1.9 Hz, 1H), 1.29 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
= 165.3, 156.3, 136.0, 132.6, 128.7, 128.3, 127.4, 126.8, 108.9, 85.8, 59.9, 34.2, 14.5; IR 
(thin film, cm-1) 2980, 1701, 1624, 1102, 751, 692; HRMS (EI) calc’d for C15H16O3 
244.1099, found 244.1098. 
(E)-ethyl 5-(4-methoxystyryl)-4,5-dihydrofuran-3-carboxylate 2-18b 
 
Reagents employed: formyldiazoacetate 2-8 (0.26g, 1.88 mmol), (E)-1-(buta-1,3-dien-1-
yl)-4-methoxybenzene (0.15g, 0.94 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-
benzenedipropionic acid)] (7mg, 0.0094 mmol), DCM (8ml): yield 63% (0.16g, 0.59 
mmol) as a green/yellowish solid; Rf = 0.45, 30% EtOAc/hexanes; melting point: 64.4-
64.6 °C  1H NMR (400 MHz, CDCl3)   7.35-7.31 (AA
’BB’, 2H), 7.27 (t, J = 1.9 Hz, 
1H), 6.88-6.84 (AA’BB’, 2H), 6.58 (d, J = 15.6 Hz, 1H), 6.14 (dd, J = 15.8, 7.5 Hz, 1H), 
5.36 (dt, J = 10.4, 7.7 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 3.08 (ddd, J = 14.7, 
10.4, 1.9 Hz, 1H), 2.72 (ddd, J = 14.4, 8.0, 1.8 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H); 13C 
NMR (100 MHz, CDCl3)   165.3, 159.8, 156.3, 132.4, 128.7, 128.1, 125.2, 114.1, 
108.9, 86.2, 59.9, 55.4, 34.2, 14.5; IR (thin film, cm-1) 2980, 1700, 1624, 1512, 1249, 
1102, 1032; HRMS (EI) calc’d for C16H18O4 274.1205, found 274.1207. 
(E)-ethyl 5-(3,4-dimethoxystyryl)-4,5-dihydrofuran-3-carboxylate 2-18c 
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Reagents employed: formyldiazoacetate 2-8 (0.27g, 1.9 mmol), (E)-4-(buta-1,3-dien-1-
yl)-1,2-dimethoxybenzene (0.18g, 0.97 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-
benzenedipropionic acid)] (7mg, 0.0097 mmol), DCM (8ml): yield 43% (0.12g, 0.42 
mmol) as a yellow oil; Rf = 0.28, 30% EtOAc/hexanes; 1H NMR (400 MHz, CDCl3) δ  
7.28 (t, J = 1.9 Hz, 1H), 6.95-6.92 (m, 2H), 6.82 (d, J = 7.9 Hz, 1H), 6.58 (d, J = 15.7 Hz, 
1H), 6.15 (dd, J = 15.7, 7.4 Hz, 1H), 5.37 (dt, J = 9.6, 7.7 Hz, 1H), 4.19 (q, J = 7.1 Hz, 
2H), 3.90 (s, 3H), 3.89 (s, 3H), 3.10 (ddd, J = 14.8, 10.5, 1.9 Hz, 1H), 2.74, (ddd, J = 
14.8, 7.8, 1.8 Hz, 1H), 1.28 (t, J = 7.1 Hz, 3H); 13C NMR (100MHz, CDCl3) δ  165.2, 
156.3, 149.4, 149.1, 132.6, 129.0, 125.3, 120.3, 111.1, 108.9, 108.8, 86.1, 59.8, 56.0, 
55.9, 34.1, 14.5; IR (thin film, cm-1) 2935, 1698, 1623, 1515, 1265, 1101, 1025; HRMS 
(EI) calc’d for C17H20O5 304.1311, found 304.1311. 
(E)-ethyl 5-(4-nitrostyryl)-4,5-dihydrofuran-3-carboxylate 2-18d 
 
Reagents employed: formyldiazoacetate 2-8 (0.19g, 1.4 mmol), (E)-1-(buta-1,3-dien-1-
yl)-4-nitrobenzene (0.054g, 0.31 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-
benzenedipropionic acid)] (2mg, 0.0031 mmol), DCM (5ml): yield 29% (0.026g, 0.09 
mmol) as a dark orange oil; Rf = 0.41, 20% EtOAc/hexanes; Reagents employed: 
cyclopropane/dihydrofuran mixture (0.026g, 0.09 mmol), Sc(OTf)3 (2mg, 0.0045 mmol), 
DCM (0.75ml): yield 100% (0.026g, 0.09 mmol) as a dark yellow oil; Rf = 0.41, 20% 
EtOAc/hexanes; 1H NMR δ 8.21-8.16 (m, 2H), 7.54-7.51 (m, 2H), 7.28 (brs, 1H), 6.69 
(d, J = 15.8 Hz, 1H), 6.44 (dd, J = 15.9, 6.5 Hz, 1H), 5.42 (dt, J = 10.6, 7.1 Hz, 4.19 (q, J 
= 7.1 Hz, 2H), 3.15 (ddd, J = 14.7, 10.7, 1.4 Hz, 1H), 2.74 (ddd, J = 14.8, 7.7, 1.5 Hz, 
1H), 1.28 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 165.1, 156.1, 147.4, 142.5, 
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132.3, 129.8, 127.4, 124.2, 109.0, 84.7, 60.1, 34.2, 14.5; IR (cm-1) 2981, 1698, 1514, 
1340, 1097; HRMS (EI) calc’d for C15H15NO5 289.0950, found 289.0963. 
(E)-ethyl 5-(2-methylstyryl)-4,5-dihydrofuran-3-carboxylate 2-18e 
 
Reagents employed: formyldiazoacetate 2-8 (0.24g, 1.7 mmol), (E)-1-(buta-1,3-dien-1-
yl)-2-methylbenzene (0.12g, 0.86 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-
benzenedipropionic acid)] (6mg, 0.0086 mmol), DCM (7.4ml): yield 50% (0.11g, 0.43 
mmol) as a yellow oil; Rf = 0.5, 20% EtOAc/hexanes; Reagents employed: 
cyclopropane/dihydrofuran mixture (0.11g, 0.43 mmol), Sc(OTf)3 (0.01g, 0.022 mmol), 
DCM (3ml): yield 100% (0.11g, 0.43 mmol) as a dark yellow oil; Rf = 0.5, 20% 
EtOAc/hexanes; 1H NMR (600 MHz, CDCl3) δ 7.46-7.43 (m, 1H), 7.29 (br s, 1H), 7.19-
7.14 (m, 3H), 6.86 (d, J = 15.6 Hz, 1H), 6.17 (dd, J = 15.7, 7.3 Hz, 1H), 5.41 (dt, J = 10.3, 
8.1 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.12 (ddd, J = 14.8, 10.5, 1.9 Hz, 1H), 2.75 (ddd, J 
= 14.7, 8.1, 1.9 Hz, 1H), 2.36 (s, 3H), 1.29 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 165.4, 156.5, 135.8, 135.0, 130.5, 130.4, 128.6, 128.1, 126.2, 125.8, 108.8, 
86.1, 59.9, 34.2, 19.8, 14.4; IR (cm-1) 2980, 1699, 1622, 1095, 749; HRMS (EI) calc’d 
for C16H18O3 258.1256, found 258.1257. 
(E)-ethyl 5-(4-fluorostyryl)-4,5-dihydrofuran-3-carboxylate 2-18f 
 
Reagents employed: formyldiazoacetate 2-8 (0.25g, 1.8 mmol), (E)-1-(buta-1,3-dien-1-
yl)-4-fluorobenzene (0.13g, 0.88 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-
benzenedipropionic acid)] (7mg, 0.0088 mmol), DCM (7.5ml): yield 65% (0.15g, 0.57 
mmol) as a yellow oil and mixture of cyclopropane and oxepine; Rf = 0.52, 30% 
EtOAc/hexanes; Reagents employed: cyclopropane/dihydrofuran mixture (0.15g, 0.57 
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mmol), Sc(OTf)3 (0.014g, 0.028 mmol), DCM (3ml): yield 98% (0.14g, 0.56 mmol) as a 
yellow oil; Rf = 0.52, 30% EtOAc/hexanes; 1H NMR (600 MHz, CDCl3) δ  7.37-7.36 
(AA’BB’, 2 H), 7.27 (t, J = 1.8 Hz, 1 H), 7.03-7.00 (AA’BB’, 2 H), 6.60 (d, J = 15.8 Hz, 1 
H), 6.19 (dd, J = 15.8, 7.2 Hz, 1 H), 5.36 (dt, J = 9.9, 7.5 Hz, 1 H), 4.19 (q, J = 7.1 Hz, 2 
H), 3.10 (ddd, J = 14.8, 10.5, 1.8 Hz, 1 H), 2.73 (ddd, J = 14.8, 7.9, 1.8 Hz, 1 H), 1.28 (t, 
J = 7.1 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ  165.2, 162.7 (d, 
 1JCF = 247.7 Hz), 
156.3, 132.2 (d, 4JCF = 3.4 Hz), 131.4, 128.4 (d, J
3
C-F = 8.1 Hz), 127.2, 115.7 (d, 
2JCF = 
21.7 Hz), 108.9, 85.6, 59.9, 34.1, 14.5; 19F NMR (376 MHz, CDCl3) δ  -113.42-(-
113.34); IR (thin film, cm-1) 2982, 1700, 1625, 1509, 1229, 1108, 755; HRMS (EI) 
calc’d for C15H15FO3 262.1005, found 262.0996. 
General procedure for the conversion of dihydrooxepines to dihydrofurans (2-14) 
In a round bottom flask containing the starting dihydrooxepine and stir bar was added 
DCM (0.12M) and Sc(OTf)3 (5 mol%) under argon gas. The reaction was heated to reflux 
for the allotted time. The reaction was then cooled to room temperature and filtered 
through celite eluting with DCM. Solvent was then removed under reduced pressure or 
with a stream of nitrogen gas for the more volatile compounds. The compounds either 
required no further purification or column chromatography eluting with EtOAc/hexanes 
or Et2O/pentane. 
Ethyl 4,6a-dihydro-3aH-cyclopenta[b]furan-3-carboxylate 2-14a 
 
Reagents employed: Dihydrooxepine 2-13a (0.11g, 0.63 mmol), Sc(OTf)3 (0.016g, 
0.032mmol), DCM (5ml): yield 98% (0.11g, 0.63 mmol) as a dark purple oil with a 
reaction time of one hour with no further purification required; Rf = 0.59, 30% 
EtOAc/hexanes; 1H NMR (400 MHz, CDCl3) δ  7.15 (d, J = 1.4 Hz, 1H), 6.08-6.05 (m, 
1H), 5.81-5.76 (m, 2H), 4.17 (q, J = 7.4 Hz, 2H), 3.79-3.74 (m, 1H), 2.76-2.68 (m, 1H), 
2.57-2.50 (m, 1H), 1.25 (t, J = 7.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ  165.5, 155.6, 
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136.9, 128.3, 113.1, 95.4, 59.8, 42.2, 39.2, 14.6; IR (thin film, cm-1) 2931, 1702, 1622, 
1104, 1028, 775; HRMS (EI) calc’d for C10H12O3 180.0786, found 180.0791. 
Ethyl 3a,4,5,7a-tetrahydrobenzofuran-3-carboxylate 2-14b 
 
Reagents employed: Dihydrooxepine 2-13b (0.084g, 0.43 mmol), Sc(OTf)3 (0.011g, 
0.022 mmol), DCM (3.6ml): yield 93% (0.078g, 0.4 mmol) as a dark purple oil with a 
reaction time of one hour and purified by column chromatography eluting with 15% 
EtOAc in hexanes; Rf = 0.61, 30% EtOAc/hexanes; 1H NMR (600 MHz, CDCl3) δ 7.30 
(brs, 1H), 6.25-6.21 (m, 1H), 5.98-5.95 (m, 1H), 4.92-4.89 (m, 1H), 4.24-4.19 (m, 2H), 
3.10-3.06 (m, 1H), 2.17-2.08 (m, 2H), 1.96-1.89 (m, 1H), 1.38-1.34 (m, 1H), 1.31 (t, J = 
7.1 Hz, 3H); 13C NMR δ 165.4, 157.1, 134.8, 123.2, 114.2, 81.0, 59.7, 38.6, 24.8, 23.1, 
14.5; IR (thin film, cm-1) 2929, 1708, 1616, 1098, 905, 766; HRMS (EI) calc’d for 
C11H14O3 194.0943, found 194.0942.  
Ethyl 5-methyl-5-(prop-1-en-2-yl)-4,5-dihydrofuran-3-carboxylate 2-14c 
 
Reagents employed: Dihydrooxepine 2-13c (0.05g, 0.25 mmol), Sc(OTf)3 (6mg, 0.012 
mmol), DCM (2ml): yield 74% (0.037g, 0.19 mmol) as a yellow oil with a reaction time 
of five hours and purified by column chromatography eluting with 5% Et2O in pentane 
and concentrated with nitrogen gas; Rf = 0.33, 10% EtOAc/hexanes; 1H NMR (400 
MHz, CDCl3) δ 7.22 (t, J = 2.0 Hz, 1H), 4.99 (brs, 1H), 4.83 (brs, 1H), 4.17 (q, J = 7.1 
Hz, 2H), 2.87, 2.63 (ABq, JAB = 14.6 Hz, 2H; with each signal split into a doublet due to 
4JCH = 1.8 Hz coupling with the methine proton), 1.78 (s, 3H), 1.49 (s, 3H), 1.27 (t, J = 
7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 165.6, 155.5, 146.9, 110.2, 107.9, 93.2, 
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59.9, 39.5, 26.2, 18.5, 14.6; IR (cm-1) 2978, 1700, 1624, 1101; HRMS (EI) calc’d for 
C11H16O3 196.1099, found 196.1102. 
Ethyl 5-methyl-5-vinyl-4,5-dihydrofuran-3-carboxylate 2-14d 
 
Reagents employed: Dihydrooxepine (2-13d,e) (0.12g, 0.69 mmol), Sc(OTf)3 (0.017g, 
0.034 mmol), DCM (6ml): yield 65% (0.082g, 0.45 mmol) as a yellow oil purified by 
column chromatography eluting with 5% Et2O in pentane and concentrated with nitrogen 
gas; Rf = 0.54, 10% EtOAc/hexanes; 1H NMR (400 MHz, CDCl3) δ = 7.18 (t, J = 1.8 Hz, 
1H), 5.95 (dd, J = 17.2, 10.8 Hz, 1H), 5.21 (d, J = 17.3 Hz, 1H), 5.08 (d, J = 10.8 Hz, 
1H), 4.14 (q, J = 7.1 Hz, 2H), 2.81, 2.65 (ABq, JAB = 14.6 Hz, 2H; with each signal split 
into a doublet due to 4JCH = 1.8 Hz coupling with the methine proton), 1.46 (s, 3H), 1.25 
(t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 165.4, 155.4, 140.9, 113.0, 107.9, 
90.8, 59.8, 39.9, 26.4, 14.5; IR (cm-1) 2978, 1700, 1622, 1099; HRMS (EI) calc’d for 
C10H14O3 182.0943, found 182.0945. 
General procedure for the conversion of dihydrofuran to dihydropyrrole (2-21) 
In a microwave vial or sealed tube containing magnetic stir bar and capped with a rubber 
septum under argon gas was added the starting dihydrofuran (1 equiv.) followed by dry 
toluene (0.12M). In the following order was added benzylamine or p-anisidine (5 equiv. 
or 3 equiv. respectively), p-TsOH·H2O (0.25 mol%) and Pd(PPh3)4 (6 mol%) under 
argon. The rubber septum was replaced with a microwave vial cap or sealed tube cap and 
heated to 100 ˚C overnight. The reaction was cooled to room temperature and 
concentrated under reduced pressure. The residue was purified by column 
chromatography (EtOAc/Hexanes) to yield the desired compounds (2-21a-j). 
Ethyl 1-benzyl-1,3a,4,6a-tetrahydrocyclopenta[b]pyrrole-3-carboxylate 2-21a 
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Reagents employed: dihydrofuran 2-14a (0.37g, 2.0 mmol), benzylamine (1.0ml, 10.0 
mmol), Tetrakis(triphenylphosphine)palladium(0) (0.14g, 0.12 mmol), p-Toluenesulfonic 
acid monohydrate (0.095g, 0.5 mmol), toluene (17ml): yield 75% (0.41g, 1.5 mmol) as an 
orange oil; Rf = 0.37, 30% EtOAc/hexanes; 1H NMR (600 MHz, CDCl3) δ  7.38-7.27 
(m, 4H), 7.26-7.25 (m, 1H), 7.04 (d, J = 1.0 Hz, 1H), 5.99-5.96 (m, 1H), 5.66-5.63 (m, 1 
H), 5.72-5.68 (m, 1 H), 4.36, 4.28 (ABq, JAB = 15.0, 2H), 4.19-4.06 (m, 2 H), 3.88 (dddd, 
J = 10.6, 8.3, 2.7, 1.0 Hz, 1 H), 2.81-2.73 (m, 1 H), 2.62-2.55 (m, 1 H), 1.24 (t, J = 7.1 
Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ  166.7, 148.9, 137.0, 135.6, 128.9, 128.1, 
127.9, 126.9, 103.9, 73.5, 58.8, 52.6, 43.3, 40.9, 14.8; IR (thin film, cm-1) 2918, 1671, 
1582, 1167, 1086, 698; HRMS (EI) calc’d for C17H19NO2 269.1416, found 269.1417. 
Ethyl 1-(4-methoxyphenyl)-1,3a,4,6a-tetrahydrocyclopenta[b]pyrrole-3-carboxylate 
2-21b 
 
Reagents employed: dihydrofuran (2-14a) (1.32g, 7.4 mmol), 4-methoxyaniline (2.82g, 
22.9 mmol), Tetrakis(triphenylphosphine)palladium(0) (0.51g, 0.44 mmol), p-
Toluenesulfonic acid monohydrate (0.35g, 1.8 mmol), toluene (62ml): yield 75% (1.58g, 
5.5 mmol) as a pale brown solid; Rf = 0.44, 30% EtOAc/hexanes; melting point: 61.6-
62.0 °C; 1H NMR (600 MHz, CDCl3) δ 7.51 (d, J = 1.2 Hz, 1H), 6.93-6.91 (AA’BB’, 
2H), 6.86-6.83 (AA’BB’ m, 2H), 6.03-6.01 (m, 1H), 5.88-5.85 (m, 1H), 5.33=5.30 (m, 
1H), 4.22-4.13 (m, 2H), 3.97 (br t, J = 9.1 Hz, 1H), 3.76 (s, 3H), 2.87-2.81 (m, 1H), 2.66-
2.64 (m, 1H), 1.28 (t, J = 7.1 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ  166.4, 154.6, 
140.7, 135.9, 134.9, 126.6, 116.2, 166.0, 115.1, 108.9, 72.8, 59.2, 55.7, 42.9, 40.2, 14.8; 
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IR (thin film, cm-1) 2928, 1679, 1596, 1514, 1243, 1211, 1100, 1034, 819; HRMS (EI)  
calc’d for C17H19NO3 285.1365, found 285.1367. 
Ethyl 1-benzyl-3a,4,5,7a-tetrahydro-1H-indole-3-carboxylate 2-21c 
 
Reagents employed: dihydrofuran (2-14b) (0.078g, 0.4 mmol), benzylamine (0.22ml, 2 
mmol), Tetrakis(triphenylphosphine)palladium(0) (0.028g, 0.024 mmol), p-
Toluenesulfonic acid monohydrate (0.019g, 0.1 mmol) toluene (3.3ml): yield 70% 
(0.079g, 0.28 mmol) as a yellow oil; Rf = 0.4, 20% EtOAc/hexanes; 1H NMR (600 MHz, 
CDCl3) δ 7.36-7.33 (m, 2H), 7.30-7.27 (m, 1H), 7.25-7.23 (m, 2H), 7.13 (s, 1H), 6.10-
6.07 (m, 1H), 5.79-5.76 (m, 1H), 4.35 (ABq, JAB = 15.0 Hz, 1H), 4.18-4.09 (overlapped 
of quartet with ABq, 3H), 3.77-3.74 (m, 1H), 2.99 (ddd, J = 11.5, 9.5, 4.5 Hz, 1H), 2.10-
2.05 (m, 1H), 2.01-1.97 (m, 1H), 1.95-1.88 (m, 2H), 1.36 (qd, J = 11.7, 4.5 Hz, 1H), 1.25 
(t, J = 7.1 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 166.4, 150.3, 136.6, 133.4, 128.9, 
128.8, 128.2, 127.9, 121.9, 105.9, 60.0, 58.9, 51.9, 39.4, 24.5, 23.6, 14.8; IR (cm-1) 2925, 
1669, 1578, 1139; HRMS (EI) calc’d for C18H21NO2 283.1572, found 283.1558. 
Ethyl 1-benzyl-5-methyl-5-(prop-1-en-2-yl)-4,5-dihydro-1H-pyrrole-3-carboxylate 2-
21d 
 
Reagents employed: dihydrofuran (2-14c) (0.048g, 0.24 mmol), benzylamine (0.13ml, 
1.2 mmol), Tetrakis(triphenylphosphine)palladium(0) (0.017g, 0.014 mmol), p-
Toluenesulfonic acid monohydrate (0.011g, 0.06 mmol) toluene (2ml): yield 70% 
(0.047g, 0.16 mmol) as a yellow oil; Rf = 0.47, 20% EtOAc/hexanes; 1H NMR (600 
MHz, CDCl3) δ 7.36-7.33 (m, 3H), 7.30-7.28 (m, 1H), 7.25-7.24 (m, 2H), 7.00 (br s, 1H), 
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4.98 (d, J = 8.4 Hz, 2H), 4.12-4.08 (overlapped of quartet with ABq, 3H) 3.99 (ABq, JAB = 
14.6 Hz, 1H), 2.94, 2.63 (ABq, JAB = 15.0 Hz, 2H; with each signal split into a doublet 
due to 4JCH = 1.3 Hz coupling with the methine proton), 1.79 (s, 3H), 1.40 (s, 3H), 1.22 (t, 
J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 166.7, 148.8, 146.8, 137.8, 128.9, 128.4, 
127.8, 112.8, 98.4, 71.6, 58.9, 48.5, 41.6, 23.6, 19.0, 14.8; IR (cm-1) 2977, 1633, 1591, 
1145; HRMS (EI) calc’d for C18H23NO2 285.1729, found 285.1716. 
Ethyl 1-benzyl-5-methyl-5-vinyl-4,5-dihydro-1H-pyrrole-3-carboxylate 2-21e 
 
Reagents employed: dihydrofuran (2-14d) (0.051g, 0.28 mmol), benzylamine (0.15ml, 
1.4 mmol), Tetrakis(triphenylphosphine)palladium(0) (0.019g, 0.017 mmol), p-
Toluenesulfonic acid monohydrate (0.013g, 0.07 mmol), toluene (2.3ml): yield 75% 
(0.057g, 0.21 mmol) as a red oil; Rf = 0.39, 20% EtOAc/hexanes; 1H NMR (600 MHz, 
CDCl3) δ 7.36-7.33 (m, 2H), 7.30-7.27 (m, 1H), 7.25-7.24 (m, 2H), 6.97 (br s, 1H), 5.98 
(dd, J = 17.4, 10.7 Hz, 1H), 5.20 (d, J = 14.7 Hz, 1H), 5.17 (d, J = 7.9 Hz, 1H), 4.14-4.08 
(overlapped of quartet with ABq, 3H), 4.05 (ABq, JAB = 14.8 Hz, 1H), 2.85, 2.72 (ABq, 
JAB = 14.7 Hz, 2H), 1.36 (s, 3H), 1.22 (t, J = 7.1 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ 
166.7, 148.8, 141.5, 138.2, 128.8, 128.2, 127.7, 114.5, 98.7, 69.4, 58.9, 48.5, 43.0, 22.1, 
14.8; IR (cm-1) 2975, 1671, 1590, 1146, 1075; HRMS (EI) calc’d for C17H21NO2 
271.1572, found 271.1571. 
(E)-ethyl 1-benzyl-5-styryl-4,5-dihydro-1H-pyrrole-3-carboxylate 2-21f 
 
Reagents employed: dihydrofuran (2-18a) (0.095g, 0.39 mmol), benzylamine (0.21ml, 
1.9 mmol), Tetrakis(triphenylphosphine)palladium(0) (0.027g, 0.023 mmol), p-
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Toluenesulfonic acid monohydrate (0.018g, 0.097 mmol), toluene (3.2ml): yield 70% 
(0.091g, 0.27 mmol) as an orange oil; Rf = 0.42, 20% EtOAc/hexanes; 1H NMR (400 
MHz, CDCl3) δ 7.38-7.27 (m, 7H), 7.25-7.21 (m, 2H), 7.17 (brs, 1H), 6.43 (d, J = 15.8 
Hz, 1H), 6.18 (dd, J = 15.8, 8.7 Hz, 1H), 4.31 (ABq, JAB = 14.9 Hz, 1H), 4.24 (dt, J = 
10.8, 9.1 Hz, 1H), 4.17-4.08 (overlapped of quartet with ABq, 3H), 3.07 (ddd, J = 14.9, 
11.1, 1.1 Hz, 1H), 2.68 (ddd, J = 14.9, 9.2, 1.3 Hz, 1H), 1.26 (t, J = 7.1 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ = 166.4, 150.3, 136.8, 136.4, 133.3, 128.9, 128.8, 128.5, 
128.3, 128.1, 127.8, 126.6, 100.6, 66.1, 59.1, 51.8, 35.4, 14.8; IR (cm-1) 2977, 1669, 
1589, 1167, 1070; HRMS (EI) calc’d for C22H23NO2 333.1729, found 333.1730. 
(E)-ethyl 1-benzyl-5-(4-methoxystyryl)-4,5-dihydro-1H-pyrrole-3-carboxylate 2-21g 
 
Reagents employed: dihydrofuran (2-18b) (0.043g, 0.16 mmol), benzylamine (0.08ml, 
0.8 mmol), Tetrakis(triphenylphosphine)palladium(0) (0.012g, 0.01 mmol), p-
Toluenesulfonic acid monohydrate (6mg, 0.03 mmol), toluene (1.3ml): yield 72% 
(0.042g, 0.11 mmol) as a yellow oil; Rf = 0.38, 30% EtOAc/hexanes; 1H NMR (CDCl3, 
600 MHz) δ 7.36-7.33 (m, 2H), 7.31-7.28 (m, 3H), 7.23-7.21 (m, 2H), 7.17 (br s, 1H), 
6.88-6.85 (AA’BB’, 2H), 6.37 (d, J = 15.7 Hz, 1H), 6.03 (dd, J = 15.7, 8.8 Hz, 1H), 4.29, 
4.10 (ABq, JAB = 14.9 Hz, 2H), 4.21 (dt, J = 11.0, 9.0 Hz, 1H), 4.14 (qd, J = 7.1, 2.3 Hz, 
2H), 3.82 (s, 3H), 3.05 (ddd, J = 15.0, 11.1, 1.1 Hz, 1H), 2.66 (ddd, J = 14.9, 9.3, 1.3 Hz, 
1H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 166.5, 159.6, 150.3, 136.9, 
132.8, 129.1, 128.8, 128.3, 127.9, 127.8, 126.3, 114.2, 100.5, 66.3, 59.0, 55.4, 51.7, 35.5, 
14.8; IR (thin film, cm-1) 2930, 1674, 1592, 1511, 1248, 1178, 1075, 700; HRMS (EI) 
calc’d for C23H23NO3 363.1834, found 363.1824. 
(E)-ethyl 1-benzyl-5-(3,4-dimethoxystyryl)-4,5-dihydro-1H-pyrrole-3-carboxylate 2-
18h 
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Reagents employed: dihydrofuran (2-18c) (0.05g, 0.16 mmol), benzylamine (0.09ml, 0.8 
mmol), Tetrakis(triphenylphosphine)palladium(0) (0.011g, 0.0096 mmol), p-
Toluenesulfonic acid monohydrate (8mg, 0.04 mmol), toluene (1.3ml): yield 85% 
(0.054g, 0.14 mmol) as a light yellow oil; Rf = 0.24, 30% EtOAc/hexanes; 1H NMR 
(CDCl3, 600 MHz) δ 7.36-7.33 (m, 2H), 7.31-7.28 (m, 1H), 7.24-7.22 (m, 2H), 7.18 (brs, 
1H), 6.91-6.88 (m, 2H), 6.82 (d, J = 8.2 Hz, 1H), 6.36 (d, J = 15.7 Hz, 1H), 6.03 (dd, J = 
15.7, 8.8 Hz, 1H), 4.30 (ABq, JAB = 15.0 Hz, 1H), 4.23 (dt, J = 11.3, 9.0 Hz, 1H), 4.16-
4.10 (overlapped of quartet with ABq, 3H), 3.91 (s, 3H), 3.89 (s, 3H), 3.06 (ddd, J = 15.0, 
11.1, 1.1 Hz, 1H), 2.68 (ddd, J = 15.0, 9.1, 1.3 Hz, 1H), 1.25 (t, J = 7.1 Hz, 3H); 13C 
NMR (150 MHz, CDCl3) δ 166.5, 150.4, 149.3, 149.2, 136.9, 132.9, 129.5, 128.9, 128.3, 
127.8, 126.5, 120.0, 111.2, 108.8, 100.5, 66.3, 59.1, 56.1, 56.0, 51.8, 35.5, 14.8; IR (cm-
1) 2933, 1669, 1588, 1512, 1263, 1137, 1071; HRMS (EI) calc’d for C24H27NO4 
393.1940, found 393.1921. 
 (E)-ethyl 1-benzyl-5-(2-methylstyryl)-4,5-dihydro-1H-pyrrole-3-carboxylate 2-21i 
 
Reagents employed: dihydrofuran (2-18e) (0.05g, 0.19 mmol), benzylamine (0.1ml, 0.95 
mmol), Tetrakis(triphenylphosphine)palladium(0) (0.013g, 0.011 mmol), p-
Toluenesulfonic acid monohydrate (9mg, 0.047 mmol), toluene (1.6ml): yield 66% 
(0.043g, 0.12 mmol) as a dark yellow oil; Rf = 0.4, 20% EtOAc/hexanes; 1H NMR (400 
MHz, CDCl3) δ 7.42-7.29 (m, 4H), 7.26-7.15 (m, 6H), 6.65 (d, J = 15.6 Hz, 1H), 6.07 
(dd, J = 15.6, 8.8 Hz, 1H), 4.33 (ABq, JAB = 14.9 Hz, 1H), 4.27 (dt, J = 11.0, 9.3 Hz, 1H), 
4.19-4.12 (overlapped of quartet with ABq, 3H), 3.09 (dd, J = 14.8, 11.2 Hz, 1H), 2.70 
(ddd, J = 14.9, 9.3, 1.3 Hz, 1H), 2.33 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 166.4, 150.4, 136.8, 135.6, 135.5, 131.2, 130.4, 129.8, 128.8, 128.3, 
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127.9, 127.8, 126.3, 125.9, 100.5, 66.3, 59.1, 51.8, 35.5, 19.9, 14.8; IR (cm-1) 2977, 
1670, 1590, 1168, 1072; HRMS (EI) calc’d for C23H25NO2 347.1885, found 347.1883. 
(E)-ethyl 1-benzyl-5-(4-fluorostyryl)-4,5-dihydro-1H-pyrrole-3-carboxylate 2-21j 
 
Reagents employed: dihydrofuran (2-18f) (0.08g, 0.3 mmol), benzylamine (0.16ml, 1.5 
mmol), Tetrakis(triphenylphosphine)palladium(0) (0.021g, 0.018 mmol), p-
Toluenesulfonic acid monohydrate (0.014g, 0.075 mmol), toluene (2.5ml): yield 68% 
(0.072g, 0.2 mmol) as an orange oil; Rf = 0.34, 20% EtOAc/hexanes; 1H NMR (400 
MHz, CDCl3) δ 7.37-7.28 (m, 5H, 7.23-7.21 (m, 2H), 7.17 (t, J = 1.2 Hz, 1H), 7.04-6.99 
(m, 2H), 6.39 (d, J = 15.8 Hz, 1H), 6.08 (dd, J = 15.8, 8.7 Hz, 1H), 4.30 (ABq, JAB = 14.9 
Hz, 1H), 4.22 (dt, J = 10.8, 9.0 Hz, 1H), 4.17-4.08 (overlapped of quartet with ABq, 3H), 
3.06 (ddd, J = 15.0, 11.1, 1.1 Hz, 1H), 2.66 (ddd, J = 15.0, 9.3, 1.3 Hz, 1H), 1.25 (t, J = 
7.1 Hz, 3H); 13C NMR 166.4, 162.6 (d, 1JCF = 247.4 Hz), 150.3, 136.8, 132.5 (d, 
4JCF = 
3.4 Hz), 132.0, 128.8, 128.33, 128.31, 128.26, 128.23, 128.1, 127.8, 115.7 (d, 2JCF = 21.6 
Hz), 100.6, 66.1, 59.1, 51.9, 35.4, 14.8 ; 19F{1H} NMR (376 MHz, CDCl3) δ -113.73; IR 
(cm-1) 2923, 1671, 1590, 1507, 1226, 1168, 1071; HRMS (EI) calc’d for C22H22FNO2 
351.1635, found 351.1629.   
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Chapter 3  
3 Synthesis of (±)-β-Allokainic Acid 
This chapter was adapted from the following manuscript: 
Piotrowski, M. L.; Kerr, M. A. Eur. J. Org. Chem. 2019, 3122-3126. 
3.1 Introduction 
The kainoid amino acids are a family of compounds that have gained considerable 
attention due to their biological properties such as neuroexcitatory and excitotoxic 
activities.108–111 α-kainic acid (3-1a) and its related structures (Figure 3-1) have been 
found to behave as agonists for the glutamate receptors mediating the effects of L-
glutamic acid and thus have been extensively used for the elucidation of the 
neurophysiological role of glutamic acid.109,113 
 
Figure 3-1. Kainoid family of compounds. Natural and unnatural 
It has been shown that when in direct contact with neurons, α-kainic acid can induce 
motor hyperactivity and seizures and can destroy neurons in specific regions that contain 
high concentrations of the molecule.108,109 This discovery helped to create model 
conditions for human diseases such as epilepsy, Huntington’s chorea and stroke.109,111 
Through the continuous study of the biological properties of the family of kainoid 
compounds, a better understanding of the structure activity relationship was obtained. It 
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was found that the stereochemistry around the pyrrolidine ring plays an important part in 
the biological activity of the molecule; the 2,3-trans-3,4-cis compounds showed potent 
activity whereas in 3-epi (2,3-cis) or 4-epi (3,4-trans) showed a dramatic reduction in 
activity.113  
We have recently shown the formation of substituted 2,5-dihydrooxepine rings (3-5) 
through a vinylogous Cloke-Wilson rearrangement (Scheme 3-1) of donor-acceptor 
cyclopropanes such as (3-4) and subsequent transformations that offer ready formation of 
dihydropyrroles such as (3-6).133 This compound was deemed a viable synthetic precursor 
to target the kainoid family of compounds. Our efforts towards the synthesis of members 
of the kainoids, resulting in the successful synthesis of (±)-β-allokainic acid, are 
described herein. 
 
Scheme 3-1. Formation of 2,5-dihydrooxepines through a vinylogous Cloke-Wilson rearrangement of 
donor-acceptor cyclopropanes and subsequent steps towards dihydropyrrole 
3.2 Results and Discussion 
Our original target compound was (±)-α-kainic acid (3-1a)134–139 which was envisioned to 
be obtained by basic hydrolysis of intermediate (3-7) which could be obtained from (3-8) 
through oxidatively cleaving the olefin to the di-acid followed by esterification (Scheme 
3-2). The benzyl group in this oxidation step will most likely oxidize to a benzoyl group. 
The isopropenyl moiety can be formed via dehydration of the tertiary alcohol. Compound 
(3-8) would be obtained from (3-6) through a vinylogous carbamate double bond 
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reduction and Grignard addition with methylmagnesium bromide to form the tertiary 
alcohol. And finally, compound (3-6) can be obtained as shown in our previous work 
(Scheme 3-1). 
 
Scheme 3-2. Retrosynthetic analysis towards kainic acid 
The vinylogous carbamate double bond in (3-6) was reduced with sodium borohydride in 
acetic acid140 providing the major diastereomer (3-9a) in a 60% yield and minor 
diastereomer (3-9b) in a 4% yield. At this time, it was still unclear as to which 
diastereomer was obtained. Treatment of (3-9a) with methylmagnesium bromide 
furnished the tertiary alcohol (3-8). Subjecting this compound to a variety of oxidative 
reactions resulted in extensive decomposition (Scheme 3-3a). Taking compound (3-8) 
and subjecting it towards Upjohn dihydroxylation conditions did furnish the desired diol 
(3-11); however, attempts at cleaving the diol to the di-aldehyde (3-12) resulted in 
decomposition (Scheme 3-3b). Attempts at protecting the tertiary alcohol (3-8) prior to 
the oxidation step was also unsuccessful (Scheme 3-3c). 
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Scheme 3-3. (a) Synthetic efforts towards the di-acid moiety. Conditions: (a) Oxone, OsO4, DMF; (b) 
RuCl3, NaIO4, CCl4, CH3CN, H2O; (c) RuO2, NaIO4, EtOAc, H2O; (d) 1) O3 2) HCO2H, H2O2; (3b) 
Attempted Johnson-Lemieux oxidation; (3c). Attempts at tertiary alcohol protection. Conditions: (a) 
MOMCl, NaI, DIPEA, DME; (b) Ac2O, DMAP, DCM; (c) Ac2O, NaOAc, 140 °C, MW. 
Due to the electron donating ability of the benzyl group, it is believed that under 
oxidative conditions, not only can the benzyl group oxidize to a benzoyl, but the C-5 
position on the pyrrolidine ring could also potentially oxidize forming a lactam, which 
could cause a mixture of products.141 Therefore, the removal of the benzyl group prior to 
the oxidative cleavage step would be ideal. 
Treatment of (3-9a) under Upjohn dihydroxylation conditions produced diol (3-14) 
followed by acetonide protection using 2,2-dimethoxylpropane (2,2-DMP) and PPTS 
producing acetonide (3-15). Transformation of the ester into the isopropenyl moiety 
began by treating (3-15) with excess methylmagnesium bromide forming tertiary alcohol 
(3-16). The use of Burgess reagent, known to be a very strong dehydrating agent for 
tertiary alcohols142, provided the isopropenyl compound (3-17a) as the major isomer in a 
50 % yield along with minor isopropylidene isomer (3-17b) in a 22% yield. After 
chromatographic separation of the two isomers, (3-17a) was treated with ethyl 
chloroformate forming carbamate (3-18)143 (Scheme 3-4). 
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Scheme 3-4. Synthetic route to carbamate 3-18 and ultimate stereochemical confirmation 
The stereochemistry of compound (3-18) was confirmed by comparing it with data 
published by the Coldham group during their work towards kainic acid143. The assigned 
stereochemistry was a disappointing revelation since the configuration of the isopropenyl 
moiety would need to be epimeric to access kainic acid. Epimerization of the ester moiety 
in (3-9a) or similar compounds was unsuccessful (Scheme 3-5).  With this information in 
hand we diverted our task to the synthesis of β-allokainic acid (3-1d).144 
 
Scheme 3-5. Attempted epimerization’s 
Starting from compound (3-17a), the benzyl group was replaced with a 
benzyloxycarbonyl group, forming carbamate (3-23) (Scheme 3-6). Acetonide removal 
yielded diol (3-24) which set the stage for oxidative cleavage. Many conditions involving 
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sodium periodate were explored with all leading to decomposition. A switch in oxidant to 
PhI(OAc)2 in DCM provided the crude di-aldehyde
145 which was subjected to a double 
Pinnick oxidation146 followed by derivatization as the methyl esters for ease of 
purification.  Thus, (3-25) was produced as a 1:1 mixture of rotamers (presumably as a 
result of the CBz group) in an overall yield of 64% over the three steps. Finally, basic 
hydrolysis provided (±)-β-allokainic acid (3-1d) in 60% yield.118,147 
 
Scheme 3-6. Final synthetic steps towards (±)-β-allokainic acid 
3.3 Conclusion 
In summary, a synthesis of (±)-β-allokainic acid has been achieved in a linear sequence 
of 12 steps with an overall yield of 3.5%. The synthesis of the pyrrolidine core (3-6) can 
be achieved in three chemical operations employing our previously reported vinylogous 
Cloke-Wilson rearrangement. Further manipulation to the final product is achieved 
through simple chemical transformations with minimal purification steps required. 
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3.5 Experimental 
3.5.1 General Considerations 
All reactions were conducted under an atmosphere of argon unless otherwise indicated. 
DCM, toluene, DMF, THF, and benzene were dried and deoxygenated by passing the 
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nitrogen purged solvents through activated alumina columns. All other solvents and 
reagents were used as purchased from Sigma Aldrich, Alfa Aesar, Caledon, VWR or 
Oakwood Chemicals and used as received. Reaction progress was monitored by TLC 
(EM Science, silica gel 60 F254), visualized with UV light, and the plates developed with 
p-anisaldehyde, vanillin, basic potassium permanganate or DMP stains. Column 
chromatography was performed using silica gel (230-400 mesh, Silicycle Chemical 
Division Inc). 
NMR experiments were performed on Varian Mercury 400, Bruker AvIII 400, Inova 400 
and Inova 600 MHz instruments with 13C operating frequencies of 100, 100, 100, and 125 
MHz respectively. Chemical shifts are reported in ppm relative to the residual solvent 
signal (CDCl3, referenced to residual CHCl3 at δ = 7.26 for 
1H and δ = 77.1 for 13C; D2O 
referenced at δ = 4.79 for 1H). Coupling constants (J) are reported in Hz, and 
multiplicities of the signals are described using the following abbreviations: s = singlet, d 
= doublet, t = triplet, q = quartet, quin = quintet, m = multiplet, br = broad. High 
resolution mass spectra (HRMS) were obtained on a Thermo Scientific DFS mass 
spectrometer using electron impact ionization. Melting points were determined using a 
Digimelt MPA160 melting point apparatus from Stanford Research Systems (SRS). 
Infrared spectra were obtained using a Bruker Alpha II Platinum ATR spectrometer or as 
thin films on NaCl plates using a Bruker Vector 33 FT-IR instrument and are reported in 
frequency of absorption (cm-1). 
3.5.2 Procedures and characterization data  
Procedure for vinylogous carbamate double bond reduction (3-9a,b): 
A round bottom flask containing 3-6 (1.13g, 4.2 mmol) was dissolved in acetic acid 
(35ml) under an open atmosphere. NaBH4 (0.79g, 21 mmol) was added slowly in small 
portions at room temperature and the reaction was stirred for one hour. The reaction was 
slowly quenched with water and extracted with DCM. The organic layers were washed 
twice with saturated NaHCO3, once with brine, dried with MgSO4 and concentrated 
under reduced pressure. The major isomer 3-9a was separated by flash chromatography 
(EtOAc/hexanes); yield: 60% (0.68g, 2.5 mmol) as an orange oil; Rfmajor = 0.32, 20% 
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EtOAc in hexanes; yield minor 3-9b: 4% (0.04g, 0.17 mmol) as an orange oil; Rfminor = 
0.18, 20% EtOAc in hexanes. 
(±)-(3S,3aS,6aS)-ethyl 1-benzyl-1,2,3,3a,4,6a-hexahydrocyclopenta[b]pyrrole-3-
carboxylate (3-9a) 
 
 1H NMR (400 MHz, CDCl3) δ 7.36-7.28 (m, 4H), 7.25-7.23 (m, 1H), 5.70-5.68 (m, 1H), 
5.42 (dq, J = 6.1, 2.1 Hz, 1H), 4.15 (q, J = 7.2 Hz, 2H), 3.84 (br d, J = 8.8 Hz, 1H) 3.75 
(ABq, JAB = 12.8 Hz, 2H), 3.10-3.02 (m, 2H), 2.72-2.65 (m, 2H), 2.63-2.55 (m, 1H), 2.28 
(dquin, J = 17.4, 2.4 Hz, 1H), 1.25 (t, J = 7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
174.3, 139.2, 131.4, 131.2, 129.2, 128.3, 127.1, 74.8, 60.6, 59.5, 56.6, 51.0, 43.3, 38.6, 
14.3; IR (cm-1) 2799, 1729, 1159, 697; HRMS (EI) m/z calc’d for C17H21NO2 271.1572 
(M+): found 271.1564. 
(±)-(3R,3aS,6aS)-ethyl 1-benzyl-1,2,3,3a,4,6a-hexahydrocyclopenta[b]pyrrole-3-
carboxylate (3-9b) 
 
1H NMR (400 MHz, CDCl3) δ 7.37-7.29 (m, 4H), 7.25-7.22 (m, 1H), 5.91-5.88 (m, 1H), 
5.68 (dq, J = 5.8, 2.2 Hz, 1H), 4.30 (br s, 1H), 4.14 (ddquin, J = 10.8, 7.2, 3.6 Hz, 2H), 
3.79, 3.65 (ABq, JAB = 13.1 Hz, 2H), 3.24-3.15 (m, 2H), 2.89-2.85 (m, 1H), 2.69-2.61 
(m, 1H), 2.50-2.43 (m, 1H), 2.14-2.07 (m, 1H), 1.26 (t, 7.1 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ = 173.0, 134.5, 129.2, 128.7, 128.4, 128.1, 127.0, 72.8, 60.3, 56.6, 51.5, 
47.5, 41.3, 35.9, 14.4; IR (cm-1) 2956, 1729, 1179, 697; HRMS (EI, source temp 250 °C) 
m/z calc’d for C17H21NO2 271.1572 (M
+): found 271.1569. 
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Procedure for dihydroxylation reaction (3-14) 
A round bottom flask containing 3-9a (1.36g, 5.0 mmol) was dissolved in 4:3 mixture of 
THF:H2O (29:21ml) under an open atmosphere. A small crystal of OsO4 was added and 
the reaction stirred for 10 minutes. NMO (0.7g, 6.0 mmol) was added and the reaction 
was stirred overnight. Sodium sulfite (12 equiv.) was added and the reaction was stirred 
for one hour. The reaction was diluted with brine and extracted with ethyl acetate. The 
organic layer was dried with Na2SO4 and the solvent was removed under reduced 
pressure providing the corresponding diol 3-14 as a white solid without the need for 
further purification; yield = 90% (1.37g, 4.5 mmol); Rf = 0.15, 50% EtOAc in hexanes; 
melting point: 119.8-120.2 °C. 
(±)-(3S,3aS,5R,6S,6aR)-ethyl 1-benzyl-5,6-
dihydroxyoctahydrocyclopenta[b]pyrrole-3-carboxylate (3-14) 
 
1H NMR (400 MHz, CDCl3) δ 7.34-7.27 (m, 5H), 4.36 (br s, 1H), 4.11 (qd, J = 7.1, 1.1 
Hz, 2H), 3.87, 3.52 (ABq, JAB = 13.0 Hz, 2H), 3.78 (br t, J = 3.3 Hz, 1H), 3.10 (dd, J = 
8.9, 6.4 Hz, 1H), 3.06-3.01 (m, 2H), 2.66-2.58 (m, 1H), 2.43 (dd, J = 10.9, 8.9 Hz, 1H), 
2.06-1.96 (m, 2H), 1.91 (br s, 1H), 2.03-1.98 (m, 2H), 1.83 (ddd, J = 13.5, 6.1, 2.4 Hz, 
1H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 173.7, 138.9, 128.9, 128.5, 
127.4, 77.3, 77.2, 74.0, 60.7, 59.4, 57.7, 50.1, 42.9, 36.7, 14.3; IR (cm-1) 3404, 3315, 
2966, 1734, 1100; HRMS (EI) m/z calc’d for C17H23NO4 305.1627 (M
+), found 
305.1628. 
Procedure for acetonide protection (3-15) 
Diol 3-14 (1.46g, 4.8 mmol) was placed in a round bottom flask under an argon gas 
atmosphere. DMF (40ml) was added followed by 2,2-dimethoxypropane (40ml). PPTS 
(1.20g, 4.8 mmol) was added and the reaction was warmed to 50 ˚C overnight. The 
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reaction was cooled to room temperature, diluted with water and extracted with ether. 
The organic extracts were washed with saturated NaHCO3, water, brine, dried with 
Na2SO4 and concentrated. Column chromatography eluting with EtOAc/hexanes 
provided the final product as a yellow oil; yield 92% (1.51g, 4.4 mmol); Rf = 0.31, 20% 
EtOAc in hexanes. 
(±)-(3aS,3bR,6S,6aS,7aR)-ethyl 4-benzyl-2,2-dimethyloctahydro-
[1,3]dioxolo[4',5':4,5]cyclopenta[1,2-b]pyrrole-6-carboxylate (3-15) 
 
1H NMR (600 MHz, CDCl3) δ 7.32-7.27 (m, 4H), 7.25-7.22 (m, 1H), 4.81 (t, J = 5.3 Hz, 
1H), 4.46 (d, J = 5.3 Hz, 1H), 4.13-4.09 (q, J = 7.1 Hz, overlapped with ABq, J = 13.3 Hz, 
3H), 3.27 (ABq, J = 13.4 Hz, 1H), 3.20 (dd, J = 9.6, 7.9 Hz, 1H), 3.10-3.06 (m, 1H), 3.01 
(d, J = 7.2 Hz, 1H), 2.68 (td, J = 8.2, 3.5 Hz, 1H), 2.42 (dd, J = 9.7, 8.5 Hz, 1H), 2.30 (dd, 
J = 13.9, 7.8 Hz, 1H), 1.81 (ddd, J = 14.4, 10.1, 4.8 Hz, 1H), 1.46 (s, 3H), 1.31 (s, 3H), 
1.23 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 174.6, 138.9, 128.7, 128.4, 
127.1, 110.0, 83.9, 83.0, 76.2, 60.8, 58.1, 57.4, 47.6, 45.3, 39.3, 26.9, 24.6, 14.3; IR (cm-
1) 2981, 1730, 1370, 1158, 1048, 700; HRMS (EI) m/z calc’d for C20H27NO4 345.1940 
(M+), found 345.1938. 
Procedure for Grignard addition (3-16) 
Starting material 3-15 (1.51g, 4.4 mmol) was placed in round bottom flask under an 
argon gas atmosphere. THF (37ml) was added and the reaction was cooled to 0 ˚C in an 
ice/water bath. MeMgBr (3.0M in diethyl ether, 7.2 ml, 21.8 mmol) was added dropwise 
over five minutes. The ice/water bath was removed, and the reaction was stirred at room 
temperature for 1.5 hours. The reaction was cooled back to 0 ˚C and slowly quenched 
with saturated ammonium chloride. The aqueous layer was extracted with ethyl acetate. 
The combined organic layers were washed with brine, dried with Na2SO4, and 
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concentrated to give 3-16 as a yellow oil without the need of any further purification; 
yield = 99% (1.43g, 4.3 mmol); Rf = 0.07, 30% EtOAc in hexanes. 
(±)-2-((3aS,3bR,6S,6aS,7aR)-4-benzyl-2,2-dimethyloctahydro-
[1,3]dioxolo[4',5':4,5]cyclopenta[1,2-b]pyrrol-6-yl)propan-2-ol (3-16) 
 
1H NMR (400 MHz, CDCl3) δ 7.20-7.25 (m, 4H), 7.23-7.18 (m, 1H), 4.77 (t, J = 5.1 Hz, 
1H), 4.42 (d, J = 5.1 Hz, 1H), 4.07, 3.14 (ABq, J = 13.3 Hz, 2H), 2.97 (dd, J = 9.4, 7.8 
Hz, 1H), 2.80 (d, J = 7.4 Hz, 1H), 2.74-2.67 (m, 1H), 2.22 (dd, J = 14.1, 8.2 Hz, 1H), 2.07 
(t, J = 9.4 Hz, 1H), 1.87-1.74 (m, 2H), 1.43 (s, 3H), 1.28 (s, 3H), 1.13 (s, 3H), 1.08 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ 139.2, 128.7, 128.3, 126.9, 109.7, 84.1, 83.4, 77.2, 
71.4, 58.4, 56.8, 54.9, 43.1, 40.8, 28.4, 27.9, 26.9, 24.6; IR (cm-1) 3493, 2973, 2928, 
1370, 1049; HRMS (EI) m/z calc’d for C20H29NO3 331.2147 (M
+), found 331.2145. 
Procedure for dehydration reaction (3-17a,b) 
Tertiary alcohol 3-16 (0.73g, 2.2 mmol) was placed in round bottom flask under an argon 
gas atmosphere. Benzene was added (31ml) followed by Burgess reagent (1.04g, 4.4 
mmol) and the reaction was stirred at 50 ˚C for two hours. The reaction was cooled to 
room temperature and the solvent was removed under reduced pressure. The product was 
purified by column chromatography eluting with EtOAc/hexanes providing (3-17a,b) as  
yellow oils; yield 3-17a = 50% (0.34g, 1.1 mmol), yield 3-17b = 22% (0.15g, 0.48 
mmol); Rf 3-17a = 0.53, Rf 3-17b = 0.66, 30% EtOAc in hexanes. 
(±)-(3aS,3bR,6R,6aS,7aR)-4-benzyl-2,2-dimethyl-6-(prop-1-en-2-yl)octahydro-
[1,3]dioxolo[4',5':4,5]cyclopenta[1,2-b]pyrrole (3-17a) 
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1H NMR (400 MHz, CDCl3) δ 7.31-7.28 (m, 4H), 7.25-7.22 (m, 1H), 4.81 (td, J = 5.1, 
1.2 Hz, 1H), 4.68-4.66 (m, 2H), 4.45 (d, J = 5.1 Hz, 1H), 4.09, 3.24 (ABq, J = 13.3 Hz, 
2H), 3.06 (dd, J = 9.4, 7.4 Hz, 1H), 2.95 (d, J = 7.8 Hz, 1H), 2.77-2.70 (m, 1H), 2.47-2.42 
(m, 1H), 2.25 (ddd, J = 14.1, 8.2, 1.2 Hz, 1H), 2.13 (t, J = 9.3 Hz, 1H), 1.84 (ddd, J = 
14.1, 9.4, 5.1 Hz, 1H), 1.69 (br s, 3H), 1.46 (s, 3H), 1.31 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 146.5, 139.2, 128.8, 128.3, 127.0, 109.9, 109.6, 84.6, 83.3, 76.6, 59.6, 58.5, 
51.0, 46.3, 39.9, 27.1, 24.8, 21.3; IR (cm-1) 3027, 2984, 1645, 1370, 1056; HRMS (EI) 
m/z calc’d for C20H27NO2 313.2042 (M
+), found 313. 2036. 
(±)-(3aS,3bR,6aS,7aR)-4-benzyl-2,2-dimethyl-6-(propan-2-ylidene)octahydro-
[1,3]dioxolo[4',5':4,5]cyclopenta[1,2-b]pyrrole (3-17b) 
 
1H NMR (600 MHz, CDCl3) δ 7.33-7.29 (m, 4H), 7.25-7.22 (m, 1H), 4.84 (t, J = 5.0 Hz, 
1H), 4.50 (d, J = 5.4 Hz, 1H), 4.14, 3.25 (ABq, J = 13.6 Hz, 2H), 3.54, 2.79 (ABq, J = 
13.4 Hz, 2H), 3.35-3.29 (m, 1H), 3.01 (d, J = 6.2 Hz, 1H), 2.55 (dd, J = 14.0, 7.7 Hz, 1H), 
1.78 (ddd, J = 14.2, 10.9, 4.7 Hz, 1H), 1.64 (s, 3H), 1.48 (s, 3H), 1.47 (s, 3H), 1.32 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ 139.4, 133.6, 128.5, 128.3, 126.9, 122.0, 109.6, 
83.9, 83.4, 76.9, 58.4, 58.0, 44.9, 37.9, 26.8, 24.4, 21.0, 20.8; IR (cm-1) 2979, 2931, 
1741, 1370, 1047; HRMS (EI) m/z calc’d for C20H27NO2 313.2042 (M
+), found 
313.2041. 
Procedure for the conversion of a benzyl group to a carbamate (3-18 and 3-23) 
92 
 
To a round bottom flask containing acetonide 3-17a (1 equiv.) under argon gas was 
added DCM (0.1M). The corresponding chloroformate (6 equiv.) was added and reaction 
was heated to 40 ˚C for 19 hours with ethyl chloroformate and 24 hours with benzyl 
chloroformate. The reaction was cooled to room temperature and the solvent was 
removed under reduced pressure. The product was purified by flash chromatography 
eluting with EtOAc/hexanes. 
(±)-(3aS,3bR,6R,6aS,7aR)-ethyl 2,2-dimethyl-6-(prop-1-en-2-yl)hexahydro-
[1,3]dioxolo[4',5':4,5]cyclopenta[1,2-b]pyrrole-4(3aH)-carboxylate (3-18) 
 
Reagents employed: Acetonide 3-17a (0.093g, 0.3 mmol), ethyl chloroformate (0.17ml, 
1.8 mmol), DCM (3ml): yield 92% (0.081g, 0.27 mmol) as an oil; Rf = 0.32, 30% EtOAc 
in hexanes; Full characterization can be found in the following published article143. 
(±)-(3aS,3bR,6R,6aS,7aR)-benzyl 2,2-dimethyl-6-(prop-1-en-2-yl)hexahydro-
[1,3]dioxolo[4',5':4,5]cyclopenta[1,2-b]pyrrole-4(3aH)-carboxylate (3-23) 
 
Reagents employed: Acetonide 3-17a (0.4964g, 1.6 mmol), benzyl chloroformate (1.4 
ml, 9.6 mmol), DCM (16ml): yield 89% (0.5108g, 1.4 mmol) as a white solid; Rf = 0.27, 
20% EtOAc in hexanes; melting point: 86.5-87.1 °C; 1H NMR (600 MHz, CDCl3) δ 
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7.44-7.29 (m, 5H), 5.30 (br d, J = 12.8 Hz, 1H), 5.15 (br s, 1H), 4.76 (br s, 1H), 4.69-4.58 
(m, 3H), 4.07 (d, J = 7.0 Hz, 1H), 3.64 (br d, J = 11.7 Hz, 1H), 3.57-3.52 (m, 1H), 2.93-
2.88 (m, 1H), 2.42 (br s, 1H), 2.16 (dt, J = 14.3, 7.5 Hz, 1H), 1.72 (br s, 3H), 1.68-1.60 
(m, 1H), 1.47 (br s, 3H), 1.29 (s, 3H); 13C NMR (100 MHz, CDCl3) mixture of rotamers; 
δ 155.0, 154.9, 145.8, 145.5, 137.1, 136.9, 128.6, 128.5, 128.2, 128.1, 127.8, 127.6, 
110.6, 110.5, 110.4, 86.4, 85.4, 81.2, 69.1, 68.4, 67.0, 66.9, 50.4, 50.0, 48.1, 47.4, 46.8, 
46.0, 36.6, 36.5, 26.9, 24.5, 21.5; IR (cm-1) 2937, 1696, 1648, 1411, 1357, 1205, 1059; 
HRMS (EI) m/z calc’d for C21H27NO4 357.1940, found 357.1935. 
Procedure for acetonide deprotection (3-24) 
Acetonide 3-23 (0.49g, 1.4 mmol) was dissolved in THF (7 ml) under an open 
atmosphere. Aqueous 1M HCl (7 ml) was added and the reaction was stirred at room 
temperature for 24 hours. The reaction was diluted with water and extracted with ethyl 
acetate, washed with saturated NaHCO3, brine and dried with Na2SO4. The solvent was 
removed under reduced pressure providing diol 3-24 as a white solid without the need for 
further purification; Yield = 97% (0.43g, 0.63 mmol); Rf = 0.19, 30% EtOAc in hexanes; 
melting point: 85.0-85.4 °C. 
(±)-(3R,3aS,5R,6S,6aR)-benzyl 5,6-dihydroxy-3-(prop-1-en-2-
yl)hexahydrocyclopenta[b]pyrrole-1(2H)-carboxylate (3-24) 
 
1H NMR (600 MHz, CDCl3) δ 7.40-7.32 (m, 5H), 5.15 (ABq, JAB = 12.3 Hz, 2H, ΔδAB = 
0.01), 4.92 (s, 1H), 4.79 (br s, 1H), 4.74 (br s, 1H), 4.27 (t, J = 3.9 Hz, 1H), 4.22 (dd, J = 
10.2, 7.2 Hz, 1H), 3.97 (dd, J = 7.2, 3.7 Hz, 1H), 3.81 (dd, J = 10.8, 7.3 Hz, 1H), 3.30 (t, J 
= 10.7 Hz, 1H), 2.92-2.87 (m, 1H), 2.85 (br s, 1H), 2.49 (td, J = 10.1, 7.3 Hz, 1H), 2.15 
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(dd, J = 14.6, 9.1 Hz, 1H), 1.70 (s, 3H), 1.62 (dt, J = 14.7, 5.2 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 156.8, 142.9, 136.3, 128.7, 128.3, 128.1, 111.8, 80.6, 75.9, 69.0, 67.5, 
53.4, 52.9, 43.4, 36.0, 20.7; IR (cm-1) 3433, 3344, 2932, 2891, 1678, 1424, 1355, 1149; 
HRMS (EI) m/z calc’d for C18H23NO4 317.1627 (M
+), found 317.1619. 
Procedure for the synthesis of protected β-allokainic acid dimethylester (3-25) 
Diol 3-24 (0.42g, 1.3 mmol) placed in a round bottom flask was dissolved in reagent 
grade DCM (13 ml) under an open atmosphere. Iodobenzene diacetate (0.50g, 1.6 mmol) 
was added in a single portion and stirred at room temperature for two hours. Solvent was 
removed under reduced pressure and the crude material was taken to the next step.  
Assuming full conversion, the crude di-aldehyde (0.41g, 1.3 mmol) was dissolved in tert-
butanol (93 ml) under an open atmosphere. 2-methyl-2-butene (0.55 ml, 5.2 mmol) was 
added followed by an aqueous mixture of sodium chlorite (0.30g, 3.4 mmol) and sodium 
phosphate monobasic monohydrate (0.43g, 3.1 mmol) in 14 ml of water using a glass 
pipette. The reaction was stirred at room temperature for 18 hours. Solvent was removed 
under reduced pressure and the residue was dissolved in 20 ml of 0.1M NaOH and 
extracted with DCM. The aqueous layer was acidified to pH 1 with concentrated HCl and 
extracted with ethyl acetate collecting in a different flask. The combined ethyl acetate 
layers were washed with brine and dried with Na2SO4. The solvent was removed 
providing the crude di-acid as a foamy white solid. The crude material was taken to the 
next step. 
The crude di-acid (0.36g, 1.0 mmol) was dissolved in a 2:5 mixture of methanol: toluene 
(6.2: 15.6 ml) under an atmosphere of argon. Trimethylsilyl diazomethane (2.0M in 
diethyl ether, 1.6 ml, 3.1 mmol) was added dropwise at room temperature. The reaction 
was stirred for 30 minutes and few drops of acetic acid was added until the bright yellow 
colour disappeared. Solvent was removed under reduced pressure. Residue was dissolved 
in methanol and washed with a small amount of HPLC grade hexanes. Methanol was 
removed under reduced pressure providing the product 3-25 (1:1 mixture of rotamers) as 
a pale-yellow oil. Yield 63% over three steps (0.29g, 0.78 mmol); Rf = 0.42, 30% EtOAc 
in hexanes. 
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(±)-(2R,3S,4R)-1-benzyl 2-methyl 3-(2-methoxy-2-oxoethyl)-4-(prop-1-en-2-
yl)pyrrolidine-1,2-dicarboxylate (3-25) 
 
1H NMR (600 MHz, CDCl3) 1:1 mixture of rotamers; δ 7.37-7.27 (m, 10H), 5.19-5.02 
(overlapped ABq, JAB = 12.4 Hz, 4H), 4.19 (dt, J = 7.9, 1.3 Hz, 2H), 4.85 (br d, J = 3.9 
Hz, 2H), 4.65 (d, J = 8.1 Hz, 1H), 4.61 (d, J = 8.3 Hz, 1H), 3.86-3.78 (m, 2H), 3.72 (s, 
3H), 3.69 (s, 3H), 3.68 (s, 3H), 3.58 (s, 3H), 3.36-3.26 (m, 2H), 2.92-2.82 (m, 2H), 2.79-
2.67 (m, 2H), 2.47 (t, J = 3.5 Hz, 1H), 2.43 (t, J = 3.5 Hz, 1H), 2.08-1.98 (m, 2H), 1.70 (s, 
3H), 1.68 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 171.88, 171.72, 171.66, 171.58, 
154.60, 153.99, 140.82, 140.76, 136.44, 136.40, 128.45, 128.37, 128.03, 127.93, 127.77, 
114.94, 114.90, 67.17, 67.05, 61.76, 61.49, 51.91, 51.86, 51.78, 51.77, 49.87, 49.54, 
49.20, 48.26, 40.73, 39.95, 33.34, 33.26, 18.51; IR (cm-1) 2952, 1738, 1702, 1412; 
HRMS (EI) m/z calc’d for C20H25NO6 375.1682 (M
+), found 375.1682. 
Procedure for the synthesis of β-allokainic acid (3-1d) 
Compound 3-25 (0.025g, 0.066 mmol) was dissolved in methanol (0.35ml) and 10M 
NaOH (0.6ml) and was heated to 100 °C for 14 hours. The reaction mixture was cooled 
to room temperature and washed with DCM. The aqueous layer was collected and 
Amberlite CG-50 (H+ form) was periodically added with stirring until the aqueous layer 
was neutralized. The mixture was filtered and concentrated. The resulting compound was 
then purified using Dowex 50WX8 resin (100-200 mesh, H+ form) eluting with 5% 
aqueous ammonia providing the final compound 3-1d in a 60% yield (8mg, 0.04 mmol) 
as an off-white solid with characterization matching the following references113,144.  
(±)-β-allokainic acid (3-1d) 
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1H NMR (600 MHz, D2O) δ 5.13 (s, 1H), 5.06 (s, 1H), 4.72 (d, J = 8.8 Hz, 1H), 3.78 (dd, 
J = 11.9, 8.2 Hz, 1H), 3.39 (dd, J = 11.9, 10.5 Hz, 1H), 3.04 (dtd, J = 11.4, 9.2, 4.9 Hz, 
1H), 2.88 (td), J = 10.9, 8.3 Hz, 1H), 2.77 (dd, J = 17.7, 5.1 Hz, 1H), 2.55 (dd, J = 17.7, 
9.7 Hz, 1H), 1.82 (s, 3H); 13C NMR (D2O, 100MHz) δ 175.7, 170.4, 139.7, 115.9, 61.5, 
48.5, 47.9, 39.6, 33.1, 17.6; HRMS (ESI) m/z calc’d for C10H15NO4 213.1001 (M
+), 
found 214.1079 (M+ + 1). 
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Chapter 4  
4 Lewis Acid Assisted Rearrangement of Dihydrofurans to 
Cyclopentenes 
This chapter is part of a manuscript that is in preparation: 
Piotrowski, M. L.; Kerr, M. A. Org Lett. 
4.1 Introduction 
Five-membered carbocycles are commonly found within a variety of bioactive 
molecules.47–51 Natural products (4-1a-c) and pharmaceuticals (4-2a-c) exemplify both 
the prevalence and importance of these scaffolds (Figure 4-1). Synthesizing these five-
membered rings has attracted the attention of the chemical community for many years. 
 
Figure 4-1. Bioactive natural products and pharmaceuticals containing a five-membered carbocycle 
Although the prevalence of cyclopentene scaffolds in bioactive molecules is limited 
compared to examples containing cyclopentanes, cyclopentenes serve as key 
intermediates towards saturated counterparts. The most common ways of synthesizing 
functionalized cyclopentenes are cycloaddition/annulation reactions148–151 and 
rearrangements.92,152–156 Rearrangement reactions constitute an important class of 
reactivity since they provide easy access to cyclopentenes in an atom-economic fashion. 
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There are only a few examples in the literature where heterocycles were rearranged to 
five-membered carbocycles. Funk et al. showcased a Ireland-Claisen rearrangement of 
lactones (4-3) forming carbocyclic compounds of various ring sizes.157 One example was 
the formation of a cyclopentane ring (4-4) (Scheme 4-1a). The Piancatelli rearrangement 
is a useful reaction for the conversion of 2-furylcarbinols (4-5) to 4-
hydroxycyclopentanones (4-6) under aqueous acid conditions (Scheme 4-1b).158,159 More 
recently, the work by Rovis showed a Lewis acid mediated [1,3]-ring contraction of 2,5-
dihydrooxepines (4-7) towards substituted cyclopentenes (4-8) (Scheme 4-1c).160 
 
Scheme 4-1. Rearrangements of heterocycles to five-membered carbocycles 
We recently reported the synthesis of a variety of dihydrofurans (4-12a) and 2,5-
dihydrooxepines (4-13) through the tandem cyclopropanation/Cloke-Wilson 
rearrangement or vinylogous variant respectively.133 Each of these heterocycles are easily 
manipulated to other useful compounds (4-12a,b), (4-14a,b) in a single transformation 
via Lewis acid or transition metal catalyzed reactions. We showcased these 
transformations in the synthesis of (±)-β-allokainic acid (see chapter 3) (4-15) (Scheme 4-
2).161 
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Scheme 4-2. Tandem cyclopropanation/(vinylogous)Cloke-Wilson rearrangement and subsequent 
transformations 
We were interested to see whether we could continue to find ways of forming other 
heterocyclic, or even carbocyclic compounds, through single step manipulations of the 
heterocycles obtained via our previous methodologies. After examining the various 
heterocycles synthesized, we noticed that dihydrofurans (4-12a) contain a 1,5-diene 
system which could potentially be utilized in a Claisen rearrangement or through an allyl 
cation intermediate to generate cyclopentenes. Herein, we report the rearrangement of 
dihydrofurans (4-16) to cyclopentenes (4-17) under Lewis acid catalysis and propose a 
mechanism for the transformation (Scheme 4-3). 
 
Scheme 4-3. Rearrangement of dihydrofurans to cyclopentenes 
4.2 Results and Discussion 
The dihydrofurans used in this study (Figure 4-2) were synthesized using our previously 
reported procedures. Dihydrofurans (4-16a, d-f, h) required an additional treatment with 
a Lewis acid to induce complete cyclization followed by filtration through a silica plug. 
Dihydrofuran (4-16k) was produced via a cross-metathesis reaction (see Experimental).  
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Figure 4-2. Dihydrofurans synthesized for cyclopentene formation. [a] additional treatment with a 
Lewis acid; overall yields as shown [b] formed via cross-metathesis  
Our study commenced by treating dihydrofuran (4-16b) with Sc(OTf)3 in DCM at 40 °C 
and to our delight we obtained cyclopentene (4-17b) in a quantitative yield with a 5:1 dr. 
However, when treating dihydrofuran (4-16a) under the exact same reaction conditions, a 
poor yield of cyclopentene (4-17a) was obtained due to a high amount of decomposition. 
Our optimization studies therefore commenced with dihydrofuran (4-16a) (Table 2). 
Table 2. Conditions tested for the rearrangement of dihydrofurans to cyclopentenes  
 
Entry Catalyst  Solvent Temp (° C) Yield % 
1 Sc(OTf)3 DCM 40 Trace 
2 Sc(OTf)3 DCM 25 No reaction 
3 Sc(OTf)3 DCE 60 Trace 
4 Sc(OTf)3 toluene 60 Trace 
5 Sc(OTf)3 toluene 110 Decomp. 
6 Sc(OTf)3 MeCN 60 Trace 
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7 Yb(OTf)3 DCM 40 Trace 
8 Yb(OTf)3 DCE 60 Trace 
9 Yb(OTf)3 toluene 60 Trace 
10 TiCl4 DCM 40 Decomp. 
11 BF3OEt2 DCM 40 Trace 
12 BF3OEt2 toluene 60 Trace 
13 Cu(OTf)2 DCM 40 Decomp. 
14 Al(OTf)3 DCM 40 Trace 
15 Sn(OTf)2 DCM 40 Trace 
16 Sc(OTf)3 HFIP 65 50% (2:1 dr) 
17 Sc(OTf)3 EtOH 65 No reaction 
18 BF3OEt2 HFIP 65 Decomp. 
19 BF3OEt2 HFIP 25 39% (2:1 dr) 
20 Yb(OTf)3 
(20mol%) 
HFIP 65 50% (2:1 dr) 
21 In(OTf)3 HFIP 65 69% (2:1 dr) 
22 In(OTf)3 HFIP 25 55% (2:1 dr) 
23 Sn(OTf)2 HFIP 65 72% (2:1 dr) 
24 Al(OTf)3 HFIP 65 83% (2:1 dr) 
25 Zn(OTf)2  HFIP 65 trace 
26 N/A HFIP 80 No reaction 
After screening a great deal of Lewis acids, solvents, and temperatures, the best 
conditions obtained in our hands was with the use of 10 mol% of Al(OTf)3 in refluxing 
hexafluoroisopropanol (HFIP) (entry 24) (Figure 4-3). Some key notes to mention: (1) 
except for the two electron rich examples (4-17b,c), the reaction gave poor results in any 
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solvent other than HFIP. (2) Cyclopentenes (4-17b,c) required milder conditions as 
mentioned in the experimental. (3) The mixture of cyclopropane/dihydrofuran that was 
obtained during the formation of (4-16a, d-f, h) can be treated under these optimized 
conditions to provide cyclopentenes (4-17a,d,f,h) with no change in yield. (4) 
Dihydrofuran (4-16l) was never isolated cleanly since both steps resulted in a mixture of 
inseparable products (note (3) was applied to cleanly obtain cyclopentene (4-17l)). (5) 
With the exception of cyclopentene (4-17k) the products are not stable to column 
chromatography as indications of regenerated starting material was seen implying that the 
reaction may be reversible. 
 
Figure 4-3. Formation of cyclopentenes. [a] the cyclopentenes can also be obtained from the 
cyclopropane/dihydrofuran mixture without going through pure dihydrofuran. [b] required milder 
conditions: DCM, 40 °C  
Interestingly, in (Figure 4-3), (4-17j) was not formed, however, extending the carbon 
chain resulted in cyclopentene (4-17k) albeit in low yield. Due to these reasons, we 
hypothesized that the rearrangement may be going through a step-wise mechanism 
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instead of a concerted [3+3] sigmatropic rearrangement (Scheme 4-4). Upon treatment 
with a Lewis acid, an allyl cation intermediate (4-18) may be generated. The allyl cation 
would undergo resonance (4-19) followed by an enolate-type cyclization generating the 
final cyclopentene products. Based on the proposed mechanism, cyclopentene (4-17j) 
was not formed because the rearrangement would require going from a tertiary to a 
primary carbocation. This mechanism also explains why the cyclopentenes containing 
aromatic groups worked so well since benzylic carbocations would be generated. HFIP is 
known to stabilize carbocations and could have positively impacted the transition state 
energy of the intermediates of this reaction162.   
 
 
Scheme 4-4. Proposed mechanism for cyclopentene formation. [a] Ruled out concerted mechanism. 
[b] Proposed step-wise mechanism involving an allyl cation intermediate followed by enolate-type 
cyclization   
With the completion of the rearrangements, we attempted improving the 
diastereoselectivity of the reaction and possibly provide kinetic resolution of the 
products. Both catalysts (Figure 4-4) have been reported in a variety of enolate addition 
reactions.163–167 Following literature procedures168,169, we synthesized [Sn(pybox)](OTf)2 
(4-20), since Sn(OTf)2 gave good results during the optimization process (see Table 2).  
104 
 
 
Figure 4-4. Chiral catalysts 
We tested this chiral catalyst under a variety of conditions and unfortunately, only 
starting material was isolated (Table 3). When using commercially available chiral 
phosphoric acid (R)-(-)-BDHP (4-21), we were excited to see the diastereoselectivity for 
cyclopentenes (4-17b,g) increase from 5:1 and 2.5:1 to 7:1 dr, but with a significant drop-
in yield. Treating the less electron-rich dihydrofuran (4-16a) resulted in no change in dr 
with a decrease in yield. We tested this rearrangement with chiral catalyst (4-21) using a 
variety of solvents and solvent mixtures containing HFIP, all of which resulted in no 
improvement in dr and poor yields. 
Table 3. Attempts at improving diastereoselectivity 
 
Catalyst (30 mol%) Solvent Temp (°C) Product Results 
[Sn(pybox)](OTf)2 HFIP 65 B No rxn 
[Sn(pybox)](OTf)2 DCM 40 B No rxn 
[Sn(pybox)](OTf)2 DCM/HFIP 65 B No rxn 
(R)-(-)-BDHP HFIP 65 B 50% (7:1dr) 
(R)-(-)-BDHP HFIP 65 C 50% (7:1dr) 
(R)-(-)-BDHP HFIP 65 A 35% (2:1dr) 
(R)-(-)-BDHP MeCN 65 A Trace 
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(R)-(-)-BDHP DCM 40 A Trace 
(R)-(-)-BDHP DCM/HFIP 65 A Trace 
To determine the relative stereochemistry of the major and minor diastereomers, we 
attempted to hydrogenate the sensitive cyclopentenes in the hopes of separating the 
diastereomers via column chromatography. Cyclopentenes (4-17b,c,f,k) were inseparable 
after hydrogenation and cyclopentene (4-17h) underwent dehalogenation under these 
conditions. However, a collection of separated diastereomers (4-22a-j) were isolated 
(Scheme 4-5). 
 
Scheme 4-5. Hydrogenation of cyclopentenes to cyclopentanes 
To determine the relative structural configuration of these products, experiments with 1H 
NMR such as NOE failed to yield conclusive results. However, reacting cyclopentane (4-
22b) with 2,4-DNPH (4-23) formed hydrazone (4-24) that was isolated as a crystal for X-
ray analysis (Scheme 4-6).  
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Scheme 4-6. Hydrazone formation 
Due to the similarities in 1H NMR of each major diastereomer, the resulting 
stereochemistry is tentatively assigned to each cyclopentene product (Figure 4-5). 
 
Figure 4-5. Determined stereochemistry for major diastereomer 
4.3 Conclusion 
In summary, we have synthesized functionalized cyclopentenes through the 
rearrangement of dihydrofurans in high yields and moderate diastereoselectivities. Based 
on the reaction yields and solvent studies, our proposed mechanism involves the 
formation of an ionic intermediate that undergoes an enolate type ring closure generating 
the desired cyclopentenes. The products obtained have useful functional handles that can 
provide access to more complex frameworks.  
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4.5 Experimental 
4.5.1 General Considerations 
All reactions were conducted under an atmosphere of argon unless otherwise indicated. 
DCM, toluene, and acetonitrile were dried and deoxygenated by passing the nitrogen 
purged solvents through activated alumina columns. All other solvents and reagents were 
used as purchased from Sigma Aldrich, Alfa Aesar, Caledon, VWR or Oakwood 
Chemicals and used as received. Reaction progress was followed by thin layer 
chromatography (TLC) (Merck, TLC silica gel 60 F254) visualized with UV light, and 
the plates developed with p-anisaldehyde, vanillin, basic potassium permanganate or 
DMP stains. Column chromatography was performed using silica gel (230-400 mesh, 
Silicycle Chemical Division Inc). 
NMR experiments were performed on Varian Mercury 400, Bruker AvIII 400, Inova 400 
and Inova 600 MHz instruments with 13C operating frequencies of 100, 100, 100, and 
150 MHz respectively. Chemical shifts are reported in ppm relative to the residual 
solvent signal; CDCl3, referenced to residual CHCl3 at δ = 7.26 for 1H and δ = 77.1 for 
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13C; d6-DMSO referenced at δ = 2.50 for 1H and δ = 39.5 for 13C. Coupling constants (J) 
are reported in Hz, and multiplicities of the signals are described using the following 
abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, quin = quintet, m = 
multiplet, br = broad. High resolution mass spectra (HRMS) were obtained on a Thermo 
Scientific DFS mass spectrometer using electron impact ionization. Melting points were 
determined using a Digimelt MPA160 melting point apparatus from Stanford Research 
Systems (SRS). Infrared spectra were obtained using a Bruker Alpha II Platinum ATR 
spectrometer or as thin films on NaCl plates using a Bruker Vector 33 FT-IR instrument 
and are reported in frequency of absorption (cm-1). The synthetic procedures for 
dihydrofurans can be found in our previous published work133 along with the following 
changes: 0.1 mol% of Rh2(esp)2 was used and a filtration through a silica plug eluting 
with EtOAc/Hexanes was required for the dihydrofurans (4-16a, d-f, h) that needed to be 
treated with Sc(OTf)3 to complete the cyclization in order to obtain good results for 
cyclopentene rearrangement. 
4.5.2 Experimental procedures and characterization data 
Synthesis of dihydrofuran (4-17k) 
Dihydrofuran (4-16j) (1 equiv.) was placed in flask with stir bar under an atmosphere of 
argon. Deoxygenated DCM (0.088M) was added followed by deoxygenated 1-hexene (5 
equiv.) that was distilled prior to use over CaH2. Grubbs second generation catalyst (4 
mol%) was added and the reaction was refluxed for 24 hours. The reaction was 
concentrated under reduced pressure and purified by column chromatography using 5 % 
EtOAc/Hexanes as the eluent providing dihydrofuran (4-16k) as an oil; yield 42% (0.12g, 
0.5 mmol); Rf = 0.27, 5% EtOAc/Hexanes. 
(E)-ethyl 5-(hex-1-en-1-yl)-5-methyl-4,5-dihydrofuran-3-carboxylate (4-16k) 
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1H NMR (400 MHz, CDCl3) δ 7.17 (t, J = 1.9 Hz, 1H), 5.69-5.57 (m, 2H), 4.15 (q, J = 
7.1 Hz, 2H), 2.80, 2.63 (ABq, JAB = 14.6 Hz, 2H); with each signal split into a doublet 
due to 4JCH = 1.9 Hz coupling with the methine proton), 2.03 (br q, J = 6.6 Hz, 2H), 1.45 
(s, 3H), 1.39-1.28 (m, 4H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
165.6, 155.4, 132.8, 129.9, 107.8, 90.9, 59.7, 40.2, 31.9, 31.3, 26.7, 22.2, 14.5, 14.0; IR 
(cm-1) 2928, 1702, 1623, 1155, 1100, 1053; HRMS (EI) m/z calc’d for C14H22O3 
238.1569 (M+), found 238.1571.  
 (E)-ethyl 5-(4-((tert-butyldimethylsilyl)oxy)styryl)-4,5-dihydrofuran-3-carboxylate 
(4-16g) 
 
Reagents employed: (E)-(4-(buta-1,3-dien-1-yl)phenoxy)(tert-butyl)dimethylsilane 
(0.32g, 1.24 mmol), formyldiazoacetate (0.35g, 2.48 mmol), Bis[rhodium(α,α,α′,α′-
tetramethyl-1,3-benzenedipropionic acid)] (1mg, 0.00124 mmol), DCM (10.5ml): yield 
51% (0.24g, 0.64 mmol) as a yellow oil; Rf = 0.37, 10% EtOAc/Hexanes; 1H NMR (400 
MHz, CDCl3) δ 7.28-7.26 (m, 3H), 6.81-6.78 (AA’BB’, 2H), 6.57 (d, J = 15.7 Hz, 1H), 
6.14 (dd, J = 15.8, 7.5 Hz, 1H), 5.35 (dt, J = 11.1, 8.1 Hz, 1H), 4.19 (q, J = 7.1 Hz, 2H), 
3.08 (ddd, J = 14.7, 10.5, 1.9 Hz, 1H), 2.72 (ddd, J = 14.7, 8.0, 1.8 Hz, 1H), 1.28 (t, J = 
7.1 Hz, 3H), 0.98 (s, 9H), 0.20 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 165.3, 156.4, 
156.1, 132.5, 129.3, 128.0, 125.3, 120.4, 108.9, 86.2, 59.9, 34.2, 25.8, 18.3, 14.5, -4.2; IR 
(cm-1) 2930, 1702, 1624, 1508, 1252, 1098; HRMS (EI) m/z calc’d for C21H30O4Si 
374.1913 (M+), found 374.1909. 
(E)-ethyl 5-(4-bromostyryl)-4,5-dihydrofuran-3-carboxylate (4-16h) 
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Reagents employed: (E)-1-bromo-4-(buta-1,3-dien-1-yl)benzene (0.27g, 1.29 mmol), 
formyldiazoacetate (0.36g, 2.58 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-
benzenedipropionic acid)] (1mg, 0.00129 mmol), DCM (10.5ml): yield 45% (0.19g, 0.59 
mmol) as an oil; Rf = 0.34, 10% EtOAc/Hexanes; Reagents employed: 
cyclopropane/dihydrofuran mixture (0.19g, 0.59 mmol), Sc(OTf)3 (0.014g, 0.029 mmol), 
DCM (5ml): yield 87% (0.16g, 0.51 mmol) as a white solid; Melting point: 38.5-39.8 
°C; Rf = 0.34, 10% EtOAc/Hexanes; 1H NMR (400 MHz, DMSO-d6) δ 7.55-7.52 (m, 
2H), 7.49-7.45 (m, 3H), 6.65 (d, J = 15.9 Hz, 1H), 6.48 (dd, J = 15.9, 6.9 Hz, 1H), 5.44 
(dt, J = 9.9, 7.3 Hz, 1H), 4.10 (q, J = 7.1Hz, 2H), 3.02 (ddd, J = 14.6, 10.6, 1.9 Hz, 1H), 
2.62 (ddd, J = 14.6, 7.9, 1.9 Hz, 1H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, 
DMSO-d6) δ 164.2, 156.6, 135.1, 131.5, 130.3, 128.9, 128.7, 121.1, 108.1, 84.8, 59.2, 
33.3, 14.3; IR (cm-1) 2979, 1699, 1618, 1127, 1097, 1071; HRMS (EI) m/z calc’d for 
C15H15BrO3 322.0205 (M
+), found 322.0192. 
(E)-ethyl 5-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-4,5-dihydrofuran-3-carboxylate (4-
16i) 
 
Note: compound may be light sensitive 
Reagents employed: (E)-5-(buta-1,3-dien-1-yl)benzo[d][1,3]dioxole (0.4g, 2.29 mmol), 
formyldiazoacetate (0.65g, 4.58 mmol), Bis[rhodium(α,α,α′,α′-tetramethyl-1,3-
benzenedipropionic acid)] (2mg, 0.00229 mmol), DCM (19.5ml): yield 47% (0.31g, 1.07 
mmol) as a yellow solid; Melting point 56.4-57.8 °C; Rf = 0.25, 25% EtOAc/Hexanes; 
1H NMR (600 MHz, CDCl3) δ 7.27 (t, J = 1.9 Hz, 1H), 6.93 (d, J = 1.8 Hz, 1H), 6.84-
6.82 (m, 1H), 6.76 (d, J = 8.0 Hz, 1H), 6.54 (d, J = 15.7 Hz, 1H), 6.10 (dd, J = 15.7, 7.4 
Hz, 1H), 5.96 (s, 2H), 5.34 (dddd, J = 10.5, 8.2, 7.4, 1.0 Hz, 1H), 4.19 (q, J = 7.1 Hz, 
2H), 3.08 (ddd, J = 14.7, 10.5, 1.9 Hz, 1H), 2.71 (ddd, J = 14.7, 8.0, 1.9 Hz, 1H), 1.28 (t, 
J = 7.1 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ 165.2, 156.3, 148.2, 147.9, 132.5, 130.4, 
125.6, 121.8, 108.9, 108.4, 106.0, 101.3, 86.0, 59.9, 34.2, 14.5; IR (cm-1) 2985, 1690, 
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1626, 1442, 1243, 1097, 1036; HRMS (EI) m/z calc’d for C16H16O5 288.0998 (M
+), 
found 288.1002. 
General procedure for the synthesis of cyclopentenes 
The starting dihydrofuran (1 equiv.) was placed in a round bottom flask under an 
atmosphere of argon. Hexafluoroisopropanol (0.12M) was added followed by Al(OTf)3 
(10 mol%) and the reaction was heated to 65 °C under reflux; (For dihydrofurans (4-
16b,c) mild conditions were required, DCM (0.12M) was used and heated to 40 °C for 30 
minutes). Once the dihydrofuran was fully consumed, the reaction was cooled to room 
temperature and concentrated under reduced pressure. The crude material was filtered 
through a silica plug eluting with the indicated mixture of EtOAc/Hexanes and 
concentrated under reduced pressure. 
(±)-Ethyl 1-formyl-2-phenylcyclopent-3-enecarboxylate (4-17a) 
 
Reagents employed: (E)-ethyl 5-styryl-4,5-dihydrofuran-3-carboxylate (4-16a) (0.32g, 
1.34 mmol), Al(OTf)3 (0.063g, 0.134 mmol), HFIP (11ml): yield 84% (0.28, 1.1 mmol) 
as a colourless oil; Rf = 0.52 and 0.44 for minor and major diastereomer respectively; 
filtered through silica plug using 10% EtOAc/Hexanes; 1H NMR (400 MHz, CDCl3) 
major diastereomer δ 9.78 (s, 1H), 7.33-7.27 overlap (m, 3H), 7.25-7.20 overlap (m, 3H), 
7.19-7.16 overlap (m, 3H), 5.93-5.90 (m, 1H), 5.70-5.64 overlap (m, 2H), 4.50-4.49 (m, 
1H), 3.71 (dq, J = 10.7, 7.1 Hz, 1H), 3.60 (dq, J = 10.8, 7.1 Hz, 1H), 3.28-3.20 overlap 
(m, 2H), 2.88-2.85 overlap (m, 1H), 2.84-2.82 overlap (m, 1H), 0.86 (t, J = 7.1 Hz, 3H); 
minor diastereomer δ 9.02 (s, 1H), 5.97-5.94 (m, 1H), 4.82-4.80 (m, 1H), 4.32-4.26 (m, 
2H), 1.32 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) mixture of diastereomers δ 
197.0, 196.8, 172.1, 169.2, 138.5, 137.3, 131.2, 131.0, 130.3, 129.7, 129.1, 129.0, 128.9, 
128.3, 127.8, 127.6, 69.4, 66.8, 62.1, 61.5, 58.6, 55.9, 36.1, 35.4, 14.3, 13.7; IR (cm-1) 
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2982, 1742, 1715, 1231, 698; HRMS (EI) m/z calc’d for C15H16O3 244.1099 (M
+), found 
244.1095. 
(±)-Ethyl 1-formyl-2-(4-methoxyphenyl)cyclopent-3-enecarboxylate (4-17b) 
 
Reagents employed: Dihydrofuran (4-16b) (0.1g, 0.36 mmol), Al(OTf)3 (0.017g, 0.036 
mmol), DCM (3ml): yield 100% (0.1g, 0.36 mmol) as a yellow oil; Rf = 0.48, 30% 
EtOAc/Hexanes; filtered through Celite plug; 1H NMR (600 MHz, CDCl3) major 
diastereomer δ 9.78 (s, 1H), 7.09-7.07 overlap (AA’BB’, 2H), 6.82-6.79 (AA’BB’, 2H), 
5.89-5.87 (m, 1H), 5.64-6.61 overlap (m, 1H), 4.45-4.44 (m, 1H), 3.77 (s, 3H), 3.74 (dq, J 
= 10.7, 7.1 Hz, 1H), 3.64 (dq, J = 10.7, 7.1 Hz, 1H), 3.22-3.17 overlap (m, 1H), 2.85-2.80 
overlap (m, 1H), 0.91 (t, J = 7.1 Hz, 3H); minor diastereomer δ 9.04 (s, 1H), 6.84-6.83 
(AA’BB’, 2H), 5.93-5.91 (m, 1H), 4.76-4.75 (m, 1H), 4.33-4.25 (m, 2H), 3.78 (s, 3H), 
1.31 (t, J = 7.1 Hz, 3H); 13C NMR (150 MHz, CDCl3) mixture of diastereomers δ 197.2, 
196.0, 172.2, 169.2, 159.2, 159.1, 131.3, 131.2, 130.3, 130.1, 130.0, 129.9, 129.4, 129.1, 
114.3, 113.6, 69.3, 66.6, 62.0, 61.4, 58.0, 55.38, 55.36, 55.31, 35.9, 35.1, 14.2, 13.7; IR 
(cm-1) 2957, 1741, 1716, 1510, 1241, 1032; HRMS (EI) m/z calc’d for C16H18O4 
274.1205 (M+), found 274.1200. 
(±)-Ethyl 2-(3,4-dimethoxyphenyl)-1-formylcyclopent-3-enecarboxylate (4-17c) 
 
Reagents employed: Dihydrofuran (4-16c) (0.1g, 0.33 mmol), Al(OTf)3 (0.015g, 0.033 
mmol), DCM (2.8ml): yield 100% (0.1g, 0.33 mmol) as a yellow oil; Rf = 0.35, 20% 
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EtOAc/Hexanes; filtered through a Celite plug; 1H NMR (400 MHz, CDCl3) δ 9.77 (s, 
1H), 6.78-6.66 (m, 3H), 5.88 (ddt, J = 5.8, 2.6, 1.9 Hz, 1H), 5.63 (dtd, J = 5.8, 2.5, 1.8 
Hz, 1H), 4.45 (apparent q, J = 2.4 Hz, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 3.76 (dq, J = 10.8, 
7.2 Hz, 1H), 3.66 (dq, J = 10.8, 7.1 Hz, 1H), 3.24-3.18 (m, 1H), 2.85-2.80 (m, 1H), 0.90 
(t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 195.8, 169.2, 148.6, 148.4, 131.4, 
130.9, 129.3, 121.3, 112.3, 110.8, 69.3, 61.4, 56.0, 55.9, 55.5, 35.3, 13.8; IR (cm-1) 2935, 
1742, 1715, 1590, 1232; HRMS (EI) m/z calc’d for C17H20O5 304.1311 (M
+), found 
304.1314. 
(±)-Ethyl 2-(4-fluorophenyl)-1-formylcyclopent-3-enecarboxylate (4-17d) 
 
Reagents employed: (E)-ethyl 5-(4-fluorostyryl)-4,5-dihydrofuran-3-carboxylate (4-16d) 
(0.1g, 0.38 mmol), Al(OTf)3 (0.018g, 0.038 mmol), HFIP (3.2ml): yield 79% (0.079g, 
0.30 mmol) as a oil; Rf = 0.4, 0.33, 10% EtOAc/Hexanes; filtered through a silica plug 
eluting with 10% EtOAc/Hexanes; 1H NMR (600 MHz, CDCl3) major diastereomer δ 
9.74 (s, 1H), 7.16-7.12 overlap (m, 4H), 6.97-6.94 (m, 2H), 5.90 (ddt, J = 5.7, 2.6, 1.9 
Hz, 1H), 5.64-5.61 overlap (m, 2H), 4.50 (apparent q, J = 2.4 Hz, 1H), 3.74 (dq, J = 10.7, 
7.2 Hz, 1H), 3.65 (dq, J = 10.8, 7.1 Hz, 1H), 3.24-3.18 overlap (m, 2H), 2.85-2.81 
overlap (m, 2H), 0.90 (t, J = 7.1 Hz, 3H); minor diastereomer  δ 9.02 (s, 1H), 7.00-6.97 
(m, 2H), 5.95-5.93 (m, 1H), 4.79 (apparent quin, J = 2.3 Hz, 1H), 4.28 (qd, J = 7.1, 4.8 
Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR mixture of diastereomers (150 MHz, CDCl3) 
δ 196.8, 195.4, 171.9, 169.0, 163.2, 163.1, 161.5, 161.4, 134.25, 134.23, 133.1, 133.0, 
131.1, 130.8, 130.7, 130.6, 130.52, 130.50, 130.4, 129.7, 115.8, 115.7, 115.1, 115.0, 69.2, 
66.7, 62.1, 61.5, 57.7, 54.8, 36.0, 35.4, 14.2, 13.7; 19F NMR mixture of diastereomers 
(564 MHz, CDCl3) δ -114.6, -115.0; IR (cm
-1) 2983, 1742, 1717, 1508, 1225; HRMS 
(EI) m/z calc’d for C15H15FO3 262.1005 (M
+), found 262.0998. 
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(±)-Ethyl 1-formyl-2-(o-tolyl)cyclopent-3-enecarboxylate (4-17f) 
 
Reagents employed: (E)-ethyl 5-(2-methylstyryl)-4,5-dihydrofuran-3-carboxylate (4-
16f) (0.03g, 0.12 mmol), Al(OTf)3 (6mg, 0.012 mmol), HFIP (1ml): yield 94% (0.028g, 
0.11 mmol) as a colourless oil; Rf  = 0.52, 0.44 for minor and major diastereomer 
respectively; filtered through silica plug using 10% EtOAc/Hexanes; 1H NMR (600 
MHz, CDCl3) major diastereomer δ 9.81 (s, 1H), 7.18-7.10 overlap (m, 5H), 7.07-7.04 
(m, 1H), 5.89 (ddt, J = 5.8, 2.7, 2.0 Hz, 1H), 5.89 (dtd, J = 5.7, 2.5, 1.8 Hz, 1H), 4.85 
(apparent q, J = 2.3 Hz, 1H), 3.68 (dq, J = 10.7, 7.1 Hz, 1H), 3.55 (dq, J = 10.8, 7.2 Hz, 
1H), 3.32-3.26 overlap (m, 2H), 2.85-2.84 overlap (m, 1H), 2.82-2.81 overlap (m, 1H), 
2.41 (s, 3H), 0.84 (t, J = 7.1 Hz, 3H); minor diastereomer δ 8.97 (s, 1H), 5.99-5.97 (m, 
1H), 5.62-5.60 (m, 1H), 5.04-5.03 (m, 1H), 4.29 (qd, J = 7.1, 1.8 Hz, 2H), 2.43 (s, 3H), 
1.31 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) mixture of diastereomers δ 197.0, 
196.6, 172.7, 169.4, 137.0, 136.9, 136.7, 135.4, 131.8, 131.5, 130.9, 130.3, 130.0, 129.0, 
128.8, 128.6, 127.7, 127.4, 126.6, 126.0, 69.2, 66.1, 62.5, 61.5, 54.6, 51.0, 36.2, 36.1, 
20.3, 20.1, 14.2, 13.5; IR (cm-1) 2981, 1742, 1715, 1231; HRMS (EI) m/z calc’d for 
C16H18O3 258.1256 (M
+), found 258.1246. 
(±)-Ethyl 2-(4-((tert-butyldimethylsilyl)oxy)phenyl)-1-formylcyclopent-3-
enecarboxylate (4-17g) 
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Reagents employed: dihydrofuran (4-16g) (0.055g, 0.14 mmol), Al(OTf)3 (7mg, 0.014 
mmol), HFIP (1.2ml): yield 89% (0.049g, 0.13 mmol) as an oil; Rf = 0.45, 0.34 for minor 
and major diastereomer respectively, 10% EtOAc/Hexanes; filtered through silica plug 
eluting with 10% EtOAc/Hexanes; 1H NMR (600 MHz, CDCl3) major diastereomer δ 
9.78 (s, 1H), 7.03-7.00 overlap (m, 3H), 6.75-6.72 (AA’BB’, 2H), 5.87 (ddt, J = 5.7, 2.5, 
1.9 Hz, 1H), 5.64-5.61 overlap (m, 1H), 4.42 (apparent q, J = 2.4 Hz, 1H), 3.74 (dq, J = 
10.8, 7.2 Hz, 1H), 3.64 (dq, J = 10.7, 7.2 Hz, 1H), 3.24-3.17 overlap (m, 2H), 2.85-2.79 
overlap (m, 2H), 0.97 (s, 9H), 0.92 (t, J = 7.2 Hz, 3H), 0.16 (s, 6H); minor diastereomer δ 
9.03 (s, 1H), 6.78-6.76 (AA’BB’, 2H), 5.93-5.90 (m, 1H), 4.74 (apparent quin, J = 2.2 
Hz, 1H), 4.32-4.24 (m, 2H), 1.31 (t, J = 7.1 Hz, 3H), 0.97 (s, 9H), 0.18 (s, 6H); 13C NMR 
(100 MHz, CDCl3) mixture of diastereomers δ 197.2, 196.0, 172.3, 169.2, 155.3, 155.2, 
131.3, 131.2, 131.0, 130.1, 130.0, 129.9, 129.8, 129.3, 120.5, 119.8, 69.3, 66.6, 62.0, 
61.4, 58.1, 55.4, 35.9, 35.1, 25.8, 25.7, 18.4, 18.3, 14.3, 13.8, -4.2, -4.3; IR (cm-1) 2930, 
1746, 1718, 1508, 1235; HRMS (EI) m/z calc’d for C21H30O4Si 374.1913 (M
+), found 
374.1910. 
(±)-Ethyl 2-(4-bromophenyl)-1-formylcyclopent-3-enecarboxylate (4-17h) 
 
Reagents employed: dihydrofuran (4-16h) (0.19g, 0.59 mmol) Al(OTf)3 (0.028g, 0.059 
mmol), HFIP (5ml): yield 77% (0.14g, 0.43 mmol) as a clear oil; Rf = 0.44, 0.37, 10% 
EtOAc/Hexanes, for minor and major diastereomer respectively; filtered through silica 
plug eluting with 10% EtOAc/Hexanes; 1H NMR (600 MHz, CDCl3) major diastereomer 
δ 9.73 (s, 1H), 7.40-7.37 (AA’BB’, 2H), 7.07-7.03 overlap (m, 3H), 5.90 (ddt, J = 5.8, 
2.6, 1.9 Hz, 1H), 5.62-5.60 overlap (m, 2H), 4.48 (apparent q, J = 2.3 Hz, 1H), 3.76 (dq, J 
= 10.8, 7.1 Hz, 1H), 3.66 (dq, J = 10.8, 7.1 Hz, 1H), 3.24-3.18 overlap (m, 2H), 2.85-2.81 
overlap (m, 2H), 0.90 (t, J = 7.1 Hz, 3H); minor diastereomer δ 9.02 (s, 1H), 7.43-7.41 
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(AA’BB’, 2H), 5.96-5.94 (m, 1H), 4.76 (apparent quin, J = 2.3 Hz, 1H), 4.28 (qd, J = 7.1, 
4.9 Hz, 2H), 1.30 (t, J = 7.1 Hz, 3H); 13C NMR mixture of diastereomers δ 196.5, 195.2, 
171.8, 168.9, 137.6, 136.4, 132.0, 131.3, 130.9, 130.83, 130.81, 130.6, 130.5, 130.0, 
121.8, 121.5, 69.2, 66.7, 62.1, 61.6, 57.8, 54.9, 36.1, 35.5, 14.2, 13.7; IR (cm-1) 2981, 
1742, 1715, 1487, 1230; HRMS (EI) m/z calc’d for C15H15BrO3 322.0205 (M
+), found 
322.0200. 
(±)-Ethyl 2-(benzo[d][1,3]dioxol-5-yl)-1-formylcyclopent-3-enecarboxylate (4-17i) 
 
Reagents employed: dihydrofuran (4-16i) (0.21g, 0.71 mmol), Al(OTf)3 (0.034g, 0.071 
mmol), HFIP (6ml): yield 87% (0.18g, 0.62 mmol) as a dark yellow oil; Rf = 0.27, 0.2 
for minor and major diastereomer respectively, 10% EtOAc/Hexanes; filtered through a 
silica plug eluting with 15% EtOAc/Hexanes; 1H NMR (400 MHz, CDCl3) major 
diastereomer δ 9.75 (s, 1H), 6.76-6.70 overlap (m, 2H), 6.67-6.63 overlap (m, 3H), 5.92 
(s, 2H), 5.90-5.87 (m, 1H), 5.63-5.60 overlap (m, 1H), 4.43 (apparent q, J = 2.4 Hz, 1H), 
3.82 (dq, J = 10.7, 7.2 Hz, 1H), 3.74 (dq, J = 10.8, 7.1 Hz, 1H), 3.25-3.15 overlap (m, 
2H), 2.85-2.79 overlap (m, 2H), 0.97 (t, J = 7.1 Hz, 3H); minor diastereomer δ 9.08 (s, 
1H), 5.94 (s, 2H), 4.73 (apparent quin, J = 2.1 Hz, 1H), 4.32-4.24 (m, 2H), 1.31 (t, J = 7.2 
Hz, 3H); 13C NMR (100 MHz, CDCl3) mixture of diastereomers δ 197.0, 195.8, 172.1, 
169.1, 148.2, 147.6, 147.2, 147.0, 132.1, 131.8, 131.3, 131.0, 130.3, 129.6, 122.4, 122.1, 
109.5, 109.1, 108.6, 108.0, 101.2, 101.1, 69.3, 66.6, 62.1, 61.5, 58.3, 55.5, 36.0, 35.2, 
14.3, 13.8; IR (cm-1) 2982, 1739, 1715, 1484, 1227, 1035; HRMS (EI) m/z calc’d for 
C16H16O5 288.0998 (M
+), found 288.0998. 
(±)-Ethyl 2-butyl-1-formyl-4-methylcyclopent-3-enecarboxylate (4-17k) 
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Reagents employed: dihydrofuran (4-16k) (0.03g, 0.12 mmol) Al(OTf)3 (5mg, 0.012 
mmol), HFIP (1ml): yield 37% (0.011g, 0.04 mmol) as an oil; Rf = 0.25, 5% 
EtOAc/Hexanes; required column purification eluting with 5% EtOAc/Hexanes; 1H 
NMR (400 MHz, CDCl3) major diastereomer δ 9.73 (s, 1H), 5.25-5.22 overlap (m, 1H), 
4.27-4.16 overlap (m, 3H), 3.38-3.33 (m, 1H), 2.95-2.84 overlap (m, 2H), 2.73-2.59 
overlap (m, 2H), 1.74 (s, 3H), 1.74-1.55 overlap (m, 1H), 1.40-1.23 overlap (m, 14H), 
0.93-0.86 overlap (m, 6H); minor diastereomer δ 9.67 (s, 1H), 3.09-3.05 (m, 1H), 1.72 (s, 
3H); 13C NMR (100 MHz, CDCl3) mixture of diastereomers δ 199.0, 197.4, 172.5, 170.4, 
138.7, 137.9, 125.5, 124.6, 67.8, 66.6, 61.6, 61.4, 53.8, 49.7, 40.2, 38.5, 31.4, 30.8, 29.8, 
22.9, 22.8, 16.5, 16.4, 14.3, 14.2, 14.1, 14.0; IR (cm-1) 2930, 1744, 1716, 1445, 1230; 
HRMS (EI) m/z calc’d for C14H22O3 238.1569 (M
+), found 238.1575. 
(±)-Ethyl 1-formyl-2-(naphthalen-2-yl)cyclopent-3-enecarboxylate (4-17l) 
 
Reagents employed: dihydrofuran/cyclopropane mixture (0.13g, 0.44 mmol), Al(OTf)3 
(0.021g, 0.044 mmol), HFIP (3.6ml): yield 75% (0.098g, 0.33 mmol) as an oil; Rf = 0.45, 
0.41 for minor and major diastereomer respectively, 10% EtOAc/Hexanes; filtered 
through a plug of silica eluting with 5% EtOAc/Hexanes; 1H NMR (400 MHz, CDCl3) 
major diastereomer δ 9.83 (s, 1H), 7.80-7.74 overlap (m, 4H), 7.65-7.7.64 overlap (m, 
1H), 7.48-7.42 overlap (m, 2H), 7.30-7.27 overlap (m, 1H), 5.98 (ddt, J = 5.7, 2.6, 1.9 
Hz, 1H), 5.77-5.71 overlap (m, 1H), 4.68 (apparent q, J = 2.4 Hz, 1H), 3.61 (dq, J = 10.8, 
7.1 Hz, 1H), 3.48 (dq, J = 10.8, 7.1 Hz, 1H), 3.35-3.28 overlap (m, 1H), 2.93-2.86 
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overlap (m, 1H), 0.70 (t, J = 7.1 Hz, 3H); minor diastereomer δ 6.03-6.01 (m, 1H), 4.98 
(apparent quin, J = 1.9 Hz, 1H), 4.36-4.26 (m, 2H), 1.33 (t, J = 7.1 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) mixture of diastereomers δ 196.9, 195.7, 172.2, 169.1, 136.0, 134.9, 
133.5, 133.3, 132.97, 132.90, 131.2, 131.0, 130.5, 129.9, 128.7, 128.0, 127.9, 127.88, 
127.85, 127.81, 127.78, 127.70, 127.1, 126.8, 126.4, 126.2, 126.0, 125.7, 69.5, 66.9, 62.1, 
61.5, 58.7, 55.9, 36.2, 35.5, 14.3, 13.5; IR (cm-1) 2981, 1740, 1715, 1231; HRMS (EI) 
m/z calc’d for C19H18O3 294.1256 (M
+), found 294.1254. 
General procedure for hydrogenation of cyclopentene 
Palladium on carbon (1 equiv.) was placed in round bottom flask with stir bar under 
house vacuum. Methanol (0.12M) was added and the flask was purged with hydrogen 
gas. The starting cyclopentene (1 equiv.) was dissolved in methanol (0.12M) under an 
atmosphere of argon and was added to the Pd/C mixture. The reaction was stirred for 
three hours, filtered through Celite and concentrated under reduced pressure. The crude 
material was purified by column chromatography eluting with the indicated 
EtOAc/Hexanes mixture. 
(±)-Ethyl 1-formyl-2-phenylcyclopentanecarboxylate (4-22a,b) 
 
Reagents employed: Cyclopentene (4-17a) (0.1g, 0.41 mmol), Pd/C (0.044g, 0.41 
mmol), methanol (7ml): crude yield (mixture of diastereomers) 95% (0.095g, 0.38 
mmol), isolated yield minor 16% (0.016g, 0.06 mmol) as an oil; Rf = 0.52, 10% 
EtOAc/Hexanes; isolated yield major 40% (0.04g, 0.16 mmol) as an oil; Rf = 0.44, 10% 
EtOAc/Hexanes; purified by column chromatography eluting with 2.5% to 5% 
EtOAc/Hexanes.  
120 
 
Data analysis for minor diastereomer (4-22a): 1H NMR (600 MHz, CDCl3) δ 9.27 (s, 
1H), 7.31-7.28 (m, 2H), 7.25-7.20 (m, 3H), 4.25 (qd, J = 7.1, 1.8 Hz, 2H), 3.88 (dd, J = 
11.5, 6.5 Hz, 1H), 2.58-2.53 (m, 1H), 2.10-2.05 (m, 1H), 2.01-1.94 (m, 3H), 1.87-1.81 
(m, 1H), 1.27 (t, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 200.0, 173.2, 137.5, 
128.7, 128.5, 127.4, 66.3, 61.7, 53.8, 31.3, 30.5, 24.0, 14.3; IR (cm-1) 2958, 1739, 1712, 
1248; HRMS (EI) m/z calc’d for C15H18O3 246.1256 (M
+), found 246.1257. 
Data analysis for major diastereomer (4-22b): 1H NMR (600 MHz, CDCl3) δ 9.83 (s, 
1H), 7.27-7.23 (m, 2H), 7.22-7.18 (m, 3H), 3.86 (dd, J = 10.7, 7.0 Hz, 1H), 3.76 (dq, J = 
10.7, 7.1 Hz, 1H), 3.64 (dq, J = 10.7, 7.2 Hz, 1H), 2.43 (ddd, J = 13.7, 10.6, 7.9 Hz, 1H), 
2.19-2.12 (m, 3H), 2.05-2.00 (m, 1H), 1.65-1.56 (m, 1H), 0.82 (t, J = 7.1 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 197.9, 171.1, 140.1, 128.6, 128.2, 127.0, 69.2, 61.2, 49.9, 
32.6, 31.4, 24.6, 13.6; IR (cm-1) 2959, 1711, 1223; HRMS (EI) m/z calc’d for C15H18O3 
246.1256 (M+), found 246.1249. 
(±)-Ethyl 2-(4-fluorophenyl)-1-formylcyclopentanecarboxylate (4-22c,d) 
 
Reagents employed: Cyclopentene (4-17d) (0.14g, 0.54 mmol), Pd/C (0.057g, 0.54 
mmol), methanol (9ml): crude yield (mixture of diastereomers) 94% (0.13g, 0.49 mmol), 
isolated yield minor 13% (0.019g, 0.07 mmol) as an oil; Rf = 0.44, 10% EtOAc/Hexanes; 
isolated yield major 24% (0.035g, 0.13 mmol) as an oil; Rf = 0.37, 10% EtOAc/Hexanes; 
purified by column chromatography eluting with 5% EtOAc/Hexanes. 
Data analysis for minor diastereomer (4-22c): 1H NMR (400 MHz, CDCl3) δ 9.27 (s, 
1H), 7.21-7.15 (m, 2H), 7.01-6.95 (m, 2H), 4.25 (q, J = 7.2 Hz, 2H), 3.85 (dd, J = 11.4, 
6.5 Hz, 1H), 2.54 (dt, J = 14.0, 8.0 Hz, 1H), 2.10-1.77 (m, 5H), 1.27 (t, J = 7.1 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 199.9, 173.0, 162.1 (d, 
1JCF = 246.1 Hz), 133.2 (d, 
4JCF = 
3.4 Hz), 130.0 (d, 3JCF = 7.9 Hz), 115.5 (d, 
2JCF = 21.1 Hz), 66.3, 61.8, 52.9, 31.5, 30.6, 
121 
 
23.9, 14.3; 19F{1H} (376 MHz, CDCl3) δ -115.2; IR (cm
-1) 2960, 1740, 1712, 1510, 
1224; HRMS (EI) m/z calc’d for C15H17FO3 264.1162 (M
+), found 264.1149. 
Data analysis for major diastereomer (4-22d): 1H NMR (400 MHz, CDCl3) δ 9.80, 7.20-
7.15 (m, 2H), 6.97-6.91 (m, 2H), 3.87 (dd, J = 10.3, 7.5 Hz, 1H), 3.79 (dq, J = 10.7, 7.1 
Hz, 1H), 3.68 (dq, J = 10.7, 7.1 Hz, 1H), 2.42 (ddd, J = 13.8, 10.7, 7.7 Hz, 1H), 2.17-2.08 
(m, 3H), 2.05-1.97 (m, 1H), 1.65-1.52 (m, 1H), 0.86 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 197.5, 171.1, 161.9 (d, 
1JCF = 245.2 Hz), 135.7 (d, 
4JCF = 3.3 Hz), 130.1 
(d, 3JCF = 7.9 Hz), 114.9 (d, 
2JCF = 21.2 Hz), 69.1, 61.3, 48.7, 32.7, 31.6, 24.5, 13.7; 
19F{1H} (376 MHz, CDCl3) δ -115.9; IR (cm
-1) 2960, 1712, 1510, 1220; HRMS (EI) m/z 
calc’d for C15H17FO3 264.1162 (M
+), found 264.1152.  
(±)-Ethyl 2-(benzo[d][1,3]dioxol-5-yl)-1-formylcyclopentanecarboxylate (4-22e,f) 
 
Reagents employed: cyclopentene (4-17i) (0.071g, 0.24 mmol), Pd/C (0.025g, 0.24 
mmol), methanol (4ml): crude yield (mixture of diastereomers) 90% (0.064g, 0.22 
mmol); isolated yield minor 15% (0.011g, 0.04 mmol) as an oil; Rf = 0.37, 5% 
EtOAc/Hexanes; isolated yield major 42% (0.03g, 0.1 mmol) as an oil; Rf = 0. 31, 5% 
EtOAc/Hexanes; purified by column chromatography eluting with 5% EtOAc/Hexanes. 
Data analysis for minor diastereomer (4-22e): 1H NMR (400 MHz, CDCl3) δ 9.31 (s, 
1H), 6.75-6.66 (m, 3H), 5.93 (s, 2H), 4.25 (qd, J = 7.1, 0.8 Hz, 2H), 3.81 (dd, J = 11.3, 
6.5 Hz, 1H), 2.53 (dt, J = 13.9, 8.0 Hz, 1H), 2.07-1.76 (m, 5H), 1.28 (t, J = 7.1 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 200.1, 173.2, 147.9, 146.8, 131.2, 121.5, 108.8, 108.3, 
101.9, 66.2, 61.7, 53.5, 31.5, 30.4, 23.9, 14.3; IR (cm-1) 2958, 1737, 1711, 1488, 1233; 
HRMS (EI) m/z calc’d for C16H18O5 290.1154 (M
+), found 290.1147. 
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Data analysis for major diastereomer (4-22f): 1H NMR (400 MHz, CDCl3) δ 9.81 (s, 
1H), 6.71-6.67 (m, 3H), 5.89 (s, 2H), 3.89-3.74 (m, 3H), 2.39 (ddd, J = 13.7, 10.4, 7.8 
Hz, 1H), 2.15-2.05 (m, 3H), 2.03-1.95 (m, 1H), 1.63-1.51 (m, 1H), 0.93 (t, J = 7.2 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 197.9, 171.2, 147.4, 146.5, 133.7, 121.7, 109.1, 
107.9, 101.0, 69.0, 61.3, 49.7, 32.7, 31.3, 24.3, 13.8; IR (cm-1) 2959, 1711, 1487, 1225; 
HRMS (EI) m/z calc’d for C16H18O5 290.1154 (M
+), found 290.1150. 
(±)-Ethyl 2-(4-((tert-butyldimethylsilyl)oxy)phenyl)-1-
formylcyclopentanecarboxylate (4-22g,h) 
 
Reagents employed: cyclopentene (4-17g) (0.093g, 0.25 mmol), Pd/C (0.027g, 0.25 
mmol), methanol (4ml): crude yield (mixture of diastereomers) 96% (0.09g, 0.24 mmol); 
isolated yield minor 19% (0.018g, 0.05 mmol) as an oil; Rf = 0.34, 5% EtOAc/Hexanes; 
isolated yield major 24% (0.023g, 0.06 mmol) as an oil; Rf = 0.28, 5% EtOAc/Hexanes; 
purified by column chromatography eluting with 5% EtOAc/Hexanes. 
Data analysis for minor diastereomer (4-22g): 1H NMR (600 MHz, CDCl3) δ 9.26 (s, 
1H), 7.06-7.04 (AA’BB’, 2H), 6.77-6.74 (AA’BB’, 2H), 4.24 (qd, J = 7.2, 5.9 Hz, 2H), 
3.81 (dd, J = 11.7, 6.6 Hz, 1H), 2.53 (dt, J = 13.8, 8.2 Hz, 1H), 2.06-2.01 (m, 1H), 2.00-
1.78 (m, 4H), 1.26 (t, J = 7.1 Hz, 3H), 0.97 (s, 9H), 0.18 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 200.4, 173.3, 154.9, 129.9, 129.4, 120.1, 66.2, 61.6, 53.3, 31.4, 30.3, 25.7, 23.9, 
18.3, 14.3, -4.2; IR (cm-1) 2955, 1741, 1715, 1509, 1226; HRMS (EI) m/z calc’d for 
C21H32O4Si 376.2070 (M
+), found 376.2061.  
Data analysis for major diastereomer (4-22h): 1H NMR (600 MHz, CDCl3) δ 9.83, 7.07-
7.04 (AA’BB’, 2H), 6.73-6.71 (AA’BB’, 2H), 3.81-3.77 (m, 2H), 3.66 (dq, J = 10.7, 7.2 
Hz, 1H), 2.39 (ddd, J = 13.7, 10.6, 7.9 Hz, 1H), 2.16-2.07 (m, 3H), 2.03-1.98 (m, 1H), 
1.62-1.53 (m, 1H), 0.96 (s, 9H), 0.89 (t, J = 7.2 Hz, 3H), 0.16 (s, 6H); 13C NMR (150 
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MHz, CDCl3) δ 198.1, 171.3, 154.7, 132.6, 129.5, 119.7, 69.1, 61.2, 49.5, 32.8, 31.3, 
25.8, 24.5, 18.3, 13.8, -4.3; IR (cm-1) 2931, 1741, 1714, 1510, 1252; HRMS (EI) m/z 
calc’d for C21H32O4Si 376.2070 (M
+), found 376.2063. 
(±)-Ethyl 1-formyl-2-(naphthalen-2-yl)cyclopentanecarboxylate (4-22i,j) 
 
Reagents employed: cyclopentene (4-17l) (0.09g, 0.31 mmol), Pd/C (0.032g, 0.31 
mmol), methanol (5ml): crude yield (mixture of diastereomers) 93% (0.085g, 0.28 
mmol); isolated yield minor 12% (0.011g, 0.04 mmol) as an oil; Rf = 0.45, 10% 
EtOAc/Hexanes; isolated yield major 45% (0.041g, 0.14 mmol) as an oil; Rf = 0.41, 10% 
EtOAc/Hexanes; purified by column chromatography eluting with 5% EtOAc/Hexanes. 
Data analysis for minor diastereomer (4-22i): 1H NMR (600 MHz, CDCl3) δ 9.27 (s, 
1H), 7.82-7.77 (m, 3H), 7.67 (br s, 1H), 7.49-7.44 (m, 2H), 7.34 (dd, J = 8.5, 1.9 Hz, 1H), 
4.27 (qd, J = 7.1, 1.9 Hz, 2H), 4.06 (dd, J = 11.6, 6.6 Hz, 1H), 2.62 (dt, J = 14.1, 8.4 Hz, 
1H), 2.19-2.13 (m, 1H), 2.11-2.02 (m, 3H), 1.93-1.85 (m, 1H), 1.27 (t, J = 7.1 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ 199.9, 173.2, 135.1, 133.4, 132.7, 128.3, 127.9, 127.7, 
127.2, 126.6, 126.4, 126.0, 66.5, 61.8, 53.9, 31.4, 30.7, 24.1, 14.3 IR (cm-1) 2957, 1738, 
1717, 1245; HRMS (EI) m/z calc’d for C19H20O3 296.1412 (M
+), found 296.1411. 
Data analysis for major diastereomer (4-22j) 1H NMR (600 MHz, CDCl3) δ 9.89 (s, 1H), 
7.79-7.77 (m, 2H), 7.74 (d, J = 8.5 Hz, 1H), 7.67 (br s, 1H), 7.46-7.41 (m, 2H), 7.34 (dd, 
J = 8.5, 1.8 Hz, 1H), 4.04 (dd, J = 10.8, 6.8 Hz, 1H), 3.68 (dq, J = 10.7, 7.1 Hz, 1H), 3.54 
(dq, J = 10.8, 7.2 Hz, 1H), 2.50 (ddd, J = 13.9, 10.5, 7.9 Hz, 1H), 2.33 (dtd, J = 12.5, 
10.8, 7.2 Hz, 1H), 2.23-2.18 (m, 2H), 2.10 (dddt, J = 12.7, 7.6, 5.3, 2.4 Hz, 1H), 0.64 (t, J 
= 7.1 Hz, 3H); 13C NMR (600 MHz, CDCl3) δ  197.9, 171.1, 137.5, 133.3, 132.6, 127.8, 
127.7, 127.6, 127.1, 127.0, 126.1, 125.7, 69.3, 61.2, 50.0 32.7, 31.65, 31.64, 24.6, 13.5; 
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IR (cm-1) 2958, 1711, 1225; HRMS (EI) m/z calc’d for C19H20O3 296.1412 (M
+), found 
296.1409. 
Procedure for the formation of hydrazone derivative 
Cyclopentane (4-22b) (0.11g, 0.45 mmol) was placed in a round bottom flask under an 
argon gas atmosphere. Absolute ethanol (7ml) was added followed by MgSO4 (0.13g, 1.1 
mmol) and the mixture was stirred. To the mixture was added 2,4-dinitophenylhydrazine 
(0.13g, 0.58 mmol) and the reaction was stirred for five hours. The reaction was 
concentrated under reduced pressure, re-dissolved in DCM, pre-absorbed onto silica and 
purified by column chromatography eluting with 10% EtOAc/Hexanes providing 
hydrazone (4-24) as a bright yellow solid; yield = 78% (0.15g, 0.35 mmol); Rf = 0.32, 
10% EtOAc/Hexanes; melting point = 133.5-134.8 °C. 
(±)-(1R,2R)-ethyl 1-((E)-(2-(2,4-dinitrophenyl)hydrazono)methyl)-2-
phenylcyclopentanecarboxylate (4-24)  
 
1H NMR (600 MHz, CDCl3) δ 11.15 (s, 1H), 9.15 (d, J = 2.5 Hz, 1H), 8.35 (dd, J = 9.6, 
2.6, 0.7 Hz, 1H), 7.98 (d, J = 9.5 Hz, 1H), 7.89 (br s, 1H), 7.30-7.27 (m, 2H), 7.25-7.22 
(m, 3H), 3.82-3.72 (m, 3H), 2.55 (ddd, J = 13.5, 9.3, 8.3 Hz, 1H), 2.41-2.35 (m, 1H), 
2.34-2.29 (m, 1H), 2.22-2.12 (m, 2H), 1.90-1.82 (m, 1H), 0.91 (t, J = 7.2 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 172.5, 153.1, 145.3, 139.9, 138.3, 130.2, 129.3, 128.4, 128.3, 
127.3, 123.6, 116.6, 61.6, 61.3, 54.5, 34.1, 32.0, 24.3, 13.8; IR (cm-1) 3277, 2954, 1716, 
1615, 1585, 1496, 1136; HRMS (EI) m/z calc’d for C21H22N4O6 426.1539 (M
+), found 
426.1544. 
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4.5.3 X-ray analysis data 
Experimental for C21H22N4O6 (b20024) 
Data Collection and Processing. The sample (b20024) was submitted by Mathew 
Piotrowski of the Kerr research group at the University of Western Ontario. The sample 
was mounted on a Mitegen polyimide micromount with a small amount of Paratone N 
oil. All X-ray measurements were made on a Bruker Kappa Axis Apex2 diffractometer at 
a temperature of 110 K. The unit cell dimensions were determined from a symmetry 
constrained fit of 9904 reflections with 4.96° < 2θ < 59.34°. The data collection strategy 
was a number of ω and φ scans which collected data up to 64.12° (2θ). The frame 
integration was performed using SAINT.   The resulting raw data was scaled and 
absorption corrected using a multi-scan averaging of symmetry equivalent data using 
SADABS.  
Structure Solution and Refinement. The structure was solved by using a dual space 
methodology using the SHELXT program.  All non-hydrogen atoms were obtained from 
the initial solution. The hydrogen atoms were introduced at idealized positions.  The 
carbon bound hydrogen atoms were allowed to ride on their parent carbon while the 
nitrogen bound hydrogen atoms were allowed to refine isotropically. 
Pseudo-symmetry.  The structure exhibits a high degree of pseudo-symmetry.  The 
structure was solved and refined as primitive monoclinic with a space group of P 21 
containing two symmetry independent molecules in the asymmetric unit (designated as A 
and B).  The structure can also be reasonably refined as primitive orthorhombic with a 
space group assignment of P na21 with one molecule in the asymmetric unit.  However, 
the systematic absences for the n and a glide planes exhibit numerous and significant 
violations.  There were 253 out of 1715 and 117 out of 416 reflections which had 
intensities above 3σ(I)/I for the n and a glide planes absences respectively.  For this 
reason, the lower symmetry structure was chosen.  It is necessary to note that the 
ADDSYM (missing symmetry) routine in PLATON  gives a 100% match for a P na21 
structure. 
126 
 
The structural model was fit to the data using full matrix least-squares based on F2.  The 
refinement model included twinning by pseudo-merohedry.  The twin law, a mirror plane 
across the (100), was derived by the COSET program.   One of the nitro groups on each 
of the symmetry independent molecules exhibits a disorder which leads to two distinct 
positions for one of the oxygen atoms.  For the A molecule the occupancy of the 
predominant conformer was 0.62(8) while for the B molecule the predominant conformer 
had an occupancy of 0.532(15).  The calculated structure factors included corrections for 
anomalous dispersion from the usual tabulation. The structure was refined using the 
SHELXL program from the SHELX suite of crystallographic software.  Graphic plots 
were produced using the Mercury program suite.   Additional information and other 
relevant literature references can be found in the reference section of this website 
(http://xray.chem.uwo.ca). 
1  .  Bruker-AXS, SAINT  version 2013.8, 2013, Bruker-AXS, Madison, WI 53711, USA  
2 .  Bruker-AXS, SADABS version 2012.1, 2012, Bruker-AXS, Madison, WI 53711, USA 
3 .  Sheldrick, G. M., Acta Cryst. 2015, A71, 3-8 
4 .  Spek, A. L., J. Appl. Cryst., 2003, 36, 7-13 
5   Boyle, P. D. J. Appl. Cryst., 2014, 47, 467-470 
6 .  Sheldrick, G. M., Acta Cryst. 2015, C71, 3-8 
7 .  Macrae, C. F.; Bruno, I. J.; Chisholm, J. A.; Edington, P. R.; McCabe, P.; Pidcock, E.;    
Rodriguez-Monge, L.; Taylor, R.; van de Streek, J. and Wood, P. A. J. Appl. Cryst., 2008, 41, 466-470 
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Table 4. Summary of crystal data for b20024 
Formula C21H22N4O6 
Formula Weight (g/mol) 426.42 
Crystal Dimensions (mm ) 0.423 × 0.268 × 0.043 
Crystal Color and Habit yellow plate 
Crystal System monoclinic 
Space Group P 21 
Temperature, K 110 
a, Å 9.2001(19) 
b, Å  6.1392(14) 
c, Å  36.280(9) 
a,° 90 
Figure 4-6. ORTEP drawing of b20024 molecule B showing naming and numbering scheme.  
Ellipsoids are at the 50% probability level and hydrogen atoms were drawn with arbitrary radii for 
clarity.  The disordered oxygen position is designated as O4B’. 
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b,° 90.137(11) 
g,° 90 
V, Å3 2049.1(8) 
Number of reflections to determine final unit cell 9904 
Min and Max 2q for cell determination, ° 4.96, 59.34 
Z 4 
F(000) 896 
r (g/cm) 1.382 
l, Å, (MoKa) 0.71073 
m, (cm-1) 0.103 
Diffractometer Type Bruker Kappa Axis Apex2 
Scan Type(s) phi and omega scans 
Max 2q for data collection, ° 64.12 
Measured fraction of data 0.999 
Number of reflections measured 55522 
Unique reflections measured 12633 
Rmerge 0.0566 
Number of reflections included in refinement 12633 
Cut off Threshold Expression I > 2sigma(I) 
Structure refined using full matrix least-squares using F2 
Weighting Scheme w=1/[sigma2(Fo2)+(0.0471P)2+0.85
26P] where P=(Fo2+2Fc2)/3 
Number of parameters in least-squares 582 
R1 0.0548 
wR2 0.1154 
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R1 (all data) 0.0722 
wR2 (all data) 0.1239 
GOF 1.034 
Maximum shift/error 0.000 
Min & Max peak heights on final DF Map (e-/Å) -0.325, 0.278 
Where: 
R1 = ( |Fo| - |Fc| ) /  Fo 
wR2 = [ ( w( Fo2 - Fc2 )2 ) / (w Fo4 ) ]½ 
GOF = [ ( w( Fo2 - Fc2 )2 ) / (No. of reflns. - No. of params. ) ]½ 
 
 
 
 
130 
 
Chapter 5  
5 Future Work and Summary 
5.1 Future work 
The use of formyldiazoacetate (5-1) towards the synthesis of DA cyclopropane (5-2) can 
offer novel and underexplored reactivity that can generate compounds of high synthetic 
interest. DA cyclopropane (5-2) can be obtained in modest yields under metal carbenoid 
conditions. Azomethine ylides could be formed via condensation between the aldehyde 
on the cyclopropane (5-2) and an amine (5-3). Upon heating, this would result in a 
decarboxylation generating the desired ylide (5-4) followed by ring-opening of the 
cyclopropane forming various tetrahydropyridine derivatives (5-5) (Scheme 5-1)170.  
 
Scheme 5-1. Generation of aldehyde/ester DA cyclopropane and subjecting it to azomethine ylide 
formation/ring-opening forming tetrahydropyridine derivatives 
Anionic oxy-Cope rearrangements could also be explored with DA cyclopropane (5-2). 
Reacting cyclopropane (5-2) with allylmagnesium bromide would generate allyl alcohol 
(5-6). Deprotonating the alcohol with KH in the presence of 18-crown-6, an oxy-Cope 
rearrangement would occur, resulting in ring-opened products such as (5-7). A one-pot 
procedure to functionalized cyclopentanes could be possible as well. Instead of isolating 
the ring-opened product (5-8), a palladium mediated cyclization (5-9) in the presence of 
aryl or alkenyl halides followed by a reductive elimination (5-10) would furnish 
cyclopentane compounds (5-11) (Scheme 5-2)171,172. 
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Scheme 5-2. Anionic oxy-Cope rearrangement of DA cyclopropane and possible one-pot procedure to 
functionalized cyclopentanes 
Recently, treatment of DA cyclopropane (5-2) with phenylhydrazine (5-12) forming 
hydrazone derivatives (5-13) has been shown to provide tetrahydropyridazines (5-14) in 
moderate to good yields173,174 (Scheme 5-3). The conditions that provided the best results 
thus far is with the use of 10 mol% of Al(OTf)3 in refluxing DCM. Further conditions 
need to be tested in order to improve the yields, more examples need to be synthesized, 
and the stereochemistry around the tetrahydropyridazine ring needs to be determined. 
 
Scheme 5-3. Intramolecular ring-opening of hydrazone derived cyclopropanes to 
tetrahydropyridazines 
5.2 Summary 
The work presented within this thesis describes new ways of synthesizing sought after 
heterocycles and carbocycles such as pyrrolidines, dihydropyrroles, dihydrofurans, 
cyclopentenes, and dihydrooxepines. Beginning with the (vinylogous) Cloke-Wilson 
rearrangement, the required vinylcyclopropyl aldehyde (5-16) was obtained in a single 
step which underwent spontaneous rearrangement in situ to either dihydrofurans (5-17) or 
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2,5-dihydrooxepines (5-18) depending on the 1,3-diene system used (5-15). Each of the 
heterocycles synthesized were capable of being transformed to other dihydrofuran 
derivatives (5-17, 5-19), dihydropyrroles (5-20, 5-21) or cyclopentenes (5-22) with 
careful choice of solvent, temperature, and catalyst (Figure 5-1). 
 
Figure 5-1. Synthesis of dihydrofurans and 2,5-dihydrooxepines via (vinylogous)-Cloke-Wilson 
rearrangement and subsequent transformations to dihydrofurans, dihydropyrroles and 
cyclopentenes 
With the successful formation of dihydropyrroles, one of the scaffolds (5-23) caught our 
attention as it was deemed a viable synthetic precursor to target kainic acid. This natural 
molecule possesses important biological properties such as neuroexcitatory and 
excitotoxic activities that were used to create model conditions for the better 
understanding of common human neurological disorders. However, due to 
stereochemical constraints, one of the less active isomers of kainic acid, β-allokainic acid 
(5-27) was synthesized instead (Figure 5-2).  
133 
 
 
Figure 5-2. Synthetic route towards (±)-β-allokainic acid 
The synthesis of cyclic systems will always dominate organic chemistry literature. 
Numerous bioactive natural products and pharmaceuticals contain the abovementioned 
cyclic systems as well as many others not mentioned within this dissertation. Therefore, 
discovering new methodologies towards carbocycles and heterocycles is of value in the 
synthetic community. The reader may ask themselves who cares about this “random” 
heterocyclic or carbocyclic compound and why is it important? The ability to easily 
synthesize sought after structural motifs, such as pyrrolidines and cyclopentenes, but also 
new and underexplored heterocycles or carbocycles can have great potential in 
pharmaceutical industries. Unknowingly, these types of academic discoveries can 
potentially result in new lead compounds to combat various diseases. 
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